Controlling the structure of peptide using ferrocene as a molecular scaffold by Chowdhury, Somenath
Controlling the Structure of Peptide Using Ferrocene as a Molecular 
Scaffold  
 
A Thesis Submitted to the College of 
Graduate Studies and Research 
in Partial Fulfillment of the Requirements 
for the Degree of Doctorate of  Philosophy  
in the Department of Chemistry 
University of Saskatchewan 
 
Saskatoon 
 
 
 
By 
 
Somenath Chowdhury 
 
   © Copyright Somenath Chowdhury, April 2007. All rights reserved. 
PERMISSION TO USE 
Presenting this thesis in partial fulfillment of the requirements for a degree of 
Doctorate of Philosophy from the University of Saskatchewan, I agree that the 
libraries of this university may make it available for inspection. I further agree that 
permission for copying of this thesis in any manner, in whole or in part, for scholarly 
purposes may be granted by the professor or professors who supervised my thesis 
work or, in their absence, by the Head of the Department of Chemistry or the Dean of 
the College of Graduate Studies and Research. It is understood that any copying or 
publication or use of this thesis or parts thereof, for financial gain shall not be 
allowed without my written permission. It is also understood that due recognition 
shall be given to me and to the University of Saskatchewan in any scholarly use 
which may be made of any material in this thesis.  
            Requests for permission to copy or to make other use of material in this thesis 
in whole or part should be addressed to:  
 
Head of the Department of Chemistry 
University of Saskatchewan 
Saskatoon, Saskatchewan, 
S7K 5C9 
 
 
 
 
 i
ABSTRACT 
The de novo design of peptides is a central area of research in chemical biology. 
Although it is now possible to design helical peptide structures from first principle, 
designing β-sheets remains a challenge. Significant advances in this area have been 
made by using molecular scaffolds, which stabilize β-sheets through intramolecular H-
bonding involving the scaffold or which direct supramolecular assembly of the 
conjugate. In my thesis, I have made use of novel strategies, using ferrocene (Fc) as a 
central scaffold for controlling the secondary structure of peptides. This approach has 
been highly successful. Four major new strategies are introduced and described in this 
thesis:  
a) Cyclization of Fc-peptide conjugates of the type Fc[CO-Xxx-CSA]2 (Xxx = Gly, Ala, 
Val, Leu) and Fc[CO-Gly-Xxx-CSA]2 (Xxx = Val, Ile; CSA = cysteamine) leads to the 
clean formation of novel cyclic bioorganometallic conjugates, which exhibit strong 
intramolecular hydrogen bonding interactions that restrict the mobility of the podand 
peptide chains. In the latter system, this intermolecular hydrogen bonding interaction 
was exploited for the design of a novel β-barrel-like structure. For Fc[CO-Gly-Val-
CSA]2 and Fc[CO-Gly-Ile-CSA]2 discrete cyclic supramolecular assemblies were 
formed in which the individual molecules assemble along the rims of the molecules, 
resulting in the formation of tubular peptide superstructures that possess a central cavity 
and are filled with water molecules.  
b) Prior to my work, work by Hirao and Metzler-Nolte clearly showed that the two 
podand peptide chains in Fc-peptide conjugates are pointing away from each other. This 
would indicate that extended β-sheets cannot be formed by simply extending the podand 
peptide chains. In my work, I clearly demonstrate that, in contrast to earlier results, it is 
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possible to use the Fc scaffold to stabilize β-sheet-like interactions in longer peptide 
chains. Two systems are described in this thesis Fc[CO-Gly-Val-Cys(Bz)-OMe]2 and 
Fc[CO-Gly-Ile-Cys(Bz)-OMe]2. In both the cases, amino acids are employed that have a 
high propensity for β-sheet formation. Both Fc-peptide conjugates exhibit strong 
interstrand hydrogen bonding, resembling that found in β-sheets. 
c) In this work, I have demonstrated the use of ferrocene amino acid (Fca) to control the 
structure in peptides. In contrast to previous work by Metzler-Nolte, my work is largely 
focusing on the design of a repetitive Fca-peptide motif. It is proposed that this 
repetition will enable strong interactions between the peptide portions of the conjugate, 
resulting in the formation of an extended structure. To this effect, a series of Fca-
conjugates of the type Boc-[Fca-Ala]n-OMe (n = 1-4) was synthesized and fully 
characterized. All systems display the expected interaction between the Ala residues 
having a 12-membered hydrogen bonded ring. Such a structural motif resembles that 
found in naturally occurring β-helical structures of the spike-region of some viral 
proteins.  
d) I have also demonstrated the use of a novel Fc-derivative, Fc[NH-Boc]2, to control 
the structure of podand amino acid chains. Fc-diamine was synthesized by the 
convenient carbazide route giving this useful scaffold in high yield. This material was 
converted into its peptide conjugate and the resulting conjugate displays the elusive 14-
membered hydrogen bonding ring.  
Thus, in my work, I have provided a new complementary tool for peptide design 
that will undoubtedly find applications for the design of de novo proteins in the near 
future.  
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Chapter 1 
Introduction 
1.1. General 
Motivated by the important roles played by the specific secondary structural 
domains of proteins, enormous efforts have been devoted to the design of structurally 
well-defined synthetic peptides. These investigations are aimed at gaining a deeper 
understanding of the mechanism of protein folding and of biochemical processes,[1] 
generating molecules with potential biological applications,[2] and developing novel 
materials.[3] Various strategies have been exploited to design the controlled structures of 
peptides such as cyclization,[4] insertion of β-amino acids,[5] disulfide bonds,[6] D-amino 
acids,[7] or molecular scaffold in the peptide backbone.[8]
In this respect, ferrocene (Fc) has recently been recognized for its ability to 
induce secondary structures and supramolecular arrangements to its peptide 
conjugates.[9] Along with its ability to function as a molecular scaffold, Fc has fully 
reversible electrochemical behavior. The combination of these two inherent properties 
can enable preparation and the investigation of various electrochemical properties and 
molecular recognition behavior of specific structural peptides.[10,11] On the basis of these 
characteristics, this present work details the use of Fc as a molecular scaffold to design 
some structural peptides. 
Before proceeding to the details of my research, I would like to briefly highlight 
the background and give a concise overview of this research area.  
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1.2. Structures of Peptides  
Proteins and peptides play a crucial role in biological systems for the 
maintenance of biochemical and biophysical activities. They are primarily the 
copolymers of twenty DNA coded amino acids. The difference in structure and function 
of various proteins and peptides arises from the variation of their amino acid sequence.  
H2N
N
N
O
O
O
N
OH
OR3
R2 R4
R1 H
H
H
 
 
Figure 1.1. Primary structure of peptides containing four amino acids in the sequence. 
R1, R2, R3 and R4 represent the side groups of the amino acids.  
 
 
 A peptide contains two or more (generally up to fifty) amino acids linked by amide 
bonds, which are so called peptide bonds. Figure 1.1 illustrates the primary structure of a 
tetrapeptide. Peptides can adopt characteristic, well-organized three dimensional 
structures that are closely linked to their biological functions. A particular protein folds 
 
 
 
 
Figure 1.2. Bond angles and bond distances of a typical peptide backbone. Φ, Ψ and ω 
are the dihedral angels, which are the determining factors of the peptide secondary 
structures.[12]
 
 2
in a distinct manner under physiological conditions to perform a specific function. In the 
folded state, various well-defined local structural domains are present in the peptide 
backbone. These secondary structures are helical, sheet-like and turn-like. A certain 
secondary structural element possesses specific torsion angles about the Cα, Φ (Cα-N) 
and Ψ (Cα-C) as shown in Figure 1.2. The torsion angles of some common peptide 
secondary structures are presented in Table 1.1.[12]  
 
Table 1.1. Parameters of some regular sheet and helical peptide structures [12]
 
  
Bond angle / º 
 Φ Ψ ω 
 
Residues 
per turn 
 
Translation 
per residue /Å 
 
 
Antiparallel β-sheet 
 
-139 
 
135 
 
-178 
 
2.00 
 
3.40 
Parallel β-sheet -119 113 180 2.00 3.20 
Right-handed α-helix -57 -47 180 3.60 1.50 
310-helix -49 -26 180 3.00 2.00 
π-helix -57 -70 180 4.40 1.15 
Polyproline I -83 158 0 3.33 1.90 
Polyproline II -78 149 180 3.00 3.12 
Polyglycine II -80 150 180 3.00 3.10 
Left-handed α-helix 57 47 -180 3.60 1.50 
 
 
Among the secondary structures, the helix is the most abundant. In a helix, the 
peptide backbone is arranged in a spiral fashion. Figure 1.3a depicts the structure of a 
typical α-helical peptide together with the H-bonding pattern of other helical structures. 
Depending upon the amino acid sequence and other external factors different helices can 
be formed, each with a specific set of dihedral angles (Φ , Ψ and ω) pitch length and a 
number of amino acid residues per turn (Table 1.1). The H-bonding pattern differs 
between helical types. For example, in a 310-helix, H-bonding occurs between the C=Oi 
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and NHi=2, in an α-helix, it is between C=Oi and NHi=3 and in a π-helix between C=Oi 
and NHi=4 etc. as shown in Figure 1.3b. Both left-handed and right-handed helices can 
occur that are best described respectively as M- and P-helical conformations. The 
different helices also vary in their H-bonding pattern, where the notation nm is used to 
specify the helix, with n being the number of amino acid residues per turn and m being 
the H-bonded ring size. The most common helical structure is the α-helix, which has a 
pitch length of 5.4 Å, 3.6 amino acid residues per turn and a 13-membered H-bonding 
ring. According to the nm notation it can be designated as a 3.613-helix. 
 (a) 
 
                                               
 
 
 
 
 
(b) 
 
 
 
      
Figure 1.3. (a) Typical structure of a part of an α-helical peptide backbone, showing its 
spiral conformation and the hydrogen bonding. Grey spheres indicate the side groups of 
the amino acids. (b) Various H-bonding patterns in different helical peptides.[12]
 
The second most common secondary structural element is the β-sheet, in which 
the peptide backbone is a highly extended strand and stabilized by H-bonding with 
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another laterally aligned and extended peptide strand. These strands can be parallel or 
antiparallel to the N- and C-terminals, and correspondingly they are called parallel β-
sheet or antiparallel β-sheet. Figure 1.4 illustrates the structures of typical β-sheet 
peptides and their H-bonding patterns. 
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Figure 1.4. Structural drawings of β-sheet peptides: (a) parallel β-sheet peptides have 
12-membered H-bonded rings; (b) Antiparallel β-sheet peptides have a series of 
alternative 10- and 14-membered H-bonded rings.[12] 
 
 
To align secondary structural elements into a tertiary structure, they must be 
connected by some linkers, such as turns (Figure 1.5). Unlike helices and sheets, turns 
are aperiodic in nature and the residues in this structural element have very different 
torsion angles. Turn structures generally reverse the direction of the chain and they often 
are found on the surface of proteins. They often take part in molecular or ion recognition 
processes. Depending upon the radius of curvature and H-bonding pattern they are again 
divided into different classes as shown in Figure 1.5. 
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Figure 1.5. Various turn structures in peptides: (a) α, β and γ-turns and (b) reverse α, β 
and γ- turns.[13] 
 
 
Depending upon the H-bonding ring size or directionality of the H-bonding pattern they 
are classified as α (13, NHi to CO-(i-4)), β (10, NHi to CO-(i-3)) and γ (7, NHi to CO-(i-2)) 
turns and reverse α (11, NHi to CO(i+3)), β (8, NHi to CO(i+2)) and  γ (5, NHi to CO(i+1)) 
turns. [13]
 
1.3. Controlling the Secondary Structures of Peptides 
The variation of secondary structures in peptides results from the differences in 
their sequence, indicating that it may be possible to design secondary structures by 
selecting appropriate amino acid sequences. From the statistical analysis of protein 
structures, it appears to be possible to predict the secondary structural preference of any 
given peptide through judicial selection of a sequence.[14] However, in many cases this 
approach does not provide the expected results.[15] Table 1.2 presents the propensity of 
certain amino acids to adopt specific secondary structure. In addition to the preference 
shown by amino acids for specific secondary structures, other important factors, such as 
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hydrophobic interactions, polar-polar interactions and van der Waals interactions need to 
be taken into consideration.  
 
Table 1.2. Propensities of different amino acids for the formation of different secondary 
structures at different positions. [14] Preference Pi,j = (ni,j /ni)/ (nj / N) where ni,j = number 
residue of amino acid i in the the secondary structure j, ni = number of residue of amino 
acid i,  nj = number of residue in structure j and N = total number of effective residue. 
 
 Preference α-Helix Preference Turn Preference 
Amino  
acid  
Residue 
α-
helix 
 (Pα) 
β-
sheet  
(Pβ) 
Reverse 
turn 
(Pt) 
 
N-
term 
 
Middle
 
C-
term 
 
Type 
I 
 
Type  
II 
 
Other 
Glu (E) 1.59 0.52 1.01 2.12 1.18 1.21 1.12 0.84 1.06 
Ala (A) 1.41 0.72 0.82 1.33 1.60 1.46 0.74 0.94 0.58 
Leu (L) 1.34 1.22 0.57 1.03 1.50 1.46 0.61 0.53 0.75 
Met (M) 1.30 1.14 0.52 0.75 1.44 1.92 0.66 0.73 0.96 
Gln (Q) 1.27 0.98 0.84 1.39 1.22 1.24 0.79 1.45 1.02 
Lys (K) 1.23 0.69 1.07 0.98 1.05 1.68 0.70 0.73 1.04 
Arg (R) 1.21 0.84 0.90 1.26 1.25 1.23 0.88 1.22 0.84 
His (H) 1.05 0.80 0.81 0.68 0.97 1.57 0.78 0.64 1.00 
Val (V) 0.90 1.87 0.41 1.00 1.09 1.08 0.39 0.61 0.48 
Ile (I) 1.09 1.67 0.47 0.96 1.31 0.99 0.39 0.43 0.93 
Tyr (Y) 0.74 1.45 0.76 0.63 0.61 1.00 0.71 0.91 0.97 
Cys (C) 0.66 1.40 0.54 0.78 0.66 0.56 1.38 0.99 0.78 
Trp (W) 1.02 1.35 0.65 1.20 1.34 0.78 1.35 0.15 0.52 
Phe (F) 1.16 1.33 0.59 0.94 1.45 1.20 0.77 0.76 0.53 
Thr (T) 0.76 1.17 0.90 0.75 0.87 0.80 1.25 0.63 0.93 
Gly (G) 0.34 0.58 1.77 0.60 0.47 0.31 1.14 2.61 1.38 
Asn (N) 0.76 0.48 1.34 0.80 0.80 0.75 1.79 0.99 1.37 
Pro (P) 0.34 0.31 1.32 0.90 0.19 0.06 0.95 1.80 1.51 
Ser (S) 0.57 0.96 1.22 0.67 0.44 0.73 1.47 0.76 1.49 
Asp (D) 0.99 0.39 1.24 1.35 1.03 0.67 1.98 0.71 1.28 
 
 
Designing helical peptides using non-proteinogenic amino acids, especially β-
amino acids, in the backbone is an excellent strategy.[16] Metal-assisted helix formation 
has also been explored (Figure 1.6). Sasaki and Hopkins have incorporated non-natural 
amino acids containing metal binding sites at different positions (i and i+3 or i and i+4 
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etc), which upon complexation with metal ions leads to helical structures.[17] Ghadiri and 
co-workers also used a similar strategy for the preparation of stable helical 
conformations, in which metal binding to proteinogenic amino acids was exploited.[18] 
 
 
Figure 1.6. Metal-assisted stabilization of helical peptides. [17]
In addition to designing single helices, attempts have been made to design the 
multi-helical bundles with the ultimate goal of de novo protein design. Using a metal 
mediated strategy, the single helical backbones can be designed to contain a metal 
binding center in a suitable position. Ghadiri and Sasaki used bipyridine and pyridine to 
ensure helix-bundle formation (Figure 1.7). Additional metal binding sites enhance the 
stability of the helix assembly.[19] Another approach for the formation of helical bundles 
has been reported, where instead of conjugating the peptide with a ligand, histidine has 
been placed  in suitable position in the peptide sequence to complex to a metal center.[20]  
Whereas the design of helical peptides and their assemblies has been extensively 
explored, the design of β-sheets is more difficult due to their folding complexity and 
high tendency to self-assemble. 
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 (a) 
 
 
 
  
             (b)  
 
 
Figure 1.7. (a) Complexation of bipyridine conjugated helical peptides containing 
amino acids with metal binding sites at the opposite termini for the formation of very 
stable triple helical bundle[19] (b) Complexation of four pyridine conjugated helical 
peptides to form a four-helix bundle.[20]
 
Although several attempts were made in designing β-sheet peptides purely from amino 
acid sequences having high β-sheet propensities (Table 1.2), this strategy has only been 
met with limited success.[15, 21] On the other hand, the use of molecular scaffolds, ranging 
from simple glucose to more complex polycyclic steroids, has been successfully 
explored for the design and stablizing the β-sheet-like structures.[22] To achieve β-sheet 
conformation, Ranganathan and co-workers used norbornene as a turn inducing motif 
for the attached peptide strands. Using endo-(2S,3R)-2-amino-3-carboxynorbornene and 
endo-(2S,3R)-2,3-dicarboxynorbornene, they could obtain antiparallel (1) and parallel 
(2) β-sheet mimics respectively (Figure 1.8).[23]         
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Figure 1.8. Use of norbornene as a molecular scaffold for the design of β-sheet-like 
peptides  leads to the formation of offset β-sheet-like structure in 1 and parallel β-sheet-
like H-bonding in 2.[23]
 
Ethylenediamine derived oligourea scaffolds have been explored by Nowick and 
co-workers for the preparation of both parallel (3) and antiparallel (4) β-sheet mimics 
(Figure 1.9). Peptides conjugates were prepared by treating the substituted diamine with 
peptide isocyanate.  
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Figure 1.9. Use of ethylenediamine derivative as a scaffold for the formation of 
parallel β-sheet like H-bonds in compound 3. Using an additional scaffold (phenyl 
group) in the backbone increases the stability of the β-sheet characteristics of 
compound 4.[24]
 
An additional template phenyl group (see Figure 1.9) in the backbone in 4 has been 
found to stabilize the structure maintaining the β-sheet conformation. By using this 
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flexible ethylene-derived template, they were even able to prepare multistranded β-sheet 
peptides.[24] Epindolidione, a highly rigid aromatic system containing suitably positioned 
H-bonding donor and acceptor groups, has been explored by Bowen and co-workers.  
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Figure 1.10. Upon attachment of peptide strands to the epindolidione amino groups 
affords a parallel β-sheet mimic 5. Pro-D-Ala sequences are incorporated proximal to the 
epindolidione skeleton in order to enforce a reverse turn conformation in the attached 
peptide which is critical for β-sheet formation. The incorporation of two urea moieties into 
the peptide portion of the β-sheet mimetic affords an antiparallel  β-sheet mimic 6.[25]
 
To turn the peptides for the formation of H-bonds with the complementary sites on the 
template, a motif “L-Pro-D-Ala” was incorporated. For the formation of parallel β-sheet 
5, the peptide was conjugated to the template through amide bonds, whereas for the 
antiparallel β-sheet 6, the conjugation was made through a urea linkage (Figure 1.10).[25]  
Other rigid aromatic scaffolds such as 2,8-dimethyl-4-(carboxymethyl)-6- 
(aminomethy1)phenoxa-thiin-S-dioxide (7),[26] 2,8-dibenzofurandiylbis(3-propanoic 
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acid) (8)[27] and 4-(2-aminoethyl)-6-dibenzofuran propionic acid (9)[28] have also been 
utilized in the designing of β-sheets (Figure 1.11). 
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Figure 1.11. Rigid aromatic systems used to design β-sheet mimics; 2,8-dimethyl-4-
(carboxymethyl)-6-(aminomethy1)phenoxa-thiin-S-dioxide (7),[26] 2,8-dibenzofuran-
diylbis(3-propanoic acid) (8),[27] and  4-(2-aminoethyl)-6-dibenzofuran propionic acid 
(9).[28]  
 
Metal coordination can facilitate β-sheet conformation, as shown by Kelly and 
co-workers, who have utilized disubstituted bipyridine peptide conjugates. In the 
absence of metal ions, the peptide strands are found to a have random coil conformation. 
However, upon the addition of Cu(II), the peptide conjugate adopts a β-sheet 
conformation, as shown in Figure 1.12.[29] 
An alternative strategy was explored by Mutter and co-workers using a peptide 
template onto which other peptides were grafted, as illustrated in Figure 1.13. The 
peptide sequence Ac-Lys-Lys-Lys-Lys-Pro-Gly-Lys-Lys-Lys-Lys acts as a template, 
which contains the β-turning motif Pro-Gly and four Lys residues at each side of the 
turn. The sequence adopts a β-hairpin conformation, in which  the side chains of Lys 1, 
3, 8, and 10 are placed on the same side of the β-sheet. 
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Figure 1.12. β-Sheet stabilization by complexation of bipyridine peptide conjugates 
with Cu(II).[29] R represents different side groups of the amino acids. 
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Figure 1.13. Schematic representation of a templated assembly of β-strands. The 
folding of a parallel β-standwich is directed via the attachment of four peptide 
sequences to an acyclic peptide-based template. The peptides are covalently attached at 
their carboxy termini, via an amide linkage to the ε-nitrogens of template lysine side 
chains.[30] Ac = Acetyl, V = Valine and K = Lysine. 
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Parallel β-strand sequences Ac-Val-Lys-Val-Lys-Val-Lys-Val-Lys were attached to the 
ε-amino groups of Lysine residues at 1,3,8, and 10 by solid-phase peptide synthesis for 
the preparation of the putative β-strand bundle. Mutter and co-workers also used an 
analogous template Ac-Lys-Lys-Lys-Lys-Pro-Gly-Lys-Lys-Lys-Lys-ε-6-aminohexanoic 
acid as a scaffold to prepare a β-barrel structure. β-strand sequences Ac-Val-Lys-Val-
Lys-Val-Lys-Val-Lys were attached to the ε-amino groups of all Lys residues in the 
sequence, affording a putative 8-stranded β-barrel.[30] 
Cyclization of peptides is another major strategy used for the formation and 
stabilization of β-sheet conformation. Moreover, cyclopeptides are conformationally  
restrained and chemically more stable, which have made them a more attractive 
alternative to linear peptidomimetics in designing simple β-sheet models for studying 
biological interactions and ion/molecular recognition.[31] Different approaches have been 
used for the preparation of cyclopeptides, which maintain β-sheet conformation in 
specific sites in the peptide backbone. Cyclization through side chains reactive sites has 
been widely used to obtain the desired cyclopeptide.[32] For example, formation of a 
disulfide bond by oxidative dimerization of two Cys thiols, as in compound 10 (Figure 
1.14), is facile and has been widely used.[33] Another important approach of cyclization 
through side group is the formation of an ether linkage utilizing the OH groups of Tyr  
as shown for compound 11.[34] 
The conformational flexibility of a cyclopeptide has been further restricted by 
incorporating semi-rigid aromatic units into the cyclic backbone.[35] Feigel and co-
workers have reported the formation of β-sheet mimics prepared from disubstituted 
biphenyls. The acyclic analogue is present in various stereoisomeric forms and the 
peptide strands do not adopt any ordered conformation.[36] However, upon cyclization, 
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the compounds 12 and 13 are found to form antiparallel β-sheet like structures, as 
depicted in Figure 1.15. 
 
N
N N
N
N
N
O
O
O
O
O
OH O
N
N
O
O
SS
H
H
H
H
H
H
H
HN N
10  
 
N
N
N
N
O
O
O
O
O
OH
H
H
H
H
O
SHHO2C
11  
 
Figure 1.14. Cyclization, using the side groups of amino acids of peptides to achieve β-
strand conformation through the formation of disulfide bond (10)[33] and through the 
formation of an ether linkage (11).[34] 
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Figure 1.15. Formation of a stable antiparallel β-sheet-like conformation upon 
cyclization of  biphenyl conjugates.[36]  
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A sequence of alternating D- and L-amino acids is found to adopt a β-strand 
conformation. Two such complementary strands arrange helically to form double 
stranded peptide helices.[37a] Ghadiri and co-workers used similar alternating sequences 
of D- and L-amino acids, which upon cyclization, adopt intermolecular β-sheet-like 
arrangement.  
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Figure 1.16. (a) Cyclopeptide from alternating D- and L-amino acids sequence, 
adopting circular conformation and (b) The axial stacking through H-bond to form 
tubular architecture.[37b]
 
Due to the steric interaction among the side groups of the adjacent amino acids in the 
backbone, the peptide strand adopts a circular geometry. The amide CO and NH groups 
of the molecule are projected perpendicular to the in circular plane and are able to stack 
over each other through β-sheet like H-bonding, which results in a cylindrical assembly 
(Figure 1.16).[37b]
 
 
 16
1.4. Ferrocene Peptides 
In the previous section, it was shown that various molecular scaffolds are able to 
form and stabilize specific secondary structures in peptides. Ferrocene (Fc) (14) has also 
been used for the design of well-defined peptide motifs. A brief overview of this 
development is described in this section. 
Fc having a Fe(II) centre sandwiched between two cyclopentadienyl (Cp) rings, 
was first discovered by Kealy and co-workers in 1951.[38] Recently, this organometallic 
compound has been introduced into a peptide environment by peptide conjugation 
strategies.   
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Figure 1.17. Three different sketches used to represent the ferrocene entity (14) and 
different ferrocene derivatives, 15, 16, 17 and 18, used to conjugate with amino acids 
or peptides through amide bonds. 
 
A series of Fc derivatives, such as ferrocene-carboxylic acid, FcCOOH (15), 1,1'-
ferrocenedicarboxylic acid, Fc[COOH]2 (16), 1-amino-1'-ferrocene carboxylic acid, 
Fc[NH2][COOH] (17) and 1,1'-diaminoferrocene, Fc[NH2]2 (18), as shown in Figure 
1.17, were coupled with amino acids or peptides. It has been found that Fc is capable of 
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stabilizing specific intra- and intermolecular arrangements of the attached peptides 
through the formation of intra- and intermolecular H-bonds. This area of research has 
been extensively reviewed by Nolte et.al., Kraatz, and Hirao et al,[9] and only the 
highlights will be provided here. 
When amino acids and peptides are attached to 15, they can adopt β-strand 
conformations, which then undergo intermolecular H-bonding and as a result, assemble 
into β-sheet like architectures (Figure 1.18).[9] 
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Figure 1.18. Intermolecular H-bond formation of various peptide conjugates of 
ferrocene monocarboxylic acid. Conjugate of single amino acid showing the formation 
of head-to-tail H-bonding in compound 19,[39] conjugate of Fc-dipeptide showing the 
formation of parallel β-sheet like H-bonding in compounds 20 and 21,[40] Fc-conjugate 
of cysteamine derived amino acid showing the parallel beta-sheet like H-bonding and  
Fc-conjugate of cysteamine derived amino acid showing the formation of offset H-
bonding in compound 22.[43]
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Single amino acid conjugates of Fc of the general formula Fc[CO-AA-COOR] show the 
formation of intermolecular H-bonding between the ferrocene-carbonyl (FcC=O) and the 
amide NH (19 in Figure 1.18) of adjacent molecules, resulting in the formation of one 
dimensional head-to-tail chain in the molecular packing.[40] In Fc-dipeptide conjugates 
of formula  Fc[CO-AA-AA-COOR], two independent molecules are held together by H-
bonding, forming a 12-membered ring similar to parallel β-sheets. Thus, they arrange 
themselves in a well-defined helical pattern at a supramolecular level.[40] For example, 
FcCO-Ala-Phe-OMe (20)  is found to arrange in a left-handed four-fold helical 
supramolecular structure with the intermolecular  H-bond distances of d(N-O) = 2.936 Å 
and 2.983 Å.[9, 41] A similar structure for  FcCO-Leu-PheOEt (21) has been reported with 
a bond distances of d(N-O) = 2.977 Å and d(N-O) = 2.983 Å.[42]  
Ferrocenoyl-diglycyl-cysteamine [FcCO-Gly-CSA]2 (22), another Fc conjugate, 
is found to form a supramolecular helical assembly. In this case, two different H-
bonding patterns are observed on different sides of the disulfide bonds (Figure 1.18). On 
one side, a parallel β-sheet like 12-membered ring is formed and on the other side, a pair 
of H-bond acceptors Os of C=O are arranged syn to each other, aligning the two Hs of 
NH donors in a syn position. This enables neighboring molecules with the same 
arrangement to form an asymmetric 12-membered H-bonded ring. These two different 
types of H-bonding lead to the formation of two different supramolecular helices.[43] Fc-
carboxylic acid (16) has also been used to conjugate with the long peptides, both in 
solution and in solid phase method, mainly with the aim of studying the electrochemical 
properties of the conjugated peptides.[9b]
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Peptide conjugates of disubstituted Fc derivatives have been most widely 
studied.[9] Fc containing two Cp rings parallel to each other at a distance of 3.3 Å and 
with a low rotational barrier of 0.8 kcal/mol, has been found suitable in imparting well-
defined structure to the peptides attached to the two Cp rings (see Figure 1.19). The 
small rotational barrier enables Fc to function as a ball bearing that conveys flexibility to 
the substituent peptide strands, which can then adopt unstrained stable alignments in 
which the adequate inter-ring separation allows the formation of suitable inter-strand H-
bonds. As a result, it has been possible to design Fc-peptide conjugates with diverse 
structures. 
 
 
Figure 1.19. (a) Cp ring separation in Fc, (b) Possible arrangements of the two 
substituents at two different Cp rings and (c) Formation of optical isomers due to the 
variation in arrangement.[13]
 
For the disubstituted 1,n΄-Fc systems, systematic nomenclature has been 
described by Kraatz and Metzler-Nolte.[13] Figure 1.19b illustrates some possible 
arrangements of the peptide substituents and their representation according to these 
rules. Depending upon the value of the rotational angle, these compounds are named as 
1,n΄, where n indicates the position of the substituent in the second ring with respect to 
the first ring in the clockwise direction.  The 1,1΄-isomer is defined by rotational angles 
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between -36o and +36º , while a 1,2΄-isomer would be defined as -36º < ω <108º, a 1,3΄ 
in the range of 108º to 180º, a 1,4΄ between 180 to -108º, and a 1,5΄ between -108º to -
36º.  These different arrangements are associated with the axial chirality of the Fc unit. 
The clockwise alignment of the bottom ring substituent (0 < ω <180º) with respect to the 
top ring substituent, gives rise to a positive band in CD spectroscopy in the Fc region at 
450 nm, and is termed the P-helical isomer. On the other hand, the alignment in the anti-
clockwise direction (0> ω > -180) gives a negative cotton effect in the Fc region and is 
called the M-helical isomer (see Figure 1.20).[13] Conjugates of disubstituted Fc with 
chiral amino acids or peptides give rise to a series of optically isomeric compounds. 
 
 
Figure 1.20. CD spectra of disubstituted Fc-peptide conjugates showing P- and M-
helicity. Reprinted with permission from Ref [44]. Copyright 2001 American 
Chemical Society. 
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Generally L-amino acids are found to induce P-helicity while D-amino acids induce M-
helicity.[13, 44] 
 The first attempt of exploiting the 1,n'-disubstituted Fc derivative for the 
preparation of peptide conjugates was made by Herrick and co-workers in 1996 using 
1,1'-ferrocene dicarboxylic acid. The first conjugate, Fc[CO-Val-OMe]2 (23), adopts an 
ordered β-sheet-like conformation in solution, as shown in Figure 1.21.[45] 
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Figure 1.21. Formation of interstrand H-bonds in amino acid conjugates of 1.1'-
ferrocenedicarboxylic acid.  
 
H-Bonding, as well as the amino acid side groups, exert steric interactions and force the 
Fc centre into a specific helical conformation. The Gly conjugate, Fc[CO-Gly-NH2]2 
(24), with the smallest side group, forms very strong H-bonds. The intramolecular H-
bonding distances are d(N···O) = 2.88 Å, which has been partially attributed to the 
higher H-bonding ability of the carbonyl in CONH2, compared to the ester carbonyl. Val 
having a bulkier isopropyl side group in 23, the intramolecular H-bonding is weaker and 
contact distances increases to d(N···O) = 3.24 Å.[45b] For Phe, which contains a benzyl 
group, the structure is disrupted as observed by Metzler-Nolte and co-workers, and the 
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conjugate Fc[CO-Phe-OMe]2 (25) exhibits a single cross-strand intramolecular H-bond 
(Figure 1.22).[41]  
 
(a) (b) 
 
 
Figure 1.22. (a) Crystal structure of Fc[CO-Val-OMe]2 (23) showing the anti-parallel β-
sheet 10-membered H-bonded ring formation and P-helical arrangement, [45b] and (b) 
crystal structure of Fc[CO-Phe-OMe]2 (25) showing the disruption of anti-parallel β-
sheet-like H-bonding pattern.[41] Grey spheres represent carbon atoms, red = oxygen, 
blue = nitrogen, and larger red = iron atoms. 
 
Dipeptide conjugates of 1,1'-ferrocendicarboxylic acid  have been found to 
arrange the podand peptide strands in a helical fashion, forming similar kind 
intramolecular H-bonds and antiparallel β-sheet like conformation (see Figure 1.23).  
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Figure 1.23. Fc-dipeptide conjugate 26, showing the formation of an antiparallel β-
sheet-like H-bonding pattern, indicating the formation of a 10-memered H-bonding.  
 
 23
In crystal structure of the conjugate Fc[CO-Ala-Phe-OMe]2 (26), Metzler-Nolte 
and co-workers observed the formation of a similar 10-membered H-bonding with 
contact distances of 2.921 and 2.924 Å in one of the two independent molecules, and 
2.901 and 2.893 Å in the second molecule. 
 
                    (a) 
 
               
                    (b) 
 
 
 
Figure 1.24. Crystal structures of (a) Fc[CO-Ala-Phe-OMe]2 (26) showing the 
formation of antiparallel β-sheet like 10-membered hydrogen bonded ring formation 
aligning the peptide strand in P-helical conformation, [41] (b) Fc[CO-D-Ala-D-Pro-
OEt]2 (28) showing the formation of antiparallel β-sheet like 10-membered hydrogen 
bonded ring aligning the peptide strand in M-helical conformation.[44] Grey spheres 
represent carbon atoms, red = oxygen, blue = nitrogen, and larger red = iron atoms. 
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The torsion angles (ω) are 70º and 69º, which shows that these species are 1,2΄-
conformer. The crystal structure is presented in Figure 1.23a showing the intramolecular 
hydrogen bonding pattern and formation of a P-helicity.[41] With different sequences of 
peptides in the conjugate Fc[CO-Ala-Pro-OEt]2 (27), Hirao and co-workers found a 
similar P-helical arrangement only with slightly different contact distances of 2.981 Å 
between the CO (Ala) and the NH of the other podand dipeptide chain. The conjugates 
of corresponding D-amino acids, Fc[CO-D-Ala-D-Pro-OEt]2 (28) has found to arrange in 
a M-1,4'-conformtion, a mirror image of 27.[44] 
Further extention of the length of the peptide strand through heterocycles shows 
that the other termini of the peptide strands move farther away and form different 
structural motifs containing γ-turns (Figure 1.25).[46] The crystal structural study of 
Fc[CO-Ala-Pro-Py]2 (29) (Figure 1.26) shows that in addition to the formation of the  
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Figure 1.25. Extention of length provide γ-turn through the formation of intrastrand 
H-bond with the 1,2' arrangement in the Fc center.[46] 
 
 
usual 10-membered intramolecular H-bonding with the distances of d(N···O) = 2.83 Å 
and 2.97 Å, it forms two extra intramolecular intrastrand H-bonds with the distances 
d(N···O) = 2.99 and 3.03 Å and thereby imparts a γ-turns into the podand peptide 
backbone. [46] 
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Figure 1.26. Crystal structures of  Fc[CO-Ala-Pro-Py]2 (29) showing the γ-turn through 
the formation of intra-strand hydrogen bonds along with keeping the antiparallel β-
sheet like 10-membered H-bonded ring for the first conjugated amino acids and P-
helical conformation intact.[46] Grey spheres represent carbon atoms, red = oxygen, blue 
= nitrogen, and larger red = iron atoms. 
 
 In addition to 1,1'-Fc dicarboxylic acid, other disubstituded Fc derivatives have 
also been used for the synthesis of peptide conjugates. In 2004, Metzler-Nolte and co-
workers first reported the amino acid conjugates of 1-amino-1'-Fc carboxylic acids. [47] It 
was found that the conjugated amino acids are aligned in a similar helical fashion as is 
found for the conjugates of 1,1'-Fc dicarboxylic acid. In this case, a different H-bonding 
pattern, a parallel β-sheet like 12-membered H-bonded ring formation was observed. 
The study was extended to D-amino acids and the expected M-helical arrangement was 
observed.[47b] The crystal structure of Boc-Ala-Fca-Ala-Ala-OMe (30) shows strong 
intramolecular H-bonding (d(N···O) = 2.81 and 2.91 Å), displaying a 12-membered H-
bonded ring and aligning the peptide strands in a P-helical fashion (Figure 1.27). 
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Figure 1.27. Crystal structure of Boc-Ala-Fca-Ala-Ala-OMe (30) showing the 
formation of parallel β-sheet like 12-membered H-bonded ring formation aligning the 
peptide strands in a P-helical conformation.[47a] Grey spheres represent carbon atoms, 
red = oxygen, blue = nitrogen, and larger red = iron atoms. 
 
In the preceding sections, the characteristics of amino acids and peptides and 
definitions of various secondary structural elements of peptides have been described. 
The diverse approaches used to control the secondary structures of peptides and their 
assembly with the aim of achieving de novo protein have also been highlighted.[1a] 
Numerous organic and inorganic molecular templates have been used to induce specific 
secondary structures in the peptide conjugates. 
Fc has been found to be a good template with the potential of inducing all three 
secondary structural motifs; a helix, a sheet (both parallel and antiparallel) and a turn, 
through the formation of well-defined intra- and intermolecular H-bonding. One would 
therefore consider this molecule as an excellent choice for the de novo designing of 
protein. In addition to controlling the secondary structure of peptides, Fc introduces 
redox activity to its conjugates. Presently, this characteristic is widely utilized to either 
investigate the electron transfer characteristics through some specific entity,[10] or study 
the molecular recognition property of its conjugates by electrochemical methods.[11] This 
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makes Fc useful also in the context of de novo design of redox active protein, providing 
the motivation to explore ferrocene peptide conjugates in detail.  
 
1.5. Research Objectives and Approaches 
The objective of my research is to explore the use of ferrocene as a molecular 
scaffold for controlling the β-sheet-like structure. Ferrocene has been found to be an 
excellent scaffold due to its multi-functional characteristics, as described in Section 1.4. 
When we focus our attention to the application of this multi-functional scaffold in 
controlling the structure of peptides, several questions arise, as illustrated in the 
following paragraphs. Answers to these questions provided the clue to design the above 
mentioned challenging and interesting peptide structural motifs. 
In peptide conjugates of 1,1'-ferrocendicarboxylic acid, it was observed that 
when a single amino acid is linked to each of the Cp rings through an amide bond, they 
align themselves through the formation of antiparallel β-sheet-like structures, causing a 
large spatial separation between the carboxyl termini. This implies that the second amino 
acid, if linked, would not form additional interstrand H-bonding, suggesting that this 
approach is not useful for the formation of extended β-sheet. This generates my first 
question, “Is it possible to bring the two termini of the amino acids together and control 
the conformation of the peptide so that it maintains its β-sheet characteristics?” 
Macrocyclization can be an answer, which has been described in Chapter 2. There, the 
synthesis and structure of a series of pseudocyclopeptide of general formula Fc[CO-AA-
CSA]2 are described. 
It was observed that upon cyclization, the amino acids retain their β-strand 
characteristics and they twist with respect to each other, aligning the H-bond donor or 
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acceptor sites, which do not participate in intramolecular H-bonding, to the same side. 
These observations raised my second question, “Is it possible to assemble these twisted 
units through H-bonding?” If so, then this approach would provide a supramolecular 
structure, where the β-sheet-like motifs will arrange in a parallel fashion providing the 
cylindrical hollow space inside, similar to the  β-barrel. Through the addition of extra β-
sheet forming amino acids, more H-bonding sites can be created in that twisted system 
and to achieve the desired assembly. Chapter 3 describes this strategy detailing the 
synthesis and structures. 
In cyclic systems, it is possible to extend the β-sheet characteristics for the longer 
peptide sequences and ring strain was found negligible. This generates my third 
question, “Will it be possible to achieve the similar extended β-sheet structures choosing 
similar amino acid sequence in acyclic conjugates?” We have seen that the nature of the 
amino acids attached to Fc dictates the strength of the intramolecular H-bonds,[41,45] 
which are responsible for providing the 10-membered β-sheet-like alignment. Taking 
this into consideration, we were able to successfully address this question as described in 
Chapter 4. 
Amino acid conjugates of 1,1'-diaminoferrocene are absent from the literature, 
largely due to a lack of convenient preparation of a suitable precursor. This poses the 
question as to the structural feature of amino acid conjugates of 1,1'-diaminoferrocene, 
“Will they adopt a novel H-bonding motif or assemble into a certain supramolecular 
archetechtures? Chapter 5 addresses this question and describing the synthesis, 
characterization and structures of a suitable derivative of 1,1'-diaminoferrocene and of 
the first amino acid conjugates of 1,1'-diaminoferrocene. 
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It is noted that peptide conjugates of disubstituted ferrocenes are capable of 
providing both the β-sheet characteristics and the helical alignment simultaneously, to 
the attached amino acids. This provides yet another question, “Can we utilize both these 
characteristics of ferrocene to form larger architecture in the form of artificial β-helical 
peptides?” Chapter 6 describes the utilization of 1-aminoferrocene-1'-carboxylic acid for 
the preparation of model parallel β-helical peptides. There, the synthesis and structures 
of a series of a series of Fca-conjugates of the type Boc-[Fca-Ala]n-OMe (n = 1-4), with 
both L- and D-Ala, are described. 
Chapter 7 provides the general discussion of my whole Ph.D. research and 
concludes the thesis. 
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Chapter 2 
Synthesis, Structure and Electrochemistry of Ferrocene 
Peptide Macrocycles 
 
2.0. Connecting Text 
Amino acid conjugates of 1,1'-Fc dicarboxylic acid  have been found to arrange in 
a β-sheet like pattern, forming a10-membered intramolecular hydrogen bonded ring. The 
carboxyl ends of the amino acids in these conjugates are not in close proximity and 
consequently attaching the second amino acid does not provide access to an extended β-
sheet. This Chapter discusses a methodology for controlling the structure. It describes the 
preparation of a series of cyclopeptide conjugates of ferrocene of general formulae 
Fc[CO-AA-CSA]2 by macrocyclization. Structural studies show that those carboxyl 
termini are now in close proximity to each other making this a potential method for 
controlling the structure of peptides. 
This paper was reproduced with the permission from Dalton Trans 2004, 1726-1730. Copyright 2004, 
Royal Society of Chemistry. This paper was co-authored by G. Schatte and H.-B. Kraatz.  All experimental 
works with the exception of crystallographic analysis were carried out by me. In addition I wrote the initial 
draft of the manuscript. The text below is a verbatim copy of the published paper. 
 
2.1. Abstract 
Redox active cyclopeptides Fc[CO-CSA]2 (5), Fc[CO-Gly-CSA]2 (6), Fc[CO-
Ala-CSA]2 (7), Fc[CO-Val-CSA]2 (8) and Fc[CO-Leu-CSA]2 (9)  are formed by the 
reaction of ferrocenedicarboxylic acid with peptide cystamines at high dilutions. These 
systems exhibit H-bonding involving the amide NH in solution as shown by their 
temperature dependent NMR spectra. With exception of 5, the ferrocene macrocycles 
   34
display intramolecular N…O cross-ring H-bonding in the solid state involving the amino 
acids proximal to the ferrocene.  
 
2.2. Introduction 
Peptides are ideally suited as building blocks in supramolecular synthesis based 
on their inherent ability to engage in inter-peptide interactions via hydrogen bonding. 
Novel peptidic materials were reported, such as cyclopeptide nanotubes[1] and 
hydrogels,[2] with potential applications in drug delivery and biomedical engineering. A 
number of 1,1'-disubstituted ferrocene peptide conjugates have been explored as 
templates in an effort to create highly ordered electroactive supramolecular systems. 
Structural investigations of a number of ferrocene-peptide conjugates display a rigid 
intramolecular cross-strand H-bonding interaction in which the amino group proximal to 
the Fc group on one strand engages in H-bonding with the CO group of the same amino 
acid on the opposite peptide strand.[3] The resulting structure resembles a β-sheet motif 
and was originally proposed by Herrick and coworkers based on NMR evidence of 
simple amino acid conjugates.[4] This structural type appears extremely robust and even 
withstands the presence of other strongly H-bonding compounds. In these conjugates, an 
interesting interplay between inter- and intermolecular H-bonding is observed. 
Intermolecular H-bonding is only observed if the second amino acid has available H-
bonding donor sites, giving raise to H-bonded supramolecular assemblies.  Connecting 
the two podand peptides on the two podand peptide chains on the two opposite Cp rings 
by a linker molecule will provide access to macrocyclic 1,1'-ferrocene cyclopeptides. 
While our study was underway, Cheng and coworkers reported the synthesis of a series 
of 1,1'-ferrocene cyclopeptides having a cystine linker and its interaction with alkali and 
earth alkaline ions.[5] Unfortunately, the report did not contain any structural data other 
than the results of the solution NMR showing strong intramolecular H-bonding.  In this 
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regard, the structural analysis of 1,1'-ferrocene cyclopeptides is of great interest. 
Ferrocenophanes in general, cyclic compounds incorporating a 1,1'-disubstituted 
ferrocene, display a range of interesting properties, ranging from metallocryptants for the 
coordination of ions to starting materials for metallopolymers.[6] In this paper, we report 
the synthesis and spectroscopic properties of an alternative set of 1,1'-ferrocenoyl 
cyclopeptides possessing cystamine linkages. We provide an analysis of their solid state 
structures and give a full account of their electrochemical behavior in solution.  
 
2.3. Experimental 
2.3.1. General: All syntheses were carried out in air unless otherwise indicated. CH2Cl2 
(BDH; ACS grade) used for synthesis was dried (CaH2) and distilled prior to use. CDCl3 
(Aldrich) were dried by, and stored over molecular sieves (8-12 mesh; 4Å effective pore 
size; Fisher) before use. DCC, HOBt, CSA·2HCl (Aldrich), MgSO4, NaHCO3 (VWR), 
and 1,1'-Fc(OH)2 (Strem) were used as received. Et3N (BDH; ACS grade) used in the 
synthesis was used as received. For column chromatography, a column with a width of 
2.7 cm (ID) and a length of 45 cm was packed 18-22 cm high with 230-400 mesh silica 
gel (VWR). For TLC, aluminum plates coated with silica gel 60 F254 (EM Science) were 
used. NMR spectra were recorded on a Bruker AMX-500 spectrometer operating at 500 
MHz (1H) and 125 MHz (13C{1H}). Peak positions in both 1H and 13C-NMR spectra are 
reported in ppm relative to TMS. The 1H-NMR spectra are referenced to the residual 
CHCl3 signal at δ 7.27. All 13C{1H}-NMR spectra are referenced to the CDCl3 signal at δ 
77.23 ppm.  
 
2.3.2. Synthesis and characterization of Cystamine-Amino acid conjugates:  The 
procedures for the peptide conjugates syntheses are identical as described in section 
2.3.2.1. 
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2.3.2.1. [Boc-Gly-CSA]2 (1): Boc-Gly-OH (1.89 g; 10 mmol) was dissolved in 30 ml of 
DCM. Solid HOBt (1.68 g; 11 mmol)  and of EDC•hydrochloride (2.10 g; 11 mmol)  
were added sequentially. After 20 minutes, the reaction mixture was cooled in an ice 
bath. To the reactions solution, a solution of CSA dihydrochloride (1.12 g; 5 mmol)  in 
50 ml of DCM and 2 ml Et3N was added dropwise over 5 minutes. After completion,  the 
reaction mixture was allowed to warm up and was kept at room temperature for 10 hours 
under constant stirring. The resulting solution was then washed successively with 
saturated NaHCO3, 10% citric acid, saturated NaHCO3 and then water. Then it was 
evaporated under reduced pressure in a rotorvap. The product was purified by column 
chromatography (silica gel 9:1 ethyl acetate : methanol, Rf = 0.33) to get the pure product 
in 63% yield (1.46 g).  1H-NMR (δ, CDCl3): 7.30 (s, 1H, amide NH), 5.78 (s, 1H, NH 
Boc), 3.78 (s, 2H, CH2 of Gly), 3.53 (d, 2H, J = 6 Hz, CH2 attached to NH), 2.77 (m, 2H, 
CH2 attached to S), 1.40 (s, 9H, Boc CH3). 
 
2.3.2.2. [Boc-Ala-CSA]2 (2): Silica gel column (EtOAc : MeOH = 93:7, Rf = 0.439 to get 
the pure product 3. Yield = 77). 1H-NMR (δ, CDCl3) 7.15 (s, 1H, amide NH), 5.56 (s, 
1H, NH Boc), 4.35(s, 1H, α-CH of Ala), 3.56 (m, 2H, CH2 attached to NH), 2.80 (m, 2H, 
CH2 attached to S), 1.51 (s, 9H, Boc), 1.42 (d, 3H, J = 7 Hz  Ala CH3). 
 
2.3.2.3. [Boc-Val-CSA]2 (3): Silica gel column, (ethyl acetate : hexane = 50:50, Rf = 
0.33) Yellowish powder. Yield = 79%. 1H-NMR (δ, CDCl3) 7.13 (s, 1H, amide NH), 
5.80 (m, 1H, NH Boc), 4.26 (s, 1H, α-CH of Val), 3.60 (m, 2H, CH2 attached to NH), 
2.80 (m 2H CH2 attached to S), 2.10 (m 1H sec. H of Val. side chain), 1.56 (s, 9H, Boc), 
0.97 (d, 3H, J = 7 Hz, CH3 of Val), 0.95 (br s, 3H, Val CH3 of Val) 
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2.3.2.4. [Boc-Leu-CSA]2 (4): Silica gel column, ethyl acetate : hexane 35:65.; Rf = 0.35 
Yellowish powder. Yield = 80%. 1H-NMR (δ, CDCl3) 7.18 (s, 1H, amide NH), 5.61 (d, 
1H, J = 7 Hz, NH), 4.21 (s 1H α H of Leu), 3.60  (m, 2H, CH2 attached to NH), 2.84 (m, 
2H, CH2 attached to S), 1.75 (m, 1H, CH of Leu side chain),1.52 (m, 2H, CH2 of Leu 
side chain), 1.42 (s, 9H, Boc CH3), 0.96 (d, 3H, J = 7 Hz, CH3 Leu), 0.95(d, 3H, J = 7 
Hz, CH3 Leu). 
 
2.3.3. Synthesis and characterization of Ferrocene-cyclopeptides:  The reactions to 
form the Fc-cyclopeptides follow a common procedure, which is described in detail for 
the formation of [FcCO-CSA]2 (5).  
2.3.3.1. Fc[CO-CSA]2 (5): In an ice-bath, ferrocenedicarboxylic acid (0.055 g; 0.2 
mmol) was dissolved in dichloromethane (10 mL), followed by the addition of HOBT 
(0.062 g; 0.4 mmol)  and EDC (0.078 g; 0.4 mmol). After half an hour, the reaction 
mixture was diluted to 300 ml by dichloromethane. In another flask, cystamine 
dihydrochloride (0.045 g; 0.2 mmol) was dissolved in 10 ml of dichloromethane and 1 ml 
of triethylmine.The resulting solution was diluted to 100 ml. Then, the cystamine 
solution was added to the orange organometallic solution and allowed to warm up to 
room temperature. Stirring was continued for 72 hours at room temperature. Then the 
solution was washed consecutively with saturated NaHCO3, 10% aqueous citric acid, 
saturated aqueous NaHCO3 and water. The organic phase was then dried over anhydrous 
Na2SO4, and then evaporated at 250C under reduced pressure to get the crude product. It 
was then purified by flash chromatography on silica (EtOAc : MeOH = 95:5 v/v, Rf = 
0.30) to get 26 mg (33 %) of the desired compound.  (KBr, cm-1): 1523 (C=O). UV-vis (λ 
in nm, [ε in M-1cm-1]): 440 [200]. HRMS (ES): Calc. for  C16H19N2O2FeS2 [M+1]+ = 
391.0237,  observed 391.0156 [M+1]+. 1H-NMR (δ, CDCl3):  6.75 (s, 1H, NH), 4.67 (s, 
2H, 2,2'-CH Cp), 4.48 (br s, 2H, 3,3'-CH Cp), 3.89 (s, 2H, CH2 attached to N), 3.12 (s, 
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2H, CH2 attached to S). 13C-NMR (δ, CDCl3): 170.0 (-CO), 77.8 (C of Cp), 71.7 (2,2′-C 
of Cp), 70.9 (3,3′-C of Cp), 41.3 (CH2  attached to NH), 38.4 (CH2 attached to S). 
 
2.3.3.2. Fc[CO-Gly-CSA]2 (6): Silica gel column, EtOAc : MeOH 93:7, Rf = 0.35, 
Yellow solid. Yield = 14 % (15 mg). FT-IR (KBr, cm-1): 1720, 1680 (C=O). UV-vis (λ in 
nm, [ε in M-1cm-1]): 440 [250]. HRMS (ES): calc. for C20H25N4O4FeS2 505.0666, 
observed 505.0647 [M+1]+.  1H-NMR (δ CDCl3): 7.71 (t, 1H, NH Fc), 6.24 (s, 1H, NH 
CSA), 4.74 (s, 2H, 2,2'-CH Cp), 4.41 (s, 2H, 3,3'-CH Cp), 4.14 (d, 2H, J = 6 Hz, α-CH2 
of Gly), 3.49 (d, 2H, J = 5 Hz, CH2 attached to N), 2.93 (br s, 2H, CH2 of CSA attached 
to S). 13C-NMR (δ, CDCl3): 180.3 (-CO Gly), 178.5 (-CO Fc) 104.2 (ipso C of of Cp), 
74.2 (2,2′-C of Cp), 72.3 (3,3′-C of Cp), 47.0 (α-C of Gly), 35.0 (CH2  attached to NH), 
36.3 (CH2 attached to S). 
2.3.3.3. Fc[CO-Ala-CSA]2 (7): Silica gel column, EtOAc : Hexanes 97:3, Rf = 0.32, 
Yellow solid. Yield = 21% (22 mg).  FT-IR (KBr, cm-1): 1780, 1680 (two C=O s). UV-
vis (λ in nm, [ε in M-1cm-1]): 440 [230]. HRMS (ES): calc. for C22H29N4O4FeS2 
533.0979, observed 533.0960 [M+1]+. 1H-NMR (δ, CDCl3): 7.20 (s, 1H, NH Fc), 6.70 
(d, 1H, J = 8 Hz, NH CSA), 4.67 (m, 1H, CH of Ala), 4.54 (s, 2H, 2,2'-Cp CH), 4.47 (s, 
2H, 3,3'-Cp CH), 3.65 (m, 2H, CH2 attached to N), 2.89 (m, 2H, CH2 attached to S), 1.56 
(d, 3H, J = 4 Hz, CH3 of Ala).  13C-NMR (δ, CDCl3 ): 173.0 (-CO CSA), 170.8 (-CO Fc) 
115.7 (ipso C of of Cp), 72.0 (2-2′C of Cp), 71.3 (3-3′ C of Cp), 49.8 (α-C of Ala), 39.4 
(CH2  attached to NH), 38.8 (CH2 attached to S), 18.0 (CH3 in Ala).  
 
2.3.3.4. Fc[CO-Val-CSA]2 (8):  Silica gel column, EtOAc 100%, Rf = 0.35, Orange 
solid. Yield  = 21 % (25 mg). FT-IR (KBr, cm-1):  1750, 1690  (C=O). UV-vis (λ in nm, 
[ε in M-1cm-1]): 445 [250]. HRMS (ES+): calc. for C26H37N4O4FeS2 = 589.1605; 
observed 589.1517 [M+1]+ .  1H-NMR (δ, CDCl3): 7.32 (s, 1H, NH Fc), 6.54 (d, 1H, J = 
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9 Hz, NH CSA), 4.67 (s, 2H, 2,2'-CH Cp), 4.56 (s, 2H, 3,3'-CH Cp), 4.47 (m, 1H, α-CH 
of Val),  3.73 (m, 2H, CH2 attached to N), 2.85 (m, 2H, CH2 attached to S), 2.45 (m,1H, 
CH of Val), 1.08 (s, 3H, CH3 of Val), 1.07 (s, 3H, Me of Val). 13C-NMR (δ, CDCl3 ): 
172.1 (-CO CSA), 171.1 (-CO Fc) 105.5 (ipso C of Cp), 72.3 (2,2′-C of Cp), 71.8 (3,3′-C 
of Cp), 70.6 (α-C of Val), 60.5 (CH Val), 39.2 (CH2 attached to NH), 38.0 (CH2 attached 
to S), 29.1 (CH3 Val), 19.4 (Me Val).   
 
2.3.3.5. Fc[CO-Leu-CSA]2 (9) : Silica gel column, EtOAc : Hexanes 9:1, Rf = 0.32. 
Yellow solid. Yield = 28% (31 mg).  FT-IR (KBr, cm-1): 1720, 1770 (two C=O s).  UV-
vis (λ in nm, [ε in M-1cm-1]): 445 [340]. HRMS (ES): calc. for C28H40N4O4FeS2 
617.1918, observed 617.1890 [M+1]+. 1H-NMR (δ CDCl3): 7.32 (s, 1H, amide NH of 
Leu linked to ferrocene), 6.35 (d, 1H, J = 7Hz, NH CSA), 4.60 (m, 1H, αCH of Leu),  
4.47 (s, 2H, 2,2'-CH Cp), 4.37 (s, 2H, 3,3'-CH Cp), 3.65 (m, 2H, CH2 attached to N), 
2.82 (m, 2H, CH2 attached to S),  1.80 (m, 1H, CH Leu), 1.62 (m, 2H, CH2 Leu), 0.98 (d, 
3H, J = 4 Hz, Me Leu), 0.95 (d, 3H, J = 6 Hz, Me Leu). 13C-NMR (δ, CDCl3): 172.6 (-
CO CSA), 170.9 (-CO Fc), 96.5 (ipso C of of Cp), 72.3 (2,2′-C of Cp), 71.9 (3,3′-C of 
Cp), 70.8 (α-C of Leu), 64.7 (C Leu), 52.9 (C of Leu) 40.9 (CH2  attached to NH), 38.9 
(CH2 attached to S), 21.4 (Me of Leu) 19.5 (Me of  Leu).  
 
2.3.4. Electrochemical Studies: All solution electrochemical experiments were carried 
out using a CV-50W Voltammetric Analyzer (BAS) at room temperature (20 ± 2oC). 
Tetrabutylammonium perchlorate was used as supporting electrolyte (0.2 M in MeCN). 
A glassy carbon electrode was used as a working electrode (BAS, diameter 3mm) and a 
platinum wire was used as a counter electrode. The glassy carbon working electrode was 
polished with alumina (3 µm followed by 1 µm, then 0.5 µm) prior to use to remove any 
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surface contaminants. The reference electrode was a Ag/AgCl electrode (BAS, 3M 
NaCl). iR compensation was applied. Backgrounds of the solvent containing the 
supporting electrolyte were collected before each set of experiments and then subtracted 
from the CVs. The experiment was repeated at least 10 times to get reliable values for 
E1/2. 
2.3.5. X-ray crystallography: Suitable crystals of compounds 5 (orange prisms 0.40 x 
0.38 x 0.28 mm) and 6 were obtained from a ether-layered solution of the compounds in 
dichloromethane. Data for 5 and 6 were measured using a Siemens Smart CCD 
diffractometer or a Bruker PLATFORM diffractometer/SMART 1000 equipped with a 
CCD area detector, respectively, using Mo-Kα radiation (graphite monochromated) with 
ω scans. An empirical absorption correction (SADABS)[7] was applied to 5 and 6.  The  
 
Table 2.1. Summary of crystallographic data for compounds 5 and 6. 
 
 5 6 
Chemical Formula C32H36Fe2N4O4S4 C20H24FeN4O4S2
FW 780.59 504.40 
Crystal size/mm 0.40 x 0.38 x 0.28 0.25 x 0.25 x 0.20 
Crystal system monoclinic monoclinic 
Space group I 2/a P21/c 
a/Å 25.1400(10) 12.4840(2) 
b/ Å 10.7111(4) 13.3040(2) 
c/ Å 24.2720(10) 26.4780(3) 
α/° 90 90 
β/° 93.0975(7) 106.1200(8) 
γ/° 90 90 
V/Å3 6526.3(4) 4224.75(10) 
Z 8 8 
D(calcd.), g/cm3 1.589 1.586 
T/K 193(2) 173(2) 
λ/Å 0.71073 0.71073 
µ/mm-1 1.190 0.948 
R (I>2σ(I))a 0.0349 0.0645 
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structures were solved using direct methods.[8] In both cases, for one of the molecules, 
the podand chain displays a significant positional disorder, which was modeled by 
assuming an occupancy of 50:50 (for 5) and 40:60 (for 6) for the two positions. The 
ordered ferrocene molecule in 5 and the ferrocene group of the disordered molecule were 
refined anisotropically, while the disordered chain was refined isotropically using full-
matrix least-squares on F2. For 6, all atoms were refined anisotropically on F2. H-atoms 
were placed in calculated positions and included in the refinement. The final R value for 
5 was R1 = 0.0349 and wR2 = 0.0870 for 6693 reflection with I > 2σ(I) (20739 total 
reflections). And for compound 6, R1 = 0.0645 and wR2 =  0.1087 for 6532  reflections 
with I > 2σ(I) (8632 total reflections). Crystallographic details for both structures are 
found in Table 2.1. CCDC reference numbers 227645 (Compound 5) and 227646 
(Compound 6). 
 
2.4. Results and Discussions 
The ferrocene-peptide macrocyles 5 – 9 are readily obtained as crystalline yellow 
to orange solids in low to moderate yields by the reaction of ferrocenedicarboxylic acid 
with the appropriate amino acid-cystamine conjugate for 6 - 8 or with cystamine in the 
case of compound 5 in the presence of carbodiimide and HOBt under high dilution 
conditions (Scheme 2.1). At concentrations above 2 mmol in ferrocenedicarboxylic acid 
the yields are decreased significantly, as expected for the synthesis of macrocycles. All 
compounds were fully characterized spectroscopically.  
 In the 1H-NMR spectrum, all macrocycles exhibit the expected 2:2 signal pattern 
for disubstituted Fc-systems with the four ortho protons on the two Cp rings shifted 
downfield compared to the meta-Hs.[3] The α-Hs are observed at δ 4.23 for 6, δ 4.47 for 
7, δ 4.62 for 8, and δ 4.44 for 9. This compares favorably to related mono-substituted Fc-
peptides described in the literature.[9]  
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Scheme 2.1. Synthesis of redox active cyclopeptides : (i) EDC, HOBt, CH2Cl2, (ii) 
CSA• 2HCl, CH2Cl2, (iii) (a) Boc-amino acid CSA dimer, TFA, (b) Et3N, CH2Cl2, (iv) 
dilution. 
 
In order to investigate the H-bonding behaviour of these systems, we decided to carry out 
a VT-NMR study in CDCl3. Figure 2.1 shows a partial 1H-NMR spectrum of the amide 
region of compound 9 at various temperatures. Both amide protons display a temperature 
dependent chemical shift, indicating their involvement in H-bonding. For compound 9, 
the amino acid NH at δ 7.44 and the cystamine NH at δ 6.52 experience an upfield shift 
as the temperature increases. The temperature influence is higher for the Fc-NHB than for 
the CSA NHA. The temperature behavior for all compounds is summarized in Table 2.2.  
 
Table 2.2. Temperature behavior of the amide NH for Fc-compounds 5 – 9 in CDCl3 (1 
mM).  
 
Compound NHA NHB 
 
Fc[CO-CSA]2 (5) - 3.3 
Fc[CO-Gly-CSA]2 (6) 0.8 7.0 
Fc[CO-Ala-CSA]2 (7) 1.5 5.4 
Fc[CO-Val-CSA]2 (8) 2.0 3.5 
Fc[CO-Leu-CSA]2 (9) 0.7 5.3 
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The temperature coefficient for the Fc-amino acid NH is invariably higher than that of 
the cystamine NH for all compounds investigated. The temperature behavior compares 
well with other H-bonded peptide systems.[10]  The CSA NH only displays a shallow 
temperature dependence, which may indicate only weak H-bonding. IR also supports the 
presence of H-bonding. For example, compound 6 displays two NH stretching vibrations 
at 3391 (H-bonded) and 3443 cm-1 (non H-bonded). Similarly, compounds 7 – 9 exhibit 
two NH bands. The presence of H-bonding involving the Fc-amide is supported by the 
structural investigation of compounds 5 and 6.  
               a) 
 
                   b)  
 
Figure 2.1. (a) Stackplot showing the amide NH region of the 1H NMR spectrum of 
compound 9 in CDCl3 (1 mM);  a = 280K, b = 286K, c = 294K, d = 302K, e = 310K and 
f = 320K and (b) showing the temperature behaviour of the Fc-amide NHB and the CSA 
amide NHA. The temperature coefficients are evaluated from the slope. 
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Our X-ray crystallographic investigations of compounds 5 and 6 show the presence of 
two crystallographically independent molecules within the asymmetric unit. The two 
molecules within the asymmetric unit display slightly different bond distances and 
angles. The molecular structure of one of the molecules of compound 5 is shown in 
Figure 2.2. Both Fc molecules adopts a 1,2'-conformation with the amide C=O pointing 
towards the outside of the macrocycle, enabling it to interact with the adjacent molecule 
via an intermolecular H-bond (N…O contact 3.027(4) Å). Intramolecular H-bonding 
interactions, often observed for bis-substituted Fc-amino acid and peptide conjugates are 
not observed.[3]  
 
Figure 2.2. Molecular structure of compound 5 showing the two adjacent molecules in 
the asymmetric unit. Please note the weak H-bonding interaction involving N(2A) and 
O(4). The CSA chain of molecule 1 is disordered over two positions both having 50/50 
occupancy. Only one of the two conformations is shown. Selected bond distances: 
d(S(1A)-S(2A) = 2.0329(18) Å, d(S(1B)-S(2B) = 2.043(3) Å; d(S(3)-S(4)) = 2.0326(9) 
Å, d(S(4)-C(47) = 1.821(3) Å, d(O(3)-C(35) = 1.237(3)  Å, d(O(4)-C(45) = 1.239(3) Å 
(see supplemental material). H-bonding contact: N(1A)…O(3) =2.980(4)Å, N(2A)…O(4) 
= 3.027(4)Å, N(3)…O(2) = 2.821(3)Å, N(4)…O(1) = 2.884(3)Å. 
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Orientation and presumably the size of the macrocycle do not allow formation of any 
intramolecular N…O H-bonding interactions involving the amide groups. The S-S 
distances are S(1A)-S(2A) = 2.0329(18) Å and S(1B)-S(2B) = 2.043(3) Å and S(3)-S(4) 
2.0326(9) Å. C-O bond distances are typical for carbonyl C=O distances found in Fc-
amides.  Both Fc molecules in 5 have virtually co-planar Cp rings (Cp-Fe1-Cp: 2.4º and 
Cp-Fe2-Cp = 0.6º).[11] For the disordered Fc1 system, the amide-Cp twists are 25.5º and 
15.3º for Cp1 (C10-C14) and chain A and chain B, respectively, and 16.5º and 19.9º for 
Cp2 (C20-C24) and chain A and chain B, respectively. For Fc2, the amide twists are 
slightly higher with 26.5º for Cp3 and 21.5º for Cp4. Compound 6 displays the same 
basic structural features. The system adopts a 1,2'-configuration, having both Fc-C=O 
pointing outwards and are engaged in intermolecular H-bonding interactions. But in 
contrast to compound 5, both amide NH in [FcCO-Ala-CSA]2 (6) are engaged in strong 
intramolecular H-bonding to the opposite peptide C=O across the ring (d(N(11)…O(22) = 
2.862(4)Å, d(N(21)…O(12)) = 2.873(4) Å, d(N(31)…O(42) = 2.959(4)Å, d(N(41)…O(32)) 
= 2.815(4) Å). The molecular structure of one of the two molecules within the 
asymmetric unit of compound 6 is shown in Figure 2.3. 6 possesses the same 
intramolecular H-bonding as displayed by the open-chain ferrocene dipeptide conjugates 
reported by Hirao and Metzler-Nolte.[3] Hirao’s Fc[CO-Glu-Leu-OEt]2 displays an 
asymmetric H-bonding interaction of the two podand peptide chains involving the 
carbonyl of the Gly of one chain and the NH of Gly of the other podand dipeptide chain 
with distances of d(N…O) = 3.042(3) Å and 2.753(4) Å.[3b]   For the related system, 
Fc[CO-Gly-Phe-OEt]2, the H-bonding is symmetrical (d(N…O) = 2.84(1)Å). In Metzler-
Nolte’s Fc[CO-Ala-Phe-OMe]2, two intramolecular cross-strand H-bonds were observed  
(d(N…O) = 2.921 Å, 2.924 Å, 2.901 Å, and 2.893Å for the two independent molecules).3g  
In all three systems the second amino acid possesses the ability to enage in additional 
intermolecular H-bonding to four neighboring molecules. In contrast the lack of N…O H-
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bonding ability of Pro in Fc[CO-Gly-Pro-OEt]2 and Fc[CO-Ala-Pro-OEt]2 restrict the H-
bonding pattern to intramolecular cross-strand H-bonding (for Fc[CO-Gly-Pro-OEt]2: 
2.910(4), 2.898(5), 2.85(1), 2.87(1) for two independent molecules; for Fc(Ala-Pro-
OEt)2: d(N…O) = 2.981(8) Å).[3f, g] Variation of the ester group for Fc(Ala-Pro-OR)2 with 
R = Me, Et, Pr, Bz show no changes in the intramolecular H-bonding between Ala NH 
and Ala CO with distances ranging from 3.030(9) Å  to 2.925(9) Å.[3e] As exemplified by 
Fc[CO-Ala-Pro-NHPyMe]2, the structural motif is not even perturbed in the presence of 
other external H-bonding interactions, such as those caused by the interaction of the Fc-
peptide-pyridine conjugate with (1R,3S)-camphoric acid,  indicating its remarkable 
stability even in the presence of other highly H-bonding agents (d(N…O) = 2.97Å and 
2.95Å).[3e]  
 
Figure 2.3. Molecular structure of compounds 6 showing the intra- and intermolecular 
H-bonding interactions a) intramolecular H-bonding: d(N(11)…O(22) = 2.862(4) Å, 
d(N(21)…O(12)) = 2.873(4) Å, d(N(31)…O(42) = 2.959(4) Å, d(N(41)…O(32)) = 
2.815(4) Å; b) intermolecular contacts: d(N(22)…O(42) = 2.974(5) Å, d(N(12)…O(31)* 
= 2.836(4) Å, d(N(32)…O(11)** = 2.843(4) Å, d(N(42)…O(41)# = 2.867(4) Å. 
Symmetry transformations used to generate equivalent atoms: * : +x, -y+0.5, +z+0.5; 
**: +x, -y+0.5, +z-0.5; #: -x+1, +y-0.5, -z+0.5. 
   47
 Despite numerous reports on the stability of the cross-strand H-bonding motif, it is also 
noteworthy that the simple amino acid conjugate Fc[CO-Phe-OMe]2, reported by 
Metzler-Nolte, displays only a single intramolecular H-bond (d(N…O) = 2.832 Å) and in 
addition engages in intermolecular H-bonding with an adjacent molecule (d(N…O) = 
2.935Å), showing the ability of the molecule to switch between two intramolecular and 
more intemolecular H-bonding.3g This of course is in contrast to earlier reports by Erker 
and Mingos who found the conventional cross-strand H-bonding motif in Fc[CO-Val-
OMe]2[12] and Fc[CO-GlyNH2]2.[13] However, the example of Fc[CO-Phe-OMe]2 is 
certainly instructive in showing that this class of compounds may possess a richer richer 
supramolecular chemistry than was initially thought. 
The redox behaviour of compounds 5 – 9 was investigated by cyclic voltammetry 
(CV). A typical CV curve is shown in Figure 4.  
 
 
Figure 2.4. Cyclic voltammogram of compounds 5 and 9 in MeCN (0.1 mM, 0.2 
M TBAP) at a scan rate of 100 mVs-1 on a glassy carbon (BAS) working 
electrode. 
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 All compounds exhibit a fully reversible one electron oxidation, with Faradaic current 
ratios close to unity and peak separations ranging from 76 – 95 mV. Table 2.3 
summarizes the electrochemical behaviour. Redox potentials in general are similar to 
those reported before for H-bonded and non-H-bonded peptides.[3,14] There are some 
noticeable variations in the E1/2 of the Fc-peptide macrocycles. Whereas the E1/2 of 
compound 5 is observed at 740 mV (versus Ag/AgCl), those of the Fc-peptide 
macrocycles 6 – 9, which show E1/2 between 773 and 794 mV (vs. Ag/AgCl). This 
increase coincides with an increase in the number of intramolecular H-bonds, which is in 
contrast to Maran’s Fc-Aib peptides,[15] which show that an decreasing oxidation 
potential with an increase in the number of H-bonds. 
 
Table 2.3. Electrochemical data for compounds 5 – 9.a 
 
Compound E1/2 
(mV) 
∆E 
(mV) 
ic/ia
Fc[CO-CSA]2 (5) 740 80 0.91 
Fc[CO-Gly-CSA]2 (6) 773 77 0.92 
Fc[CO-Ala-CSA]2 (7) 780 95 0.80 
Fc[CO-Val-CSA]2 (8) 789 76 0.92 
Fc[CO-Leu-CSA]2 (9) 794 92 0.88 
 
a 1 mM solution in MeCN, 0.2 M TBAP, scan rate = 100 mVs-1, glassy carbon (BAS) 
working electrode, Pt counter electrode, Ag/AgCl reference electrode. 
   
Cheng andcoworkers also observed small changes of the redox potential in their Fc–
cystine systems that are explained as amino acid specific changes.[5] Similar effects were 
reported earlier for monosubstituted systems[9,16] and maybe rationalized in terms of 
small differences in solvation for the various peptide systems.[9d] However, at the present 
time no rationale backed by solid high-level quantum chemical calculationsis available to 
explain these observations in detail. 
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Chapter 3 
Discovery of the first Pseudo β-Barrel: Synthesis and 
Formation by Tiling of Ferrocene cyclopeptides. 
 
3.0. Connecting Text 
This chapter describes the preparation of synthetic models of a secondary 
structural domain of protein, the β-barrel. Because of the complexity associated in 
managing the β-strand peptides, it was not possible to prepare the synthetic model of this 
important structural motif. By using Fc as a molecular scaffold and Macrocyclization, 
we were able to maintain the β-sheet characteristics of the peptides and moreover, we 
were able to align them in a suitable fashion and assemble through H-bonding providing 
a β-barrel like architecture. Therefore, it demonstrates a critical method for controlling 
the structure of peptides making it relevant to my Ph.D. research objective. 
 
This paper was reproduced with the permission from Angew. Chem. Int. Ed 2006, 45, 751-754, Copyright 
2006, Wiley VCH. This paper was co-authored by D. A. R. Sanders, G. Schatte and H.-B. Kraatz.  All 
experimental works with the exception of crystallographic analysis were carried out by me. In addition I 
wrote the initial draft of the manuscript. The text below is a verbatim copy of the published paper. 
 
3.1. Introduction 
Inspired by channel-forming proteins involved in trans membrane transport and 
controlling biological functions,[1] the construction of porous organic architectures with 
well-defined shapes and sizes from simple building blocks has emerged as an important 
subject in biological chemistry as well in material science.[2-8] In this regard recently 
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introduced peptide-derived materials are used to mimic biological channels and serve as 
models for trans-membrane pores or as antibacterial pore-forming agents,[9-10] with 
potential applications in drug delivery or as constrained chiral reaction environments.[2, 
11-12] These channels are mainly self-assembled from cyclopeptides, which stack on top 
of each other to give large hollow tubes, having the individual cyclopeptides connected 
via H-bonding akin to that found in antiparallel β-sheets. Peptide β-barrel presents a 
particular challenge. This ubiquitous structural motif is present in a wide range of 
proteins, including pore forming proteins present as membrane proteins of gram 
negative bacteria, mitochondria and chloroplast and control many sophisticated 
biological functions.[13] In β-barrel the peptide strands are arranged more or less parallel 
to the axis of the barrel. To date it has not been possible to synthesize a model for such 
an ubiquitous biological structural motif.[14]  Here, we report the synthesis and the 
structure of first artificial β-barrel obtained by self-assembly from smaller bio-
organometallic ferrocene-peptide conjugates. In this model, eight β-strands are arranged 
almost parallel to the axis of the channel having an internal pore diameter of 8Å. 
Experimental evidence shows that the pore appears to be filled with water molecules 
(see below). Our approach offers the potential to exploit such structures for the de novo 
design of functional trans-membrane channels. Such structures may also find 
applications in separation science, supramolecular host-guest chemistry and in molecular 
electronics. 
3.2. Results and Discussion 
The structure of 1-1′ bis-substituted ferrocene-peptide conjugates is controlled by a fine 
balance between inter- and intramolecular H-bonding and attached peptide strands attain 
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β-sheet conformation.[15-18] In general, P-helical and M-helical conjugates with respect 
to ferrocene are formed if L-amino acids and D-amino acids are respectively attached to 
the metallocene and the substituents adopt a flexible anti conformation, which is not 
suitable for sheet-like intramolecular interaction of the elongated peptide strands. We 
decided to force the attached strands arrange parallel to each other by chemically linking 
the two podant peptide chains with cysteamine, a disulfide linker, thereby restricting the 
mobility of the strands. We expected this to have a profound consequence in that this 
chemical modification should foster intermolecular hydrogen bonding, which is akin to 
that found in antiparallel β-sheets. 
In order to optimize intramolecular H-bonding between the two peptide 
substituents, a small twist of the Cp-amide planes is required, resulting in the peptide 
strands to turn towards each other.[19] From this observation we predicted that restricting 
the formation of a “flat” β-sheet by tying the two peptide substituents via a cystamine 
linker will induce additional curving of the peptide strands and thus may allow to create 
hollow H-bonded assemblies based on a β-sheet motif. For this purpose, we designed the 
two ferrocene cyclopeptides, Fc[CO-Gly-Val-CSA]2(5) and Fc[CO-Gly-Ile-CSA]2(6) 
(Gly =  glycine, Val =  valine, Ile = isoleucine, CSA = cysteamine), each having glycine 
as the first amino acid to be attached to the ferrocene, giving maximum flexibility to the 
podant peptide chains, followed by valine or isoleucine, the amino acids with very high 
propensity to form β-sheets. Compounds 5 and 6 were synthesized by the cyclization of 
1-1′ ferrocene dicarboxylic acid and cysteamine peptide conjugates at very high dilution 
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Figure 3.1. The crystal structure of Fc[CO-Gly-Val-CSA]2(5) and schematic view of 
the formation of the pseudo β-barrel: a) molecular structure of compound 5 showing 
the P-helicity of the ferrocene unit and the intramolecular H-bonding between the 
two podant peptide strands. The geometry of the Fc group, the amide substitutents 
and bond lengths and angles  are well within established parameters for Fc-peptide 
conjugates;[20] b) formation of  β-sheets through intermolecular N(H)•••O=C 
hydrogen bonding. The head-to-tail interaction of the molecules results in an unusual 
up-up-down-down arrangement of  the peptide strands. The arrangement between 
the two peptide strands on the two Fc conjugates is antiparallel; c) four molecules 
interact via H-bonding to form  a β-barrel. A view down the c-axis is shown. The 
disordered water molecules inside  the cavity of the barrel were omitted for clarity; 
d) molecular surface representation  showing a side view of the half barrel viewed 
along the c-axis formed by tiling of cyclic ferrocene peptides. Crystal data for 5: 
C30H42Fe1N6O6S2; formula weight: 702.67; crystal system: orthorhombic; space 
group: P212121;  cell dimensions: a = 14.4808(4) Å, b = 16.2650(5) Å,  c = 
16.4770(4) Å, α = β = γ = 90°, Z = 4; µ = 0.543 mm-1, dcalc. = 1.209 Mg/m3. 
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and were characterized spectroscopically. They are poorly soluble in organic solvents, as 
expected for strongly H-bonded materials.[21] Compound 5 is readily obtained in a 
crystalline form suitable for structural analysis by X-ray diffraction from solutions at 
low concentrations. The molecular structure of compound 5, together with its 
supramolecular arrangement is shown in Figure 3.1. 
There are three different types of H-bonding present in the structure of 5. 
Intramolecular H-bonding is observed between the C=O group and the adjacent (H)N 
group [N(21)-O(12), 2.7848(4) Å; N(23)-O(13), 2.848(3) Å and N(11)-O(22), 3.013(4) 
Å]. The Fc[CO-Gly-Val-CSA]2 units are liked via intermolecular H-bonding (2.898(4) 
and 3.036(4) Å). The intermolecular H-bonding interactions between head-to-tail 
connected ferrocene peptides results in the formation of a 14-membered ring, as 
expected for two peptides interacting in an antiparallel β-sheet fashion (see Figure 3. 
1b).[16] The β-sheets are parallel to the bc-plane. Additional H-bonding (2.824(4) Å; 
involving the atoms O23 and N13) between adjacent sheets results in the formation of β-
barrels with a diameter of ca 8 Å (measured between adjacent oxygen atoms of the C=O 
groups, see Figure 3.1c). Importantly, the structural rigidity allows the molecules to act 
as tiles forming what can be described as pseudo-barrels. (Figure 3.1d). 
Figure 3.2 gives a stereoview of a pseudo-barrel formed by tiling of the Fc-
conjugates and superimposed the direction of the individual β-strands. The barrel is 
formed by eight β-strands arranged in a up-up-down-down-up-up-down-down pattern. 
The axis of the barrel is parallel to the ac-plane and perpendicular to the bc-plane. The 
φ/Φ angles for the four residues are (Gly1 -134°/194°, Val1 -56°/146°, Gly2 -76°/161° ,  
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Figure 3.2. Stereoview of the pseudo-barrel formed by tiling of compound 5. 
Indicated are the individual molecules as well as the direction of the individual β-
strands. The φ/Φ angles for the four residues are (Gly1 -134°/194°, Val1 -56°/146°, 
Gly2 -76°/161° , Val2 -115°/64°). These residues all fit close to the theoretical region 
of β-sheet conformations (φ : -180° to -45° and Φ : 45° to 225°). As is  seen with 
naturally occurring β-sheets, there is distortion, but the angles still  fall within the 
“allowed” Ramachandran region associated with beta-sheet  structures.  The third 
“residue” (the cystamine) of one substituent (chain 1)  has a φ value of approx. –97°, 
making the one substituent of the molecule  a fairly close approximation of a β-
strand.[22]
 
Val2 -115°/64°). These residues all fit close to the theoretical region of β-sheet 
conformations (φ : -180° to -45° and Φ : 45° to 225°).[22] As is seen with naturally 
occurring β-sheets, there is distortion, but the angles still fall within the “allowed” 
Ramachandran region associated with beta-sheet structures.[23-27] The third “residue” 
(the cystamine) of one substituent (chain 1) has a φ value of approx. –97°, making the 
one substituent of the molecule a fairly close approximation of a β-strand. 
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There is precedence for naturally occurring an eight-stranded β-barrels. For 
example, OmpX[28], OmpA[29], PagP[30] are all eight stranded barrels with various 
biological functions, ranging from toxin binding, to controlling enzymatic activity. 
Another example is NspA from N. meningitides, which is involved in cell adhesion and 
which has potential applications in structure-based vaccine design.[31] In these natural β-
barrel the β- strands are tilted from the barrel axis where as in our pseudo β-barrel the β-
strands are almost parallel to the barrel axis. 
 Figure 3.3a provides a view of the interior surface of the pseudo barrel, showing 
hydrophilic and hydrophobic characteristics. Some of the peptide carbonyls point 
towards the inside of the pseudo-barrel. We assume that this imparts sufficient 
hydrophilic character on the interior of the barrel to enable water to be inside the 
pseudo-barrels. An X-ray analysis shows a significant amount of residual electron 
density inside the pore, which is best modeled as approximately 12 disordered water 
molecules, with adjacent water molecules separated from each other by approximately 
2.8 Å, which corresponds to strong H-bonding. The closest contact between the water 
and the interior walls of the pseudo barrel is 3.5 Å, indicating weak H-bonding 
interactions with the walls. The solution 1H-NMR of compound 5 in clearly indicates the 
presence of water as part of the crystalline solid. The NMR indicates the presence of 
approximately 1.2 - 1.5 molecules of water per molecule of Fc-peptide for a total of 
approximately 9 to 12 molecules of water per 8-mer or pseudo-barrel. Since the space 
within the barrel is 386 Å3, theoretically ten water molecules, each occupying 40 Å3, 
could fit the pore. Therefore, a model including only water molecules inside the pore 
best fits all the experimental evidence. This compares well with pore-forming 
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cyclopeptides, described before by Ghadiri, who has interpreted residual electron density 
present within the pores of the cylindrical β-sheet peptide as water molecules.[32]
 
 
Figure 3.3. a) van der Waals surface representation of a cut-away side view of the 
interior of the pseudo-barrel showing the hydrophilic and hydrophobic characteristics. 
The colour coding corresponds to atoms: red (oxygen), blue (nitrogen), yellow 
(sulphur), gray (carbon); b) The same side view of the pseudo-barrel is presented as in 
Fig 3a generated by tiling of molecules of compound 5. This channel has an interior 
diameter of ca 8Ǻ. The residual electron density within this channel is interpreted as 
water molecules which are disordered over several positions and only the approximate 
envelope of the channel content is shown. 
 
 
FT-IR is also a powerful technique in examining the secondary structure of 
peptides.33 In particular, the Amide-I region offers a characteristic footprint that allows 
to distinguish between an α-helix, a β-sheet and a random coil conformation. The FT-IR 
spectrum of compound 5 in the solid state exhibits amide-I bands at 1640cm-1 and 1682 
cm-1 and an amide-II at 1536 cm-1 which are the characteristic peaks for β-sheet.[33,34] 
Importantly, the IR absorptions are virtually identical for the Ile derivative 6 (1640 cm-1, 
 59
1680 cm-1 and 1535 cm-1 respectively) (see 3.S1), indicating that the structures of 5 and 
6 are similar in the solid state. As expected, the amide N-H are involved in H-bonding 
and absorptions are observed in the Amide-A region at 3280 cm-1 and 3282 cm-1 for 5 
and 6, respectively. Our observations are closely related to those made by Ghadiri and 
co-workers who showed that cyclo-peptides having an alternating D- and L amino acid 
sequence, assemble via intermolecular H-bonding into peptide nanotubes where the 
individual building blocks have antiparallel β-sheet conformation.[5] 
 
3.3. Conclusions 
In summary, we outline a potential strategy for the design of porous peptide 
materials, in which the barrel-like pores are formed by the self-assembly of bio-
organometallic peptide conjugates. Although solubility of these systems is at present a 
challenge, the use of hydroxyl-containing amino acids such as serine and threonine 
should allow us to study the self-assembly in solution. Our approach may hold promise 
for the assembly of large porous peptide materials from readily available starting 
materials, which may find applications in biological chemistry as well as materials 
science. If successful, the strategy described here should lend itself to the preparation of 
de novo proteins incorporating the β-barrel motif.  
 
3.4. Acknowledgements: We acknowledge support from NSERC in the form of an 
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Supporting information describing synthesis characterization of 5 , 6  and intermediates, 
IR spectra of 5 and 6 and X-ray structural data for compound 5 is presented below, after 
references. 
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3.6. Supporting Information 
3.6.1. Experimental 
3.6.1.1. General: All syntheses were carried out in air unless otherwise indicated. 
CH2Cl2 (BDH; ACS grade) used for synthesis was dried (CaH2) and distilled prior to 
use. CDCl3 (Aldrich) were dried by, and stored over molecular sieves (8-12 mesh; 4Å 
effective pore size; Fisher) before use. CD3CN (Aldrich) was used immediately opening 
the sealed ampoule.  EDC, HOBt, BOP, CSA·2HCl (Aldrich), MgSO4, NaHCO3 
(VWR), and 1,1'-Fc(OH)2 was synthesised by known method. Et3N (BDH; ACS grade) 
used in the synthesis was used as received. For column chromatography, a column with 
a width of 2.7 cm (ID) and a length of 45 cm was packed 18-22 cm high with 230-400 
mesh silica gel (VWR). For TLC, aluminum plates coated with silica gel 60 F254 (EM 
Science) were used. NMR spectra were recorded on a Bruker AMX-500 spectrometer 
operating at 500 MHz (1H) and 125 MHz (13C{1H}). Peak positions in both 1H and 13C 
spectra are reported in ppm relative to TMS. The 1H-NMR spectra are referenced to the 
residual CHCl3 signal at δ 7.27. All 13C{1H}-NMR spectra are referenced to the CDCl3 
signal at δ 77.23 ppm.  
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3.6.1.2. Synthesis of Cysteamine -Amino acid conjugates   
3.6.1.2.1. [Boc-Val-CSA]2 (1): Boc-Val-OH (1.89 g; 10 mmol) was dissolved in 30 ml 
of DCM. Solid HOBt (1.68 g; 11 mmol)  and of EDC•hydrochloride (2.10 g; 11 mmol) 
were added sequentially. After 20 minutes, the reaction mixture was cooled in an ice 
bath. To the reactions solution, a solution of CSA dihydrochloride (1.12 g; 5 mmol) in 
50 ml of DCM and 2 ml Et3N was added dropwise over 5 minutes. After completion, the 
reaction mixture was allowed to warm up and was kept at room temperature for 10 hours 
under constant stirring. The resulting solution was then washed successively with 
saturated NaHCO3, 10% citric acid, saturated NaHCO3 and then water. Then it was 
evaporated under reduced pressure in a rotorvap. The product was purified by column 
chromatography Silica gel column, (ethyl acetate : hexane =50:50, Rf = 0.33) yellowish 
white powder. Yield = 79%. 1H NMR (δ, CDCl3) 7.13 (d, 1H, amide NH), 5.80 (m 1H 
NH attached to Boc), 4.26(s 1H α H of Val), 3.60 (d, 2H, CH2 attached to NH), 2.80 (m, 
2H, CH2 attached to S), 2.10 (m, 1H,  β-H of Val), 1.56 (s, 9H, Boc), 0.97 (d, 3H, Val 
CH3), 0.95 (d, 3H, another Val CH3) 
 
3.6.1.2.2. [Boc-Ile-CSA]2 (2): Procedure for the synthesis is similar to 1. Column (ethyl 
acetate: hexane = 75 : 25, Rf = 0.28) white powder. Yield = 82%. 1H-NMR (δ, CDCl3) 
7.13 (d 1H amide NH), 5.80 (m 1H NH attached to Boc), 4.26(s 1H α H of Ile), 3.60 (d 
2H CH2 attached to NH), 2.80 (m 2H CH2 attached to S), 2.10 (m 1H sec. H of Ile. side 
chain),1.56 (s 9H Boc), 1.3 (2H, CH2 of Ile) 0.97 (d 3H Ile CH3), 0.95 (d 3H another Ile 
CH3) 
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3.6.1.2.3. [Boc-Gly-Val-CSA]2 (3): Boc-Gly-OH (0.95 g; 5 mmol) was dissolved in 30 
ml of DCM. Solid HOBt (0.84 g; 5.5 mmol) and of EDC•hydrochloride (1.05 g; 5.5 
mmol) were added sequentially. After 20 minutes, the reaction mixture was cooled in an 
ice bath. To the reactions solution, a solution of [Boc-Val-CSA]2 (1) (1.38 g; 2.5 mmol) 
deprotected by the treatment with TFA followed by basification by the addition of 
tryethyl amine in 50 ml of DCM was added dropwise over 5 minutes. After completion, 
the reaction mixture was allowed to warm up and was kept at room temperature for 10 
hours under constant stirring. The resulting solution was then washed successively with 
saturated NaHCO3, 10% citric acid, saturated NaHCO3 and then water. Then it was 
evaporated under reduced pressure in a rotorvap. The product was purified by column 
chromatography (silica gel ethyl acetate 100%, Rf = 0.28) to get the pure product in 60% 
yield (1.02 g).  1H NMR (δ, CDCl3 ) 7.33(s, 1H, NH close to Cp) , 7.25 (s, 1H, NH form 
Val), 6.53 (s, 1H, NH of CSA) 4.02 (d, 1H, α-H of Val), 3.86 (m, 2H, α-H of Gly), 3.57 
(d, 2H, CH2 attached to NH of CSA), 2.84 (d, 2H, CH2 attached to S of CSA), 1.91(d, 
1H, β-H of Val), 1.46 (s, 9H, CH3 of Boc), 0.96 (d, 3H, CH3 of Val), 0.94 (d, 3H, 
another CH3 of Val) 
3.6.1.2.4. [Boc-Gly-Ile-CSA]2 (4): Procedure for the synthesis is similar to 3. Column, ( 
ethyl acetate : hexane = 75:25, Rf = 0.31) white powder. Yield = 82%.  1H-NMR (δ, 
CDCl3 ) 7.21(s, 1H, NH close to Cp) , 7.15 (s, 1H, NH form Ile) , 5.68 (s, 1H, NH of 
CSA) 4.51 (d, 1H, α-H of Ile), 3.69 (m, 2H, α-H of Gly), 3.59 (d, 2H, CH2 attached to 
NH of CSA), 2.85 (d, 2H, CH2 attached to S of CSA), 1.90 (d, 1H, β-H  of Ile), 1.59 (m, 
2H, CH2 of Ile) 1.44 (s, 9H, CH3 of Boc), 0.96 (d, 3H, CH3 of Ile), 0.91 (d, 3H, another 
CH3 of Ile) 
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 3.5.1.3. Synthesis of Macrocycles 
3.5.1.3.1. Fc[CO-Gly-Val-CSA]2 (5): In an ice-bath, ferrocenedicarboxylic acid (0.055 
g; 0.2 mmol) was dissolved in dichloromethane (10 mL), followed by the addition of 
HOBt (0.062 g; 0.4 mmol) and EDC (0.078 g; 0.4 mmol). After half an hour, the 
reaction mixture was diluted to 300 ml by dichloromethane. In another flask, cystamine 
dihydrochloride (2) (0.045 g; 0.2 mmol) was dissolved in 10 ml of dichloromethane and 
1 ml of triethylmine.The resulting solution was diluted to 100ml. In another 2L flask 
0.132 g (0.2 mmol) of [Boc-Gly-Val-CSA]2(3) deprotected by the treatment with TFA 
followed by basification by the addition of triethylamine. Then it was diluted to 1400ml 
by dry DCM. To this solution was added the first solution over 5 minutes in ice bath. 
Stirring was continued for 48 hours at room temperature. Then the solution was washed 
consecutively with saturated NaHCO3, 10% aqueous citric acid, saturated aqueous 
NaHCO3 and water. The organic phase was then dried over anhydrous Na2SO4, and then 
evaporated at 250C under reduced pressure to get the crude product. It was then purified 
by flash chromatography on silica (EtOAc:MeOH = 95:5 v/v, Rf = 0.30) to get 77 mg 
(42 %) of the desired compound. FTIR (Resolusion 1 cm-1) : 1640 cm-1, 1682 cm-1 
(C=O), 1536 cm-1 (C-N of amide) 3280 cm-1 (N-H stretching) UV-vis: (λ in nm, [ε in M-
1cm-1]): 442 [280] HRMS (ES): Calc. for  C30H42N6O6FeS2 [M]+, 702.6870  observed 
mass [M+1]+ 703.6921;  1H NMR (δ, CD3CN ): 8.27 (s, 1H, NH closest to Cp), 7.18 (s, 
1H, NH form Val), 6.76 (d J=1.7Hz NH from CSA), 4.86 (d j=12.6Hz 1H αH of Val), 
4.61 (s 1H ortho-H of Cp), 4.54 (s, 1H, another ortho-H of Cp), 4.37 (s, 1H, meta-H of 
Cp), 4.35 (s, 1H, another meta-H of Cp), 3.67 (m, 2H, α-H of Gly) 3.47 (m, 2H, CH2 
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attached to NH of CSA), 2.83 ( m, 2H, CH2 attached to S of CSA), 2.12 (m, 1H,  β-H of 
Val), 0.93 (d, 3H, CH3 of side chain of Val) 0.92 (d, 3H, another CH3 of side chain of 
Val);  13C{1H}-NMR (δ, CD3CN): 172.1 (C=O closest to Cp), 171.9 (C=O from Gly), 
169.8 (C=O of Val), 76.4 (ipso-C of Cp), 72.3 (ortho-C Cp), 71.6 (another ortho-C Cp), 
71.3 (meta-C Cp), 70.1 (another meta-C Cp), 59.1 (α-C of Val), 42.6 (αC of Gly), 38,5 
(CH2 of CSA attached to NH), 38.1 (CH2 of CSA attached to S), 30.7 (β-C of Val), 18.9 
(CH3 of Val), 17.5 (another CH3 of Val).  
 
 
                           R=isopropyl (5) and isobutyl (6) 
 
Scheme 3.S1. Synthesis of ferrocene-cyclopeptides : (a) EDC/HOBt in CH2Cl2; (b) 
CSA• 2HCl and TEA  solution  in CH2Cl2; (c) 50% TFA in CH2Cl2, stirred for half an 
hour (d) TEA in ice bath (e) Boc-amino acid activated by EDC/HOBT (f) solution of A 
at 0.05mM dilution and stirred for 48 hours. 
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3.5.1.3.2. Fc[CO-Gly-Ile-CSA]2 (6): Synthesis procedure is similar to 5. Column on 
silica (EtOAc:MeOH = 95:5 v/v, Rf = 0.30), yield 49 %. FTIR: 1640 and 1680 cm-1 
(C=O), 1535 cm-1 (C-N of amide) 3282 cm-1 (N-H stretching); UV-vis: (λ in nm, [ε in 
M-1cm-1]): 441 [278]; HRMS (ES): Calc. for  C32H46N6O6FeS2 [M]+ 730.4221 observed 
mass [M+1]+ 731.4256 ; 1H-NMR (δ, CD3CN ): 8.41 (s, 1H NH closest to Cp), 7.35 (s, 
1H NH form Ile), 6.70 (d, J = 5.7 Hz, NH from CSA), 4.87 (d, J = 12.6 Hz, 1H, αH of 
Ile), 4.61 (s, 1H, ortho-H of Cp), 4.53 (s, 1H, another ortho-H of Cp), 4.36 (s, 1H, meta-
H of Cp), 4.34 (s, 1H, another meta-H of Cp), 3.71 (m, 2H αH of Gly), 3.64 (m, 2H, 
CH2 attached to NH of CSA), 2.85 ( m, 2H, CH2 attached to S of CSA), 1.88 (m, 1H, β-
H of Ile), 1.54 (d, 2H, CH2 of Ile), 0.95 (m, 2H, CH3 of Ile), 0.87 (d, 2H, CH3 of Ile) ; 
13C{1H}-NMR (δ, CD3CN): 172.5 (C=O closest to Cp), 171.2 (C=O from Gly), 170.9 
(C=O from Ile), 76.0 (ipso-C of Cp), 72.4 (ortho-C Cp), 71.7 (another ortho-C Cp), 71.4 
(meta-C Cp), 70.2 (another meta-C Cp), 58.4 (αC of Ile), 43.3 (αC of Gly), 39.1 (CH2 of 
CSA attached to NH), 38.8 (CH2 of CSA attached to S), 37.6 (β-C of Ile), 25.0 (CH2 of 
Ile) 15.9 (CH3 of Ile), 12.6 (another CH3 of Ile). 
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3.6.2. Structural Study 
3.6.2.1. FT-IR study  
FT-IR spectra were recorded in BIO-RAD, FTS-40 in solid state (KBr) from 400 
cm-1 to 4000cm-1. 
 
Figure 3.S1.  Representative partial FT-IR spectrum (1 cm-1 resolution) for  Fc[Gly-
Val-CSA]2(5) and  Fc[Gly-Ile-CSA]2(6), in the solid state (KBr). Components peaks 
are obtained by deconvolution of the original spectrum with single component Gaussian 
function using origin software (a) amide-I and amide-II region of 5, (b) amide-I and 
amide-II region of 6 and (c) amide-A  region of 5 (d) amide-A region of 6. 
 
3.6.2.2. Determination of Water Content in the Crystals by 1H-NMR Spectroscopy     
NMR Spectra were obtained in DMSO-D6.Crystals were made by the same 
method as was used to prepare the crystal for X-ray diffraction i.e. by diffusing hexanes 
in the 1 mM solution of 5% methanol in chloroform (all solvents used were undistilled). 
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Crystallization was done in crystallization tubes of approximate same dimension as an 
NMR tube. After one day crystals were taken out washed by ether, dried under vacuum 
and put in NMR tube. 400µL of DMSO was added. In an another blank NMR tube, 
400µL of DMSO was taken from the same bulk. Immediately tubes were closed and 
wrapped carefully to avoid air entry. 
For blank solvent the integration of water peaks were calibrated to 1 and the 
corresponding value for the solvent residual peaks were noted. In sample solution the 
integration of solvent residual peak were calibrated to the value of the blank. Thus the 
integration of corresponding water peak was the summation of water in the solvent plus 
the water from the crystal. In this case the two protons from cysteamine residue were 
merging to the water peak and was taken into consideration. The integration of the α-
proton of Valine residue was taken as standard and each molecule contains two alpha 
protons. Calibrating the integration of α-protons of Valine to two, the amount of water 
per molecule was calculated.  
 
3.6.2.3. X-ray Crystallography 
 Crystalllization of Fc[Gly-Val-CSA]2(5) was done by slowly diffusing hexane to 
the very dilute solution in metanol and chloroform mixture. Yellow rod shaped crystal  
of approximate dimension of 0.15 × 0.15 × 0.15 mm suitable for x-ray crystallography 
was deposited after 3 days. All measurements were made on a Nonius KappaCCD 4-
Circle Kappa FR540C diffractometer using monochromated Mo Kα radiation (λ = 
0.71073 Å) at -100 °C. An initial orientation matrix and cell was determined from 10 
frames using φ scans.[S1] Data were measured using φ- and ω-scans. [S1] Data reduction 
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was performed with the HKL DENZO and SCALEPACK software [S2], which corrects 
for beam inhomogeneity, possible crystal decay, Lorentz and polarisation effects. A 
multi-scan absorption correction was applied (SCALEPACK,).[S2]
The 20276 collected reflections were merged (Rint = 0.0704) to provide 6518 
data, of which all were unique (Rsigma = 0.0640) and 5690 observed (I > 2σ(I)) 
reflections (SHELXL97-2).[S5] The ranges of indices were –16 ≤ h ≤ 16, -19 ≤ k ≤ 15, -
16 ≤ l ≤ 19 corresponding to a θ-range of 1.88 to 24.71°. The structure was solved using 
direct methods (SIR-97 [S4]) and refined by full-matrix least-squares method on F2 with 
SHELXL97-2.[S5] The non-hydrogen atoms were refined anisotropically. Hydrogen 
atoms were included at geometrically idealized positions (C-H bond distances 
0.95/0.98/0.99 Å) and were not refined. The isotropic thermal parameters of the 
hydrogen atoms were fixed at 1.2 times that of the preceding carbon atom. Attempts to 
refine peaks of residual electron density as water were unsuccessful. The data were 
corrected for disordered electron density through use of the SQUEEZE [S7] procedure as 
implemented in PLATON.[S8] A total solvent-accessible void volume of 774.9 Å3 
(20.1% of the unit cell volume) with a total electron count of 241 was found in the unit 
cell. Electron density identified in solvent accessible areas are given in Table S1. 
 
Table 3.S1. Electron density per void and volumes. 
 
No. of 
Void 
       Centre of Void Volume [Å3] % volume  Electron 
Count/void
 Xav Xav Xav    
1 -0.024 0.025 0.000 386 7.5 120 
2 0.007 0.7504 0.500 386 1.2 120 
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Table 3.S2.  Crystal data and structure refinement for compound 5. 
_________________________________________________________________ 
 
Empirical formula                                         C30H42FeN6O6S2
Formula weight                                         702.67 
Temperature                                                     173(2) K 
Wavelength                                                     0.71073 Å 
Crystal system                                         orthorhombic 
Space group                                                     P212121 (No. 19; Hall: P2ac 2ab) 
Unit cell dimensions                                        a = 14.4080(4) Å b = 16.2650(5) Å  
                                                                           c = 16.4770(4) Å;  α= 90° β= 90°γ = 90° 
Volume                                                    3861.32(19) Å3 
Z                                                                4 
Density (calculated)                                        1.209 Mg/m3 
Absorption coefficient                             0.543 mm-1 
F(000)                                                                 1480 
Crystal size                                                     0.15 x 0.15 x 0.15 mm3 
Theta range for data collection                 1.88 to 24.71°. 
Index ranges                                                    -16<=h<=16, -19<=k<=15, -16<=l<=19 
Reflections collected                                          20274 
Independent reflections                              6518 [R(int) = 0.0704] 
Completeness to theta = 24.71°                  99.7 %  
Max. and min. transmission                              0.9230 and 0.9230 
Refinement method                                          Full-matrix least-squares on F2 
Data / restraints / parameters                              6518 / 0 / 410 
Goodness-of-fit on F2 [6]                              1.087 
Final R indices [I>2sigma(I)]                              R1 = 0.0485, wR2 = 0.0983 
R indices (all data)                                          R1 = 0.0612, wR2 = 0.1021 
Absolute structure parameter                              0.046(19) 
Largest diff. peak and hole                              0.397 and -0.421 e.Å-3 
___________________________________________________________________ 
 
Expected volume for H2O solvent molecules is 40 Å3. The modified data improved the 
R-factors (before SQUEEZE: R1 = 0.1010, wR2 = 0.2631; largest difference peak and 
hole, 3.07 and -0.81 e-/Å3; after SQUEEZE: R1 = 0.0485, wR2 = 0.1021; largest 
difference peak and hole, 0.397 and -0.421 e-/Å3). Derived values (formula weight, 
density, absorption coefficient) do not contain the contribution of the disordered solvent. 
The final cycle of full-matrix least squares refinement using F2 (SHELXL97-2,)[S5] was 
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based on 6518 reflections and 410 variable parameters. Neutral atom scattering factors 
for non-hydrogen atoms and anomalous dispersion coefficients are contained in the 
SHELXTL-NT 6.14[S3] program library. 
 
 
 Table 3.S3. Hydrogen bond distances [Å] for compound 5. 
_____________________________________________________ 
 
Intramolecular: 
 
N(21)(H)····O(12) 2.784(4) 
N(11)(H) ····O(22) 3.013(4) 
N(23)(H) ····O(13) 2.848(4) 
 
Intermolecular: 
 
O(23)····(H)N(13))* 2.823(4) 
N(13)(H)····O(23)** 2.823(4) 
O(11)····(H)N(22)’ 3.036(4) 
N(12)(H)····O(21)’ 2.898(4) 
N(22)(H)····O(11)” 3.036(4) 
O(21)····(H)N(12)” 2.898(4) 
_____________________________________________________ 
Symmetry transformations used to generate equivalent atoms: 
 
*: -x, y - 0.5, -z + 0.5 
**: -x, y + 0.5, -z + 0.5 
’: -x + 0.5, -y + 1, z - 0.5 
”: -x + 0.5, -y + 1, z + 0.5 
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Figure 3.S2. (a) Molecular structure of compound Fc[CO-Gly-Val-CSA]2(5), (b) 
Representation of barrel formed by the tiling of the cyclopeptides and (c) Picture of 
the crystals of compound five formed by slow evaporation of solvent from the 
solution in methanol and chloroform on glass slide. For slow evaporation the glass 
slide was put inside a beaker, covered by aluminium foil. 
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Figure 3.S3. Crystal structure of Fc[CO-Gly-Val-CSA]2(5) in space filling mode, 
diffused water molecules are taken out (a) Showing the three dimensional network 
of pores. 
 
 
 
 
 
Figure 3.S4. Crystal structure of Fc[CO-Gly-Val-CSA]2(5) showing the hydrogen 
bonding between diffused water molecules, between the molecules of the barrel and 
the diffused water molecules and the molecules of the barrel.[S9]
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Chapter 4 
Synthesis and Structure of Extended β-Sheet Like Peptides 
Using Ferrocene as Molecular Scaffold 
 
4.0. Connecting Text 
Acyclic Fc-peptide conjugates do not form inter-strand intramolecular H-bond 
beyond the first amino acid. They even adopt γ-turn through the formation of intra-
strand H-bonding. In this chapter, we have described the rational design and preparation 
of two Fc-tripeptide conjugates, Fc[CO-Gly-Val-Cys(Bz)-OMe]2 and Fc[CO-Gly-Ile-
Cys(Bz)-OMe]2. Structural studies in solution and solid states showed the formation of 
extended β-sheet-like structures. This shows that, by selecting the proper sequence of 
amino acids, it would be possible to extend the inter-strand H-bonding in acyclic Fc-
peptide conjugates and longer β-sheet like structures could be achieved. Hence, this is a 
critical method for controlling the structure of peptides.  
This chapter is the reproduced from the prepared manuscripts to be submitted to Organic Letters. 
Permissions have been obtained from the co-authors G. Schatte and H.-B. Kraatz. All experimental works 
with the exception of crystallographic analysis were carried out by me. In addition I wrote the initial draft 
of the manuscript.  
 
4.1. Introduction 
β-sheets are the crucial secondary structural elements of proteins. Due to a very 
high tendency of self-aggregation and complexity of their folding, β-sheet models are 
difficult to study. Out of numerous attempts in preparing the β-sheet models of 
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peptides,[5] conjugation of peptides with non-natural scaffolds has been a successful 
strategy.[6] Ferrocene, an organometallic molecule having two easily rotating parallel 
cyclopentadiene (Cp) rings, has been widely explored as a molecular scaffold to impart a 
specific secondary structure to the attached peptide.[7] These conjugates self-assemble 
through H-bonding, resulting in novel and interesting supramolecular architectures. It 
has been found that podant amino acids and peptide attached to the two different Cp 
rings engage in H-bonding interaction akin to that found in β-sheet peptides. The design 
of these Fc-conjugates have been systematically studied by various researchers.[8] It is 
observed that when a single amino acid is linked to each Cp ring of ferrocene 
dicarboxylic acid through an amide bond, they form 10-member intramolecularly H-
bonded rings, as is found in antiparallel β-sheets (1 in Figure 4.1).  
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Figure 4.1. Formation of β-sheet-like conformations of disubstituted ferrocene-
peptide conjugates with the different lengths of peptide strands. 
 
However, as the peptide chain is extended to a dipeptide, the two peptide chains point in 
opposite directions, giving rise to a helical arrangement with respect to Fc moiety (2 in 
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Figure 4.1). Hirao and co-workers have reported Fc-dipeptide-heterocycle conjugates, 
where the peptide strands are engaged in intrastrand H-bonding with the formation of γ-
turn motifs.[9] Apparently, it seems that it is not possible to align the conjugated peptide 
strands in an extended interstrand H-bonded conformation. Here, we report the design of 
two peptide conjugates of ferrocene that adopt a β-sheet-like conformation through the 
formation of extended intramolecular interstrand H-bonding (3 in Figure 4.1).  
 
4.2. Results and Discussions 
In our earlier study,[10] we attempted to get extended H-bonded β-sheet-like 
structures by cyclization, and we realized that it might be possible to prepare acyclic Fc-
peptide conjugates in extended H-bonded form if the proper sequence of amino acids is 
chosen. The systems with Gly as the first amino acid attached to Fc provide the 
maximum flexibility to the podand peptide chains. The following the amino acids with 
high propensity for β-sheet seemed to be able to maintain β-sheet-like conformation in 
extended form. In this present study we have explored that hypothesis. With the 
aforementioned idea, we selected the sequences Gly-Val-Cys and Gly-Ile-Cys and 
conjugated to 1,1'-Fc-dicarboxylic acid through Gly. Structural investigation of these 
conjugates has been performed in the solution and solid states, which reveal the 
formation of extended β-sheet-like conformation of the peptide backbone. 
Suitably protected dipeptides, Boc-Val-Cys(Bz)-OMe (4) and Boc-Ile-Cys(Bz)-
OMe(6) and tripeptides Boc-Gly-Val-Cys(Bz)-OMe (5) and Boc-Gly-Ile-Cys(Bz)-OMe 
(7) were synthesized by the standard solution peptide coupling method using HBTU as a 
coupling reagent. The target compounds  Fc[CO-Gly-Val-Cys(Bz)-OMe]2 (8) and 
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Fc[CO-Gly-Val-Cys(Bz)-OMe)2 (9) were synthesized by coupling the tripeptides to 
ferrocene dicarboxylic acid using the same coupling techniques. All the compounds 
were fully characterized spectroscopically (see section 4.6.1.2.). In compound 8, the 1H-
NMR spectrum shows that the NH of both Gly and Cys resonates at down fields, 
respectively at 8.64 ppm and 7.14 ppm which indicates their strong involvement in H-
bonding. This is expected for the proposed structure, where these NHs are supposed to 
participate in intramolecular H-bonding. The NH of Val resonates at higher field, δ 6.55, 
suggesting its weaker involvement in H-bonding. This fact also correlates with the 
proposed structure. A similar 1H-NMR resonance pattern has been observed in 
compound 9 (where chemical shifts are δ 8.68, 7.20 and 6.63 respectively for Gly, Cys 
and Ile). This hypothesis was further tested by a variable concentration 1H-NMR study 
(see Figure 4.2).  
 
Figure 4.2. 1H-NMR spectra of the amide regions of compound 8, Concentration 
(mM) from bottom to top; 2.00, 1.60, 1.33, 1.14, 1.00, 0.98 and 0.80. Peak A for Gly 
NH, B for Cys NH and C for Val NH. 
 
 
In this study, it is observed that as the concentration of the solution decreases, the 
chemical shifts for NHs of Val in 8 and Ile in 9, shift towards upfield, suggesting their 
involvement in intermolecular hydrogen bonding. On the other hand, the chemical shifts 
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for NHs of Gly and Cys, in both the compounds remain almost constant with the 
variation of concentration. 
 Circular dichroism (CD) spectroscopy is a reliable tool to evaluate the 
conformation of Fc-conjugates by using the Fc band (+ or –) at about 450 nm and has 
been extensively used to determine the conformation of Fc-peptide conjugates. CD 
spectral study (Figure 4.3) of our proposed β-sheet-like peptide conjugates show  the 
positive absorption for ferrocene d-d transition at around 480 nm, which is the indication 
of the formation of P-helical structure as expected for intramolecularly hydrogen bonded 
L-amino acid conjugates of disubstituted ferrocene. The negative absorption bands 
around 217 and 219 nm respectively in 8 and 9 indicate the presence of β-sheet 
conformation of the peptide backbones.  
 
 
Figure 4.3. CD spectra of compound 8 and 9 in CH3CN solution at 25ºC, showing the 
presence of P-helical arrangement of podand peptides with respect to ferrocene and 
signature of β-sheet conformations. 
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Suitable crystals of compound 8 and 9 were obtained by slow evaporation of 
solvents from solutions in chloroform at 0ºC temperature. Single crystal structural 
analysis by X-ray diffraction show that both of the compounds crystallize in the P212121 
space group. The molecular structures of the compounds 8 and 9, are shown in Figure 
4.4. 
                 (a) 
 
                    (b) 
 
 
 
Figure 4.4. Molecular structures of compounds 8 (a) and 9 (b) as obtained from single 
crystal X-ray diffraction study, showing the extended β-sheet-like forms. Hydrogen 
atoms are omitted for clarity. Grey spheres represent carbon, red spheres oxygen, blue 
spheres nitrogen, yellow spheres sulfur and orange spheres represent iron atoms.  
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The crystal structures clearly show the formation of extended β-sheet 
conformation. In both the molecules 8 and 9, several intramolecular H-bondings are 
observed between the C=O group of one peptide strand and the (H)N group of other 
strand (O12···N21 = 2.846 Å, O22···N12 = 2.915 Å, O14···N23 = 3.082 Å and O24···N13 
= 3.054  Å in 8 and O12···N21 = 2.825 Å, O22···N12 = 2.887 Å, O24···N13 =  3.341 Å 
and O14···N23 = 3.125 Å  in 9). It is observed that the H-bond distances involving Gly-
NH are shorter, which correlates with the downfield shift of the resonances in 1H-NMR 
spectroscopy. The longer H-bonds involving Cys-NH may be due to the steric repulsion 
between the bulky protecting groups on Cys.  
 
 
 
 
Figure 4.5. Intermoleculecular arrangement of 8 showing the formation of sheet-like 
assembly. The intermolecular hydrogen bonding distances are O11···N22* = 2.869 Å, 
and N12···O22** = 3.064 Å; * = -x + ½, -y, z - ½, ** = -x + ½, -y, z + ½. 
Compound 9 shows the identical supramolecular assembly. The intermolecular 
hydrogen bonding distances are O11···N22* = 2.926 Å, and N12···O22** = 2.894 Å; * 
= -x + 1, y + ½, -z + ½, ** = -x + 1, y - ½, -z + ½. 
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Each single molecule is linked to two other molecules via intermolecular H-bonding 
(O11···N22* = 2.869 Å, and N12···O22** = 3.064 Å in 8 and O11···N22* = 2.926 Å and 
N12···O22** = 2.894 Å in 9) to form the sheet like continuous assembly (Figure 4.4). 
The intermolecular H-bonding interactions between head-to-tail connected ferrocene 
peptides results in the formation of a 14-member antiparallel β-sheet like structure. 
FT-IR is also a powerful technique in examining the secondary structure of 
peptides.[11] Absorptions in the Amide-I region offer a characteristic signature that 
allows to distinguish an α-helix, a β-sheet and a random coil 
 
 
Figure 4.6. FTIR spectroscopy of 8 showing (a) amide-I, amide-II and (b) amide-A 
regions. 
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conformation. The FT-IR spectrum of compound 8 in the solid state exhibits amide-I 
bands at 1634 cm-1 and 1680 cm-1 and an amide-II at 1531 cm-1, which are the 
characteristic peaks for β-sheet conformation.[11,12] The IR absorptions of 9 (1638 cm-1, 
1679 cm-1 and 1533 cm-1 respectively) are identical to those of compound 8  (see Figure 
4.S1).This also indicates that the structures of 8 and 9 are similar in the solid state. In 
Amide-A regions the absorptions are 3294 cm-1 and 3282 cm-1 for 8 and 9 respectively 
suggesting the involvement of N-Hs in H-bonding which is expected in the proposed 
structures. 
 
4.3. Conclusions 
In conclusion, we have designed the Fc-peptides conjugates which can adopt 
extended β-sheet-like conformations. The proposed structures have been confirmed by 
NMR, CD and, IR and X-ray crystallography. These are the first examples of extended 
β-sheet conformation in acyclic Fc-peptide conjugates. 
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4.6. Supporting Information 
4.6.1. Experimental 
4.6.1.1. General: All syntheses were carried out in air unless otherwise indicated. 
CH2Cl2 (BDH; ACS grade) used for synthesis, was dried (CaH2) and distilled prior to 
use. CDCl3 (Aldrich) was dried and stored over molecular sieves (8-12 mesh; 4Å 
effective pore size; Fisher) before use. CD3CN (Aldrich) was used immediately opening 
the sealed ampoule. BocGly-OH, BocVal-OH, H-Cys(Bz)-OMe (Advanced Chemtech), 
HOBt, HBTU, (Aldrich), MgSO4, NaHCO3 (VWR), and 1,1'-Fc(OH)2 was synthesised 
by known method. Et3N (BDH; ACS grade) used in the synthesis was used as received. 
For column chromatography, a column with a width of 2.7 cm (ID) and a length of 45 
cm was packed 18-22 cm high with 230-400 mesh silica gel (VWR). For TLC, 
aluminum plates coated with silica gel 60 F254 (EM Science) were used. NMR spectra 
were recorded on a Bruker AMX-500 spectrometer operating at 500 MHz (1H) and 125 
MHz (13C{1H}). Peak positions in both 1H and 13C spectra are reported in ppm relative 
to TMS. The 1H-NMR spectra are referenced to the residual CHCl3 signal at δ 7.27. All 
13C{1H}-NMR spectra are referenced to the CDCl3 signal at δ 77.23.  
 
4.6.1.2. Synthesis and Characterization  
 4.6.1.2.1. Boc-Val-Cys(Bz)-OMe (4): Boc-Val-OH (1.09 g; 5 mmol) was dissolved in 
200 ml of DCM 1.00 ml (7.5 mmol) of triethyl amine was added in ice cold condition. In 
another flask 1.31 g (5 mmol) of HCl·HCys(Bz)-OMe was dissolved in 50 ml DCM and 
1.40 ml (10 mmol) of triethylamine was added and stirred for 10 minutes. Then the 
second solution was added to the first solution in ice cold condition. After 5 minutes, 
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3.79 g of solid HBTU (10mmol) was added and after 30 minutes the ice bath was taken 
away and the reaction mixture was stirred for 6 hours at room temperature. The reaction 
mixture was worked up by washing sequentially with saturated aqueous NaHCO3, 10% 
aqueous citric acid, saturated aqueous NaHCO3 and water. 
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Scheme 4.S1. Synthesis of dipeptides, tripeptides and the ferrocene dicarboxylic acid 
conjugates of the tripeptides.  a) TEA, HBTU in DCM, (b) TFA, evaporate after 20 
minutes to completely remove TFA and suspended in DCM and TEA added, c) Boc 
Gly-OH, HBTU in DCM stirring for 5 hrs, d) Ferrocene dicarboxylic acid /TEA/ HBTU 
in DCM stirring 10hrs. 
 
Then it was dried with anhydrous sodium sulfate and evaporated under reduced pressure. 
The product was purified by column chromatography using silica gel column, (ethyl 
acetate : hexane =50 : 50, Rf = 0.51) to get 1.81 g  (85%) of white solid. 1H-NMR (δ, 
CDCl3) 7.32 (m, 5H, H of Ph), 6.71 (d  1H, NH attached to Boc), 4.78 (d, 1H, α-H of 
Val) 4.26 (m, 1H, α-H of Cys), 3.76 (s, 3H, ester OCH3) 3.72 (s, 2H, CH2 attached Ph), 
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2.88-2.86 (m, 2H, β-H  of Cys), 2.10(m, 1H, β-H of Val), 1.56 (s, 9H, Boc), 0.96 (d, 3H, 
Val CH3), 0.95 (d, 3H, another Val CH3) 
 
4.6.1.2.2. Boc-Gly-Val-Cys(Bz)-OMe (5): 1.07 g (2.5 mmol) of Boc-Val-Cys(Bz)-OMe 
(4) was treated with minimum amount of TFA (50% in DCM). After 30 minutes TFA 
was completely removed in rotovap. Then it was suspended in 50 ml of DCM followed 
by dropwise addition of tryethyl amine in ice cold condition to make the solution basic. 
0.43 g (2.5 mmol) of Boc-Gly-OH was added to the solution followed by addition of 
0.70 ml (5mmol) of TEA in ice bath. Then 1.9 g (5 mmol) of HBTU was added. After 
30 minutes the reaction mixture was allowed to warm up to room temperature and kept 
for 7 hours under constant stirring. The resulting solution was then washed successively 
with saturated NaHCO3, 10% citric acid, saturated NaHCO3 and water. Then it was 
evaporated under reduced pressure in a rotorvap. The product was purified by column 
chromatography using silica gel column (ethyl acetate Rf = 0.28) to get the pure product 
in 75% yield (0.91 g).  1H-NMR (δ, CDCl3 ): 7.37-7.28 (m, 5H, of Ph) 6.69 (d, J = 7Hz, 
1H, NH of Val) , 6.58 (d, J = 5 Hz, NH of Cys), 5.14 (s, 1H, NH of Gly), 4.79-4.75 (m, 
1H, α-H of Val), 4.34 (dd, 1H, α-H of Cys), 3.89-3.81 (dd, 2H α-H of Gly), 3.75(s, 3H, 
ester OCH3), 3.72 (s, 2H, CH2 attached Ph), 2.90-2.88 (dd, 2H, β-H of Cys), 2.16 (m, 
1H, β-H of Val), 1.46 (s, 9H, CH3 of Boc), 1.00 (d, J = 8.7 Hz, 3H, CH3 of Val), 0.96 (d, 
J = 7.2 Hz, 3H another CH3 of Val) 
 
4.6.1.2.3. Boc-Ile-Cys(Bz)-OMe  (6): The procedure is identical to that used for the 
preparation of 4. Column (ethyl acetate : hexane =40 : 60, Rf = 0.45), white solid, yield 
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= 81% (0.88 g). 1H-NMR (δ, CDCl3) : 7.32-7.30 (m, 5H, Ph), 7.10 (d, 1H, NH of Cys), 
6.69 (d, 1H, NH attached to Boc), 4.77 (m, 1H, α H of Ile), 4.10 (m, 1H, α-H of Ile), 
3.77 (s, 3H, CH3 of ester), 3.73 (s, 2H, CH2 attached to Ph), 2.90 (d, 2H, β-H of Cys), 
1.90 (m, 1H, β-H of Ile), 1.52 (m, 1H, one γ-H of Ile), 1.45 (s, 9H, CH3 of Boc), 1.18 
(m, 1H, another γ-H of Ile), 0.98 (d, 3H, CH3 of Ile), 0.96 (d, 3H, another CH3 of Ile). 
 
4.6.1.2.4. Boc-Gly-Ile-Cys(Bz)-OMe (7): The procedure is identical to that used for the 
preparation of 5. column (ethyl acetate 100%, Rf = 0.36) to get the pure product in 71% 
yield (0.87 g).  1H-NMR (δ, CDCl3 ) 7.37-7.31 (m, 5H, Ph), 6.67 (d, 1H, NH of Ile), 
6.56 (d, 1H, NH of Cys), 5.11 (s, 1H, NH of Gly), 4.79 (dd, 1H, α-H of Val), 4.35 (dd, 
1H, α-H of Cys), 3.86 (dd, 2H, α-H of Gly), 3.76 (s, 3H, CH3 of ester), 3.72 (s, 2H, CH2 
attached to Ph), 2.89 (d, 2H, β-H of Cys), 1.91 (dd, 1H, β-H of Ile), 1.53 (m,1H, one γ-H 
of Ile), 1.44 (s, 9H, CH3 of Boc), 1.17 (m, 1H, another γ-H of Ile), 0.97 (d, 3H, CH3 of 
Ile), 0.94 (d, 3H, another CH3 of Ile). 
  
4.6.1.2.5. Fc[CO-Gly-Val-Cys(Bz)OMe]2 (8): 0.48 g (1 mmol) of Boc-Gly-Val-
Cys(Bz)-OMe (5) was treated with 2 ml of TFA (50% in DCM). After 30 minutes TFA 
was completely removed in rotovap. Then it was suspended in 50 ml of DCM followed 
by dropwise addition of triethyl amine in ice cold condition to make the solution basic. 
0.14 g (0.5 mmol) of ferrocene dicarboxylic acid was added to the solution followed by 
addition of 0.42 ml (3mmol) of TEA in ice bath. Then 1.1 g (3 mmol) of HBTU was 
added. After 30 minutes the reaction mixture was allowed to warm up to room 
temperature and kept for 7 hours under constant stirring. The resulting solution was then 
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washed successively with saturated NaHCO3, 10% citric acid, saturated NaHCO3 and 
water. Then it was evaporated under reduced pressure in a rotoevaporator. The product 
was purified by column chromatography using silica gel column (ethyl acetate : 
methanol = 95 : 5, Rf = 0.31) to get the pure product in 65% yield (0.32 g). FTIR in KBr 
(resolution 4 cm-1) : 1634 cm-1, 1680 cm-1 (C=O), 1531 cm-1 (C-N of amide), 3294 cm-1 
(N-H stretching); UV-vis: (λ in nm, [ε in M-1cm-1]): 442 [280]; HRMS (ES): Calc. for  
C48H60N6O10FeS2 [M]+, 1000.3162  observed mass [M+1]+ 1001.4221;  1H-NMR (δ, 
CDCl3 ): 8.64 (t, 1H, NH of Gly), 7.33-7.32 ( m, 5H, of Ph), 7.12 (d, J = 5.7Hz, 1H, NH 
of Cys), 6.68 (d, J = 7 Hz, 1H, NH of Val), 4.85 (s, br, 2H, ortho-H of Cp), 4.75-4.71 (q, 
1H, α-H of Cys), 4.44-4.42 (q, 1H, α-H of Val), 4.38 (s, br, 2H, meta-H of Fc) 4.04-3.79 
(dd, 2H α-H of Gly), 3.73 (s, 2H, CH2 attached Ph), 3.72(s, 3H, ester OCH3),  2.90 (d, J 
= 9.1 Hz, 2H, β-H of Cys), 2.35 (m, 1H, β-H of Val), 1.04 (d, J = 6.2Hz, 3H, CH3 of 
Val), 0.99 (d, J = 6.0 Hz, 3H another CH3 of Val); 13C{1H}-NMR (δ, CDCl3): 172.3, 
171.7, 171.5, 171.3, 137.9, 129.3, 129.1, 127.7,  75.9, 72.1, 71.9, 71.2, 70.7, 59.0, 53.0, 
52.2, 43.8, 36.7, 33.2, 30.7, 19.8, 17.8. 
 
4.6.1.2.6. Fc[CO-Gly-Ile-Cys(Bz)OMe]2 (9): The procedure is identical to that used for 
the preparation of 8. Column on silica (EtOAc : MeOH = 95:5 v/v, Rf = 0.35), yield 59 
%. FTIR: 1638cm-1 and 1679cm-1 (C=O), 1533 cm-1 (C-N of amide), 3282 cm-1 (N-H 
stretching); UV-vis: (λ in nm, [ε in M-1cm-1]): 441 [278]; HRMS (ES): Calc. for  
C32H46N6O6FeS2 [M]+ 1028.3475 observed mass [M+1]+ 1029.4228; 1H-NMR (δ, CDCl3 
): 8.67 (t, 1H, NH of Gly), 7.49-7.34 (m, 5H, Ph), 7.21 (d, J = 8.5 Hz, 1H, NH of Cys), 
6.55 (d, J = 5.8 Hz, NH of Ile), 4.86 (d, J = 9.6 Hz, 2H, ortho-H of Cp), 4.73 (dd, 1H, α-
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H of Cys), 4.50 (q, 1H, α-H of Ile), 4.40 (d, J = 7.0 Hz, 1H, meta-H of Cp), 3.84 (m, 2H, 
α-H of Gly), 3.76 (s, 2H, CH2 attached to Ph), 3.74 (s, 3H, CH3 of ester), 2.98 ( dd, 2H, 
β-H of Cys), 2.14 (s, br, 1H, β-H of Ile), 1.54-1.21 (dd, 2H, CH2 of Ile), 1.02 (m, 2H, 
CH3 of Ile), 0.97 (d, 2H, CH3 of Ile) ; 13C{1H}-NMR (δ, CDCl3): 172.0, 171.4, 171.1, 
171.0, 137.7, 128.9, 128.7, 127.4, 75.5, 75.4, 71.8, 71.4, 70.8, 70.5, 58.5, 52.6, 51.9, 
43.6, 36.8, 36.2, 32.7, 29.7, 24.7, 15.9, 11.8.  
 
4.6.2. FT-IR Study 
 FT-IR spectra were recorded in BIO-RAD, FTS-40 in solid state (KBr) from 
400 cm-1 to 4000cm-1 with 4 cm-1 resolution. 
 
 
Figure 4.S1.  Representative partial FT-IR spectrum (4 cm-1 resolution) for  Fc[CO-Gly-
Ile-Cys(Bz)OMe]2 (9), in the solid state (KBr). (a) amide-I and amide-II region of 9 and 
(b) amide-A  region of 9. 
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4.6.3. X-ray Crystallography 
 Crystallization of Fc[CO-Gly-Val-Cys(Bz)OMe]2 (8) and Fc[CO-Gly-Ile-
Cys(Bz)OMe]2 (9) were carried out by slowly diffusing the solvent from the solution in 
chloroform in refreegerator. Orange rod shaped crystals suitable for x-ray 
crystallography were deposited after 3-4 days. All measurements were made on a 
Nonius KappaCCD 4-Circle Kappa FR540C diffractometer using monochromated Mo 
Kα radiation (λ = 0.71073 Å) at -100 °C. An initial orientation matrix and cell was 
determined from 10 frames using φ scans.[S1] Data were measured using φ- and ω-scans. 
[S1] Data reduction was performed with the HKL DENZO and SCALEPACK software 
[S2], which corrects for beam inhomogeneity, possible crystal decay, Lorentz and 
polarisation effects. A multi-scan absorption correction was applied (SCALEPACK,).[S2]
The structures were solved using direct methods (SIR-97 [S4]) and refined by full-
matrix least-squares method on F2 with SHELXL97-2.[S5] The non-hydrogen atoms were 
refined anisotropically. Hydrogen atoms were included at geometrically idealized 
positions (C-H bond distances 0.95/0.98/0.99 Å) and were not refined. The isotropic 
thermal parameters of the hydrogen atoms were fixed at 1.2 times that of the preceding 
carbon atom. 
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Table 4.1. Summary of crystallographic Data of  Fc[CO-Gly-Val-Cys(Bz)OMe]2 (8)
and Fc[CO-Gly-Ile-Cys(Bz)OMe]2 (9). 
 
             8            9 
Chemical formula C48H60Fe1N6O10S2 C50H64Fe1N6O10S2
FW 1000.99 1029.04 
Crystal system orthorhombic orthorhombic 
Space group P212121 [No. 19] P212121 [No. 19] 
a/ Å 16.2410(7) 13.5790(4) 
b/ Å 17.8260(9) 16.5860(5) 
c/ Å 16.8370(7) 22.5580(7) 
α/° 90.00 90.00 
β/° 90.00 90.00 
γ/° 90.00 90.00 
V/Å3 4878.5(4) 5080.5(3) 
Z 4 4 
D(calcd)/g cm–3 1.364  1.345 
T/K 173(2) 173(2) 
λ/ Å 0.71073 0.71073 
µ/mm–1 0.458 0.442 
R1 (I > 2 σ(I))a 0.0670 0.0483 
wR (all data)b 0.1252 0.1306 
GOOF on F2 0.935 1.093 
 
R1=[Σ||Fo|-|Fc||]/[Σ|Fo|]; wR2 = {[Σw(Fo2-c2)2]/[Σw(Fo2)2]}1/2;  w = [σ(Fo2) + (aP)2 + 
(bP)]-1 where P = [Max(Fo2,0) + 2 Fc2]/3. 
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Table 4.S2. Inter and intramolecular hydrogen bonding distances of  8. 
N(11)(H)····O(22)=C 2.916(8) 
N(13)(H)····O(24)=C 3.082(8) 
N(21)(H)····O(12)=C 2.846(7) 
N(23)(H)····O(14)=C 3.054(8) 
N(22)(H)····O(11)*=C 3.064(8) 
O(11)=C····N(22)**(H) 3.064(8) 
N(12)(H)····O(21)**=C 2.869(8) 
O(21)=C····N(12)*(H) 2.868(82) 
 
Symmetry transformations used to generate equivalent atoms: 
 
*: -x + ½, -y, z - ½ 
**: -x + ½, -y, z + ½ 
 
 
 
Table 4.S3. Inter and intramolecular hydrogen bonding distances of 9. 
 
N(11)(H)····O(22)=C 2.887(4) 
N(21)(H)····O(12)=C 2.758(5) 
N(22)(H)····O(11)*=C 2.926(4) 
O(11)=C····N(22)**(H) 2.926(4) 
N(12)(H)····O(21)**=C 2.894(4) 
O(21)=C····N(12)*(H) 2.894(4) 
 
Symmetry transformations used to generate equivalent atoms: 
  
*: -x + 1, y + ½, -z + ½ 
**: -x + 1, y - ½, -z + ½ 
 
 
Supramolecular arrangments of the molecules in the crystals: Through 
intermolecular hydrogen bonding both the molecules assemble into pleated beta-sheet 
like archetechtures. Views of these supramolecular arrangements in different directions 
are presented in the following figures (Figure 4.S2 to Figure 4.S7).  
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 Figure 4.S2. Packing of Fc[CO-Gly-Val-Cys(Bz)OMe]2 (8), view along x axis. 
 
 
Figure 4.S3. Packing of Fc[CO-Gly-Val-Cys(Bz)OMe]2 (8), view along y axis. 
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 Figure 4.S4. Packing of Fc[CO-Gly-Val-Cys(Bz)OMe]2 (8), view along z axis. 
 
 
Figure 4.S5. Packing of Fc[CO-Gly-Ile-Cys(Bz)OMe]2 (9), view along x axis. 
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Figure 4.S6. Packing of Fc[CO-Gly-Ile-Cys(Bz)OMe]2 (9), view along y axis. 
 
 
Figure 4.S7. Packing of Fc[CO-Gly-Ile-Cys(Bz)OMe]2 (9), view along z axis. 
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Chapter 5 
Amino Acid Conjugates of 1,1'-Diaminoferrocene. Synthesis 
and Chiral Organization 
 
5.0. Connecting Text 
In this chapter, the preparation of Fc[NH-Boc]2 and its amino acid conjugates is 
described. To date, only 1,1'-Fc dicarboxylic acid and 1-amino-1'-Fc carboxylic acid 
have been exploited for the preparation of peptide conjugates, exhibiting specific H-
bonding pattern associated with the β-sheet-like structure. Peptide conjugates of  1,1'-
diaminoferrocene display the illusive 14-membered H-bonding with an anti-parallel 
alignment of the peptide strands, which adds a new scaffold for controlling the structures 
of peptides. 
This paper was reproduced with the permission from Org. Biomol. Chem. 2005, 3, 3018-3013. Copyright 
2005, Royal Society of Chemistry. It was co-authored by K. A. Mahmoud, G. Schatte and H.-B. Kraatz. 
The major part of it was contributed by me. The text below is a verbatim copy of the published paper. 
 
5.1. Abstract 
1,1'-Bis(tert-butoxycarbonylamino)ferrocene (6), a protected derivative of 1,1'-
diaminoferrocene, has been synthesized by a very convenient method and serves as a 
synthon for 1,1-diaminoferrocene. Its structure in solid state and in solution has been 
studied by NMR and X-ray crystallography. 1,1'-bis(tert- butoxycarbonylamino) 
ferrocene serves as starting material for the synthesis of amino acid conjugates of L- and 
D-alanine. The structures of these bioconjugates have been studied by NMR and CD 
spectroscopy and X-ray crystallography and reveal that the chiral organization of the 
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podant amino acid chains is controlled by the chirality of the attached amino acid. The 
substituents engage in strong intramolecular H-bonding generating 14-membered H-
bonded rings, a motif previously unrealized in ferrocene–amino acid and peptide 
conjugates 
 
5.2. Introduction 
Controlling the secondary structures of peptides is of great importance in 
designing functional peptidic materials[1,2] and understanding the function of proteins 
and enzymes.[3] Among various means, use of molecular scaffolding has attracted 
greatattention in achieving specific secondary structures.[4] In this context, ferrocene 
(Fc) derivatives 1–3 are widely used as a redox active scaffold. Having the 
cyclopentadienyl rings separated by 3.3 Å , allows effective intramolecular interstrand 
H-bonding in peptide conjugates of disubstituted Fc, where the peptide strands are on 
the two different cyclopentadienyl (Cp) rings. Hydrogen bonding imposes a specific 
secondary structure onto the bioconjugates, first described by Herrick and co-workers.[5] 
The particular choice of Fc-scaffold will influence the ability for forming H-bonded 
assemblies. For example, conjugates of 1 often give rise to one dimensional H-bonded 
chains, whereas 2 and 3 can give rise to H-bonded b-sheet like structures or even engage 
in chiral helical  arrangements.[6–12] It is also observed that, based on the torsional twist 
about the Cp(centroid)–Fe–Cp(centroid) axis, conformational enantiomerization is 
possible for the case of 1,1'-disubstituted ferrocene[13] and the conformations can be 
stabilized by intramolecular hydrogen bonding between the two peptides strands, when 
the substituents are peptides, as described by Hirao using 2 as a scaffold.[10] Given the 
general difficulty in preparing mono- and diaminoferrocene derivatives in sufficiently 
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high yields,[14–17] peptide derivatives of 1,1'-diaminoferrocene (4) are completely absent 
from the literature. We set out to develop a synthetic procedure that circumvents the use 
of the explosive 1,1'-diazoferrocene.[18]
Fe
COOH
COOH
Fe
COOH
NH2
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Here, we report the convenient synthesis of 1,1-bis(tertbutoxycarbonylamino) 
ferrocene (6), a convenient synthon of 1,1-diaminoferrocene (4). The bis-Boc derivative 
is compatible with the peptide synthesis protocol, as is demonstrated by the preparation 
of its first amino acid conjugates. To test the chiral organization pattern of the Fc 
conjugate, L- and D-alanine conjugates were prepared. Importantly, the systems exhibit a 
previously unknown H-bonding motif for Fc–peptide conjugates. 
 
5.3. Results and Discussions 
1,1'َ-bis(carbonylazido)ferrocene (5) was synthesized from 1,1'َ-
ferrocenedicarboxylic acid (2) by treatment with ethyl chloroformate, followed by the 
reaction with sodium azide. The reaction of the carbonylazido compound 5 with tertiary 
butanol at 80°C for 8 hours cleanly leads to the desired bis-Boc-protected compound 6 
in 72 % yield (Scheme 5.1). The material is stable in solution and in the solid state and 
does not decompose in solution even after several months. Compound 6 was 
characterized spectroscopically and by single-crystal X-ray analysis. The 1H-NMR 
spectrum shows the two carbamide NHs upfield from typical amide at δ6.06. 
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Scheme 5.1. Synthesis of 1,1'-bis(Boc-amino)ferrocene (6) via 1,1'-
bis(carbonylazido)ferrocene (5) and its amino acid derivatives with L-Ala (7) and D-Ala 
(8). (i) Reflux in tert-BuOH,  80ºC, 8 hrs (ii) a) TFA, b)TEA, c) Boc-Ala-OH activated 
by EDC/HOBt. 
 
Similarly, the 13C-NMR exhibitis a resonance at δ153.2, typical for the Boc carbonyl.  
The IR spectrum shows a strong absorption for the C=O group at 1695 cm-1.  Single 
crystals of compound 6 were obtained by slow diffusion of hexane into a chloroform 
solution. The X-ray diffraction study  reveals the presence of three independent rotamers 
having the two substituents at different rotational angles (70º, 144º, 180º) with an 
approximate 1,2' and 1,3' conformation. Two molecules in general positions in the 
asymmetric unit and one molecule with its Fe atom on an inversion centre. All three 
rotamers are linked via intermolecular N(H)•••O=C bonding. In one of the rotamers, 
strong intramolecular H-bonding is present (see Figure 5.1, ferrocene Fe(1)). The 1H-
NMR provides an indication for the presence of more than one rotamer even in solution. 
At 250 K, the 1H-NMR  spectrum shows the presence of three N-H signals of different 
intensities. Upon increasing the temperature to 295 K, the signals merge to a single peak, 
indicating rapid interconversion of the rotamers on the NMR time scale (Figure 5.1b). 
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Figure 5.1. (a) ORTEP diagram of 1,1'-bis(tert-butoxycarbonylamino)ferrocene (6) 
showing three rotamers and intra- and intermolecular hydrogen bonds are indicated by 
dotted lines. Relevant bond distances [Å] and angles [º]: Fe(3)-C(Cp)av.,1,99(6); N(31)-
C(30), 1.509(4); N(31)-C(35), 1.417(4); N(41)-C(40), 1.423(4); N(41)-C(45), 1.471(4); 
C(35)-O(31) 1.203(4); C(35)-O(32), 1.411(4); C(45)-O(41) 1.217(3), C(45)-O(42), 
1.384(3); Cp/Cp twist angle, 0.3(1); βav., 4.7(2) [A: 1-x, 1-y,-z]. (b) Partial 1H NMR 
spectrum recorded at different temperatures showing the amide N-H region of 
compound 6, indicating the presence of at least three distinct rotamers in solution at low 
temperatures and facile interconversion between the rotamers at high temperatures. 
 
Compound 6 is a convenient starting material for the preparation of amino acid 
bioconjugates. The synthesis of the L-Ala and D-Ala conjugates 1,1'-bis(tert-
butoxycarbonyl-L-alanine-amido)ferrocene (7) and 1,1'-bis(tert-butoxycarbonyl-D-
alanine-amido)ferrocene (8) were readily achieved after deprotection of the amino 
group, followed by coupling with the corresponding Ala derivatives in the presence of a 
carbodiimide under inert atmosphere, to prevent the oxidation of the diaminoferrocene 
formed in situ (see Scheme 5.1). Compounds 7 and 8 were characterized by 
spectroscopic methods. Both compounds display a single broad absorption in the visible 
region with λmax = 448 nm due to the Fc-based d-d transition, which experiences a 
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bathochromic shift compared to the Boc-protected 6. In the IR, a new signal appears at 
1671 cm-1 due to the presence of the Fc-amide C=O, in addition to the signal due to the 
Boc C=O group at 1575 cm-1. Similarly, the 13C-NMR spectrum exhibits two resonances 
in the carbonyl region at δ171.7 (Fc-amide C=O) and at δ155.5 (Boc C=O). The 
corresponding NH signals are observed at δ9.00 for the Fc-NH-CO group and at δ5.11 
for the Boc-protected Ala. The α-H of Ala is observed at as a multiplet at δ 4.35, while 
the Ala-CH3 is observed upfield at δ17.5.  
The compound readily crystallizes from a chloroform solution by slow diffusion 
of hexanes to produce yellow-orange needles. Two single crystal X-ray diffraction 
studies of these compounds were carried out showing that the compounds crystallize in 
the space group C2.‡ A graphical representation of compound 8 is shown in Figure 5.2.  
The Cp rings in both ferrocenoyl groups are co-planar (angle between Cp planes: 
2.8(2)°). The amide and Cp rings are twisted by 18.9(2)°. Importantly, the molecules 
maximize their H-bonding through formation of intermolecular and intramolecular 
N(H)•••O=C bonding. Two intramolecular H-bonds (2.805(6) Å) are formed between 
the amide groups connected to the Cp rings and the adjacent carbonyl of the Boc causing 
M-helicity of the compound. Thus, the two podand amino acid substituents have the 
same arrangement as was observed for L- and D-amino acid conjugates of 
ferrocenedicarboxylic acid 2[9] and for the conjugates offerroceneamino acid 3.[12] 
Importantly, for amino acid conjugates of compound 4 intramolecular NH•••O=C H-
bonding results in the formation of a previously unobserved 14-membered H-bonded 
ring. Thus, the nature of the parent Fc derivative (2 – 4) appears to direct the size of the 
H-bonded ring, as depicted in Scheme 5.2. The bonded ring size in peptide conjugates 
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increases from 10 for the derivatives of 2[5],  to 12 for the derivatives of 3[12] to 14 for the 
derivatives of 4.  
 
 
 
Figure 5.2. ORTEP diagram of the X-ray single crystal structure of 8 (30% 
probability) showing intramolecular hydrogen bonds. Relevant bond distances [Å] and 
angles [º]: Fe-C(Cp)av., 2.040(5); N(11)-C(10), 1.419(4); N(11)-C(15), 1.349(3); 
C(15)-O(11), 1.224(3); C(15)-C(16), 1.536(4) C(16)-N(12) 1.445(3); Cp/Cp twist 
angle, 3.43(9); ct(Cp)-Fe-ct(Cp* ), 159.7(9); β, 19.08(9) [*:-x+1, y, -z+1]. 
 
 
Scheme 5.2.  Intramolecular H bonding pattern in amino acid conjugates of 
disubstitued Fc derivatives results in the formation of 10-membered rings for 
conjugates of 2, 12-membered rings for conjugates of 3 and novel 14-membered rings 
for conjugates of 4. 
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Table 5.1. Summary of crystallographic data for 1,1'-bis(tert-
butoxycarbonylamino)ferrocene (6), 1,1'-bis(tert-butoxycarbonyl-L-alanine-
amido)ferrocene (7) and 1,1'-bis(tert-butoxycarbonyl-D-alanine-amido)ferrocene (8). 
 
          6         7         8 
 
Chemical 
formula 
 
C22H31Fe1N2O4
 
C26H38FeN4O6
 
C26H38FeN4O6
FW 416.31 558.45 558.45 
Crystal 
system 
Monoclinic Monoclinic Monoclinic 
Space group P21/n C2 C2 
a/ Å 10.8116(1) 15.4790(8) 15.490(3) 
b/ Å 11.8065(1) 9.3380(5) 9.3390(19) 
c/ Å 40.9023(4) 11.0340(9) 11.036(2) 
α/° 90.00 90.00 90.00 
β/° 91.0490(4) 117.034(2) 117.09(3) 
γ/° 90.00 90.00 90.00 
V/Å3 5220.19(8) 1420.62(16) 1421.3(6) 
Z 10 2 2 
D(calcd)/g 
cm–3
1.324 1.306 1.305 
T/K 173(2) 173(2) 173(2) 
λ/ Å 0.71073 0.71073 0.71073 
µ/mm–1 0.748 0.575 0.575 
R (I > 2 σ(I))a 0.0636 0.0614 0.0393 
wR (all data)b 0.1134 0.1846 0.0755 
GOOF on F2 0.935 1.123 1.058 
R1 = [Σ||Fo|-|Fc||]/[Σ|Fo|]; wR2 = {[Σw(Fo2-Fc2)2]/[Σw(Fo2)2]}1/2;  w = [σ(Fo2) + (aP)2 + 
(bP)]-1 where P = [Max(Fo2,0) + 2 Fc2]/3. 
 
This is an important result, which may allow the use of ferrocenediamine as a 
scaffold for in the rational design of structurally well-defined peptide assemblies.  
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Figure 5.3. Crystal structure of 8 showing the intramolecular H-bonding, interaction 
between ferrocene moiety and tert-butyl group (viewed down the a-axis (top and 
down the c-axis (bottom)). Dotted lines indicate hydrogen bonding. 
 
In addition, the molecules are engaged in intermolecular NH•••O=C hydrogen 
bonds (2.825(6) Å), see Figure 5.3), showing a honeycomb structure, which contrasts the 
helical arrangement for ferrocenedicarboxylic acid derivatives observed by Hirao and 
coworkers.[7]  We decided to study the H-bonding ability of compounds 7 and 8 in 
solution. Variable temperature 1H-NMR at various concentrations allows the detection 
of both inter- and intramolecular H-bonding (see Figure 5.4). Upon increasing the 
temperature, intermolecular H-bonding is weakened (-6.9 ppb/K for N(12)), while the 
intramolecular H-bonding, responsible for stabilizing the particular helicity about the Fc 
core exhibits a positive temperature behaviour (+4.2 ppb/K) (Figure 5.4), which may 
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indicate that as the intermolecular H-bonding is broken, the intramolecular H-bonding 
may be strengthened.  
 
               (a) 
 
 
                   (b)  
 
 
Figure 5.4. (a) 1H-NMR spectra compound 8 at different temperature in 1mM solution 
in CDCl3 (b) Corresponding plot of chemical shift vs. temperature compound 8, NH1 
(slope=+4.2 ppb/K) amide hydrogen attached to Cp ring of ferrocene and NH2 (slope =-
6.9 ppb/K) is the amide proton from alanine. 
 
CD provides evidence that compounds 7 and 8 maintain their helicity in solution. 
The CD spectra for compounds 7 and 8 were measured in CH2Cl2 at a concentration of 
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1mM and are shown in Figure 5.5. As expected for the D and L form, the two 
compounds give CD spectra that are the exact opposite of each other, indicating that a 
chiral rigid structure is maintained in solution. This necessitates the absence of free 
roation about the Cp-Fe-Cp axis and the lack of free rotation of the podant ligand about 
the Cp-N bond. Thus, the presence of the intramolecular H-bonding between the amino 
acid substituents is crucial for maintaining the structure in solution and is seen as the 
major cause for chirality organization in these systems. 7 is found to form a P-helical 
structure as indicated from the positive Cotton effect at the ferrocene function region 
(480 nm) as was observed by Metzler-Nolte for L-amino acids conjugates with 1,1'-
ferrocedicarboxylic acid.  
 
Figure 5.5. CD Spectra of 1,1-َbis(tert-butoxycarbonyl-L-alanine-amido)ferrocene (7) 
and 1,1-َbis(tert-butoxyarbonyl-D-alanine-amido)ferrocene (8) in 1mM solution in 
CH2Cl2  showing opposite chirality with respect to ferrocene. 
 
A negative Cotton effect of same intensity and in the same region for 8 was observed 
which corresponds to the observation of Hirao’s D-amino acid conjugates.[9] The 
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electrochemical behavior of compounds 6 – 8 was  studied by cyclic voltammetry (CV) 
and differential pulse voltammetry (DPV) in CH2Cl2. The electrochemical parameters 
for compounds 6 - 8 are summarized in Table 5.2. All three compounds exhibit only 
quasi-reversible behavior with a Faradic current ratio of close to unity by large peak 
separations. The halfwave potential, E1/2, for the Boc-derivative is observed at 306 mV 
(vs Ag/AgCl), while the  a redox potential for compounds 7 and 8 are shifted to higher 
oxidation potential. 
 
Table 5.2. Electrochemical data of compounds 6-8a. 
 
           Compound E1/2(mV) ∆Ep(mV) ia/ic
                  6 306 (±5) 361 1.06 
                  7 366 (±5) 151 1.11 
                  8 
 
370 (±5) 154 1.10 
a measured using GCE working electrode vs. Ag/AgCl , scan rate 0.1 V s−1, compounds 
6, 7, 8 at 0.1 M in CH2Cl2 0.1 M TBAP. The E1/2 of the Fc/Fc+ couple under the 
experimental conditions is 448(+/-5) mV (vs. Ag/AgCl). The E1/2 of the Fc/Fc+ couple 
under the experimental conditions is 448(+/-5) mV. 
 
5.4. Conclusions 
In conclusion, we provide a new synthetic approach to bis-Boc protected 1,1'-
diaminoferrocene, a very convenient derivative of unstable diamino ferrocene and show 
that this novel ferrocene compound can be converted cleanly to amino acid conjugates. 
Thus resulting bioconjugates show a specific secondary structure through the 
involvement of strong intramolecular H-bonding in the solid state as well as in solution, 
forming a 14 membered ring as is seen in antiparallel beta sheet peptide. The chirality of 
amino acid is found to change the chiral organization of peptide strands with respect to 
ferrocene.  
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5.5. Experimental 
5.5.1. Synthesis and Characterization: All syntheses were carried out in air unless 
otherwise indicated. CH2Cl2 (BDH; ACS grade) used for synthesis was dried (CaH2) and 
distilled prior to use. CDCl3 (Aldrich) was dried (CaH2), and stored over molecular 
sieves (8-12 mesh; 4Å effective pore size; Fisher) before use. EDC·HCl, HOBt 
(Quantum), MgSO4, and NaHCO3 (VWR) were used as received. For column 
chromatography, a column with a width of 2.7 cm (ID) and a length of 45 cm was 
packed 18-22 cm high with 230-400 mesh silica gel (VWR). For TLC, aluminum plates 
coated with silica gel 60 F254 (EM Science) were used. NMR spectra were recorded on a 
Bruker Avance 500 MHz spectrometer using a 5-mm broadband probe operating at 
500.134 MHz (1H) and 125.766 MHz (13C {1H}). Peak positions in both 1H and 13C 
spectra are reported in ppm relative to TMS. The 1H-NMR spectra are referenced to the 
residual CHCl3 signal at δ 7.27. All 13C {1H} spectra are referenced to the CDCl3 signal 
at δ 77.23. Mass spectrometry was carried out on a VG Analytical 70/20 VSE 
instrument. Infrared spectra were obtained in KBr and recorded with a Perkin-Elmer 
model 1605 FT-IR (resolution: 4 cm-1).  
 
5.5.1.1. 1,1'-bis(tert-butoxycarbonylamino)ferrocene (6): 1,1'-
bis(azidocarbonyl)ferrocene (1.52 g, 10 mmol) was refluxed in tert-butanol at 80°C for 
12 hours. After rotorevaporation of butanol, the crude product was purified by flash 
column chromatography using hexane/ethyl acetate (3.5/1.0; Rf  =  0.35), and dried under 
reduced pressure to give 1.70 g (72%) of compound 6. HRMS (ES): calc for 
C20H28N2O4Fe: 416.1449; found: 416.1410 [M]+. FT-IR (KBr, cm-1): 3316 (b, s, N-H), 
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1695 (s, C=O), 1542 (s, Amid I). UV-vis (CH2Cl2; λ in nm [ε in Lmol-1cm-1]: 442[154]. 
1H-NMR (CDCl3, δ/ppm): 6.06 (br, s, 2H, NH) 4.36(s, 4H, ortho-H  of  Cp), 3.99 (s, 4H, 
meta-H of Cp) 1.49 (s, 18H, CH3 of Boc). 13C{1H}-NMR (CDCl3, δ/ ppm): 153.2 
(C=O),  95.0 (ipso-C  Fc) 79.3 (ortho-C  of  Fc),  68.3 (ortho-C  of  Fc),  64.4 (meta-C 
of Fc),  62.1 (meta-C of Fc), 62.0 (tertiary C of Boc),  27.1 (CH3 of Boc). 
 
5.5.1.2. 1,1'-bis(tert-Butoxycarbonyl-L-alanine-amido) ferrocene (7): 1,1'- bis-
(butoxycarb onylamino) ferrocene (6) (0.42 g 1 mmol) was dissolved in CH2Cl2 (2 ml) 
and cooled to 0 °C.  TFA (2 mL) was added dropwise under a nitrogen atmosphere. 
Then the ice bath was removed and stirring was continued. After 30 min, CH2Cl2 (10 
mL) was added and the solution was cooled before an excess Et3N was added dropwise.  
To this mixture, a solution of Boc-L-Ala-OH (0.38 g 2 mmol), HOBt (0.38 g 2.5 mmol), 
and EDC•HCl (0.48 g 2.5 mmol) in dry CH2Cl2) was added.  The reaction mixture was 
stirred for 12 hours at room temperature and then washed consecutively with saturated 
aqueous sodium bicarbonate, 10% aqueous citric acid, saturated sodium bicarbonate, and 
water. The organic phase was separated and dried over Na2SO4, filtered and then 
evaporated to dryness. After purification by flash column chromatography (hexane/ethyl 
acetate 3/1; Rf = 0.3) the product was obtained in 77 % yield (0.43 g)  (77%) as an 
orange crystalline solid. HRMS (ES): calc for C26H38N4O6Fe: 558.2210; found: 
558.2181 [M]+. FT-IR (KBr, cm-1): 3284 (b, s, N-H), 1671 (s, C=O), 1575 (s, C=O), 
1549 (s, Amid II). UV-vis (CH2Cl2; λ in nm [ε in M-1cm-1]): 448[250]. 1H-NMR (CDCl3, 
δ/ppm) : 9.00 (1H, s, NH of Fc), 5.39 (1H, s,  ortho-H  of  Fc), 5.11 (1H, d,  J = 7 Hz, 
NH Ala), 4.36 (1H, m, α CH Ala),  4.11 (1H, s, ortho-H  of  Fc), 3.93 (1H, s, meta-H of 
Cp), 3.93 (1H, s, meta-H of Cp), 1.48 (9H, s, CH3 of Boc), 1.35 (3H, d, J = 7 Hz, CH3 of 
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Ala). 13C{1H}-NMR (CDCl3, δ/ppm): 171.7 (C=O), 155.5 (C=O of Boc), 95.1 (ipso-C of 
Cp), 80.2 (tertiary C of Boc), 64.8 (ortho-C  of  Cp), 63.8 (ortho-C  of  Cp),  61.7 (meta-
C of Cp), 60.0 (meta-C of Cp),  50.1(α-C of Ala),  27.6 (CH3 of Boc), 16.7 (CH3 of Ala) 
 
5.5.1.3. 1,1'-bis(tert-Butoxycarbonyl-D-Alanine-amido)ferrocene (8):  The synthetic 
procedure was identical to that reported for the synthesis of compound 7. Column 
chromatography using hexane/ethyl acetate 3/1; Rf = 0.35.  HRMS (ES): calc for 
C26H38N4O6Fe: 558.2210; found: 558.2182 [M]+. FT-IR (KBr, cm-1): 3284 (b, s, N-H), 
1671 (s, C=O), 1575 (s), 1548 (s, Amid II). UV-vis (CH2Cl2; λ in nm [ε in M-1cm-1]: 448 
[240]. 1H-NMR CDCl3, δ/ppm): 9.00 (1H, s, NH of Fc), 5.39 (1H, s, ortho-H of Cp), 
5.11 (1H, d, J = 7 Hz,  NH Ala), 4.36 (1H, m, α-CH of Ala),  4.11 (1H, s, ortho-H of 
Cp), 3.98 (1H, s, meta-H of Cp), 3.93(1H, s, 1H, s, meta-H of Cp), 1.49 (9H, s, CH3 of 
Boc), 1.35 (3H, d, J = 7 Hz, CH3 Ala). 13C{1H}-NMR (CDCl3, δ/ppm): 13C{1H}-NMR 
(CDCl3, δ/ppm): 171.7 (C=O), 156.7 (C=O of Boc), 95.2 (ipso-C of Fc), 80.7 (tertiary C 
of Boc), 65.6 (ortho-C  of  Cp), 64.5 (ortho-C  of  Cp), 62.5 (meta-C of Cp), 60.9 (meta-
C of Cp), Cp), 50.8 α CH Ala, 28.4 (CH3 of Boc), 17.5 (CH3 of Ala). 
 
5.5.2. CD Measurements: CD spectra were recorded using a PiStar-180 
spectropolarimeter (from Applied Biophysics) in the CH2Cl2 solution with the 
concentration (1.0 x 10-3 M) by using quartz cell of path length 1cm under an argon 
atmosphere at 25 0C. 
 
5.5.3. X-ray Crystallography: Suitable crystals of compound 6 (yellow; 0.14 × 0.11 × 
0.09 mm), 7 (reddish yellow; 0.12 × 0.14 × 0.09 mm) and 8 (reddish yellow crystal; 0.25 
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× 0.20 × 0.13 mm) were obtained from a hexane-layered solution of the compounds in 
chloroform. All measurements were made on a Nonius Kappa CCD 4-Circle Kappa 
FR540C diffractometer using monochromated Mo Kα radiation (λ = 0.71073 Å) at -100 
°C. An initial orientation matrix and cell was determined from 10 frames using φ scans. 
Data were measured using φ- and ω-scans and were processed using the standard Nonius 
software.[19-20] The structures were solved using direct methods (2: SIR-97; 3: SHELXS-
97) and refined by full-matrix least-squares method on F2 with SHELXL97-2.[21] The 
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were included at 
geometrically idealized positions (C-H bond distances 0.95/0.99 Å; N-H bond distances 
0.88 Å) and were not refined. The isotropic thermal parameters of the hydrogen atoms 
were fixed at 1.2 times that of the preceding carbon or nitrogen atoms.[22-23] 
 
5.5.4. Electrochemical Measurements: The electrochemical experiments were carried 
out at room temperature using CV-50W voltammetric analyzer. A gold electrode 
(diameter 50 µm) was used as working electrode. 1 mM solutions of compounds 6 - 8 
were prepared in 0.1 M tetrabutylammonium perchlorate (TBAP) in CH2Cl2. Cyclic 
voltammetry (CV) experiments were carried out at a scan rate of 100 mV/s. Differential 
Pulse Voltammetry (DPV) was carried out at 10 mV/s. A platinum wire (1 mm) was 
used as the counter electrode and a Ag/AgCl (BAS) was used a the reference electrode. 
The E  of the Fc/Fc+ couple under the experimental conditions is 448(+/-5) mV (vs. 
Ag/AgCl).
1/2
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5.8. Supporting Information 
 
Figure 5. S1. Sheet like arrangement in the X-ray single crystal structure of compound 6  
involving three different rotamers present in the asymmetric unit cell and their linkages 
though hydrogen bonding. Selected hydrogen bond distances are O51····N41 = 2.709Å, 
N51A····O31 = 2.763Å, N51····O31A = 2.763Å, O51A····N41A =  2.709Å, O41····N11 = 
2.781Å, N31····O21B = 2.735Å, O11····N21 = 2.614Å, O21····N31B = 2.735Å . [A =1-
x,1-y,-z B=1.5-x,1/2+y,1/2-z] 
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Figure 5.S2. Variable NMR study of 1,1'-bis(tert-Butoxycarbonyl-L-Alanine-amido) 
ferrocene (7), NH1 is close to ferrocene and NH2 is the one which is attached to Boc. 
 
 
 
 
Figure 5.S3.  Cyclic voltammogram SWV spectra of  0.1 M  compounds 6-8 
measured using GCE electrode vs. Ag/AgCl , scan rate 0.1 v/s, in CH2Cl2 /0.1 M 
TBAP. The E1/2 of the Fc/Fc+ couple under the experimental conditions is 448(+/-5) 
mV (vs. Ag/AgCl). 
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Figure 5.S4.  SWV spectra of  0.1 M  compounds 6-8 measuredusing GCE electrode 
vs. Ag/AgCl , scan rate v/s, in CH2Cl2 /0.1 M TBAP. The E1/2 of the Fc/Fc+ couple 
under the experimental conditions   is 448(+/-5) mV (vs. Ag/AgCl). 
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Chapter 6 
Rational Design of a New Class of Bioorganometallic 
Foldamers: A Potential Model for Parallel β-Helical Peptides. 
 
6.0. Connecting Text 
This chapter describes the synthesis of a series of Fca-peptide conjugates which 
can adopt the β-helical conformation, a critical structural domain of proteins. It is known 
that peptide conjugates of disubstituted Fc are capable of providing β-sheet motif to the 
attached peptide strands and in the same time the peptides align themselves in helical 
fashion with respect to Fc. In this attempt, we exploited both these charteristics in 
extended form. Structural studies of the Fca-peptide conjugates in solution and solid 
states indicated the formation of β-helical conformation. Thus, it is an efficient novel 
method to control the structure of peptides using molecular scaffold. 
 
This paper was reproduced with the permission from Angew. Chem. Int. Ed 2006, 45, 6882-6884, 
Copyright 2006, Wiley VCH. This paper was co-authored by G. Schatte and H.-B. Kraatz. All 
experimental works with the exception of crystallographic analysis were carried out by me. In addition I 
wrote the initial draft of the manuscript. The text below is a verbatim copy of the published paper. 
 
 
6.1. Introduction 
 
The design of structurally well-defined peptide motifs has been an active area of 
research aimed at gaining a deeper understanding of biochemical processes,[1] to 
generate molecules with potential biological applications,[2] or to develop novel 
biomaterials.[3] Synthetic foldamers that resemble the structure of helical[4] and sheet 
conformations,[5] two of the major secondary structural motifs in proteins, can now be 
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designed de novo using non-proteinogenic amino acids or molecular scaffold. 
Alternating D- and L-amino acid sequences have been found to generate helical 
conformations maintaining the β-sheet in the same time so called β-helix as is seen in 
Gramicidin A.[6]  In 1993, a new kind β-helix formed only from the sequence of L-amino 
acids, was discovered in bacterial Pectate Lyase C.[7] and was recognized to play various 
important roles in biological systems.[8] In this structural motif, a series of β-strands are 
linked by a turn-region, resulting in a virtually perpendicular arrangement of the 
individual β-strands with respect to the axis of the helix. Little effort has been dedicated 
in designing the model for this important secondary structural domain. In 2001, Nolte 
and coworkers reported the synthetic analogue, where peptide strands are attached to a 
central polyiscyanide backbone and adopt a β-sheet running the length of the central 
helical core.[9] Disubstituted ferrocenes, and ferrocene amino acid (Fca) in particular, are 
known to induce β-turns in peptide conjugates and have the appropriate structural 
rigidity due to efficient H-bonding interactions between the peptide chains attached to 
the two Cp rings.[10] Thus, we hypothesized that it should be possible to design helical 
foldamer exploiting the turn-inducing properties of Fca and linking them to α-amino 
acids. It was thought that the H-bonding interactions between the peptide substituents on 
opposite Cp rings would favor the formation of a helical foldamer which displays the 
main features of the natural β-helical motif. Here, we wish to present the results of a 
synthetic and structural study of a series of helical foldamers formed from L- and D-
alanine and Fca. Our results unequivocally show the utility of our design approach for 
the formation of a series of unprecedented helical foldamers displaying right- and left-
handedness.  
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6.2. Results and Discussions 
 Starting from the fully protected Fca derivative 1,[11] the desired “monomers” 
Fca-L-alanine (2) and Fca-D-alanine (3), their corresponding oligomers 6-11, and 
poly(Fca-L-alanine) 12 were synthesized in solution by peptide coupling strategies as 
indicated in Scheme 6.1 and were characterized spectroscopically (see section 6.6.1.2.). 
The 1H-NMR spectra of 2 and 3 in CDCl3 show the presence of amide NH signal at δ 
7.61 (NH of Fca) and δ 6.50 (NH of Ala). As the length of the peptide increases, the 
amide resonances gradually shift downfield, indicating an increasingly H-bonded system 
(see Figure 6.S1). In the case of the polymeric 12, the two amide NH resonances are 
observed δ 10.87 (for NH attached to Cp) and δ 9.07 (for NH of Ala) as is expected for 
strongly H-bonded systems.  
 
 
Scheme 6.1. a) Preparation of P and M helical foldamers from the conjugates of Fca 
with L- and D-alanine respectively (detail description of the synthesis and 
characterization is given in section 6.6.1.2.); b) Schematic representation of the 
formation of right and left handed beta helical structures from the alternating conjugates 
of Fca and L-amino acids and D- amino acids respectively which are mirror image of 
each other. 
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Structural studies in solution by ROESY-NMR of the Fca-foldamers 6, 8, and 10 
show the cross correlations between the Fc-NHi and the β-H of Alai+1,  between the Ala-
NHi+1 and the α-H of Alai and between β-H of Alai+1 and the α-H of Alai (see Figure 
6.S2 - Figure 6.S4), which correspond to the β-helical conformations. Circular dichroism 
(CD) spectroscopy is a reliable tool to evaluate the conformation of chiral Fc-conjugates 
displaying a band (+ or –) at about 450 nm. CD  studies of our foldamers in acetonitrile 
solution (Figure 6.1) show that the oligomers 6, 8, and 10, derived from L-Ala, exhibit a 
weak positive Cotton effect (P-helicity) in the ferrocene region at λ = 450 nm, while the 
D-Ala derivatives 7, 9 and 11 exhibit a negative Cotton effect (M-helicity).  
 
 
Figure 6.1. Circular dichroism spectra of the Fca-Ala “monomers” 2 and 3 and 
the right handed and left handed parallel β-helical Fca-Ala oligomers (6-11) and 
polymer (12) in acetonitrile at 25°C. Intensity is normalized for one repeating unit.
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The Fca-Ala “monomers” 2 and 3 do not exhibit any Fca-based band, but display a weak 
signal in the peptide region, which are mirror images of each other. The absence of the 
band in the Fca region is not surprising, since the intramolecular H-bonding required to 
establish a stable secondary structure is not possible in these “monomers”. For the 
dimers 6 and 7 in which two Fca-Ala units are connected to each other through an Ala 
unit, strong intramolecular H-bonding (see Figure 6.2, vide infra) exists between the two 
Ala groups. The resulting effect on the CD spectrum normalized to a single Fca-Ala is 
significant enhancement of the bands. Additional Fca-Ala units increase the signal 
intensity of the normalized CD spectrum in both the Fca and peptide region. Peptides of 
equal length have CD signals of equal magnitude but of opposite sign, indicating that the 
helicity pattern is identical but of opposite handedness. Upon elongation, the conjugates 
are able to establish stronger intramolecular H-bonding between adjacent Ala units 
resulting in more rigid helical arrangement. Importantly, the polymer displays a 
characteristic band at 215 nm indicative of β-sheet peptides, which is absent in the 
smaller oligomers. The helices are stable at elevated temperatures and do not show a 
distinct melting behavior at temperatures up to 70˚C (see Figure 6.S5). 
The dimers (6 and 7 in P212121 space group) and trimers (8 in P41212 and 9 in P43212 
space group) were easily crystallized either by slow diffusion of non solvent into the 
sample solution or by slow evaporation of solvent from the solution (see section 6.6.6). 
The single crystal structure analyses of those show the expected axial chirality for each 
of the Fca residues. All systems derived from L-Ala adopt a P-helical conformation, 
while D-Ala gives rise to M-helicity, corroborating the CD results. The amino acid 
residues are involved in intramolecular H-bonding, forming parallel β-sheet-like 
structure with 12-membered H-bonded rings.  
 123
  
 
Figure 6.2. a) Crystal Structure of 6, b) Showing the helical backbone of 6, c) Crystal 
Structure of 8, d) Showing the helical backbone of 8. Black spheres are carbon, blues are 
nitrogen, reds are oxygen and yellows are iron. Hydrogen atoms are omitted for clarity. 
Dashed lines represent H-bond. The intramolecular and intermolecular H-bonding 
patterns are identical (12-membered rings including the H-atoms, parallel β-sheet like). 
Crystal structure of 7 is the mirror image of 6 and 9 is the mirror image of 8 (see Figure 
6.S15).
 
As the length of the helix increases, the number of 12-membered H-bonded rings 
increases. The intramolecular H-bonding distances (N-O) are 2.95-2.92 Å between the 
NH of Fca and C=O of Ala and 2.99-2.97Å between the NH of Ala and C=O of Fca. 
 124
The dihedral angles of all peptide segments for compounds 6 and 8 are -79 > φ > -67° 
and 155 < ψ < 138°, which fall within the regions of the Ramachandran plot (φ = -180° 
to - 45° and ψ = 45° to 225°) assigned to β-sheet conformations although it deviates 
from the perfect parallel β-sheet conformation.[13] For the foldamers 7 and 9 derived 
from D-Ala, the dihedral angles are similar in magnitude but of opposite in sign. 
Importantly, on the supramolecular level, the same H-bonding pattern as intramolecular 
(12 membered parallel beta sheet like ring formation and similar N-O distances) is 
propagated forming a continuous helical structure. The individual supramolecular 
helices arrange parallel to each other to generate solvent filled hydrophobic pockets 
(CH2Cl2 for 6 and 7, hexane for 8, CHCl3 for 9). FTIR of the foldamers in KBr (see 
Figure 6.S6 – Figure 6.S9) show the amide A absorption in the range 3266-3272 cm-1 
which clearly indicates the involvement of the amide NH in H-bonding. The Amide I 
and II regions of the conjugates are complex and show a series of bands (1627-1639 cm-
1 and 1680-1690 cm-1) that may be attributed to a β-sheet conformation.[14] 
 
6.3. Conclusion 
In conclusion, we presented the results of a study into the preparation and 
structural properties of organometallic peptide conjugate foldamers which adopt a 
structure that shows some structural similarities to the β-helical motif found in naturally 
occurring proteins, exploiting the turn-inducing ability of Fca. This novel redox active β-
helical system may have potential for the electrochemical screening of “beta-breakers”. 
We are now exploring the electronic and electrochemical properties of these systems in 
solution and surface using surface-supported helical foldamers. In addition, we are 
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expanding our approach to include other amino acids, such as glutamic acid, which 
should allow us to synthesize and study artificial anti-freeze peptides.  
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6.6. Supplementary Information 
6.6.1. Experimental 
6.6.1.1. General: All syntheses were carried out in air unless otherwise indicated. 
CH2Cl2 (BDH; ACS grade) used for synthesis was dried (CaH2) and distilled prior to 
use. CDCl3 (Aldrich) was dried (CaH2) , and stored over molecular sieves (8-12 mesh; 
4Å effective pore size; Fisher) before use., Amino Acids, HBTU (Advanced Chemtech), 
MgSO4, Citric Acid and NaHCO3 (VWR), TFA, TEA, DIEPA (Aldrich) were used as 
received. For column chromatography, a column with a width of 2.7 cm (ID) and a 
length of 45 cm was packed 18-22 cm high with 230-400 mesh silica gel (VWR). For 
TLC, aluminum plates coated with silica gel 60 F254 (EM Science) were used. NMR 
spectra were recorded on a Bruker Avance-500 spectrometer using a 5-mm broadband 
probe operating at 500.134 MHz (1H) and 125.766 MHz (13C {1H}). Peak positions in 
both 1H and 13C spectra are reported in ppm relative to TMS. The 1H NMR, COSY, 
TOCSY, HMQC, HMBC and ROESY spectra are referenced to the residual CHCl3 
signal at δ 7.27. All 13C {1H}, HMQC and  HMBC spectra are referenced to the CDCl3 
signal at δ 77.23. ROESY spectra were taken using spin lock period 200msec and 
relaxation delay 3.5sec. Mass spectrometry was carried out on a VG Analytical 70/20 
VSE instrument. Infrared spectra were obtained with a Perkin-Elmer model 1605 FT-IR 
at 4 cm-1 resolution.  
 
6.6.1.2. General Procedure for the Synthesis of the Monomers and Oligomers 
Boc protected precursors*, were stirred in 60% of trifluoroacetic acid (TFA) in 
dichloromethane for 30 minutes in nitrogen atmosphere. The TFA was completely 
 128
removed as an azeotrope by repeated evaporation using a rotovap using 
dichloromethane. The remaining solid material was dissolved in dichloromethane, 
placed in an ice bath (0-5°C) and was made basic using N-N-diisopropylethylamine in an 
approximately 1: 2.5 molar ratio. Then the acid component was added in a 1:1 molar 
ratio. After 15 minutes, HBTU (1:1.4 molar ratio ) was added and stirred for 7-8 hours. 
The reaction mixture was washed sequentially with saturated aqueous sodium 
bicarbonate, 10% aqueous citric acid, saturated sodium bicarbonate and then water. The 
organic phase was dried over anhydrous sodium sulfate, filtered and then evaporated to 
dryness. The crude product was purified by flash column chromatography. 
*Boc protected ferrocene-1-amino-methyl carboxylate(1) in 10 mmol scale for the 
preparation of monomers(2 and 3), monomers in 2.5mmol scale for the preparation of 
dimmer (6 and 7), dimers in 1mmol scale for the preparation of trimers (8 and 9) and 
trimer in 0.5 mmol scale for the tetramer (10 and 11)) 
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Scheme 6.S1. Synthesis of monomers, oligomers and polymers (a) Stirring in 60% TFA 
in DCM, (b) TFA removed, dissolved in DCM, made basic by DIEPA, add Boc 
protected D- or L-Ala, add HBTU and stir overnights under N2 atmosphere. (c) TFA 
removed, dissolved in DCM, made basic by DIEPA, added respective carboxylic acid, 
added HBTU and stirred for 7 hours.(d) Along with 5 mol % of 2 stirred in 60% TFA in 
DCM, (e) TFA removed, dissolved in DCM, made alkaline by DIEPA, added respective 
carboxylic acid, added HBTU and stirred for 10 hours then 5 % (mol) of 4 was added 
and stirred foe 2 hours. 
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6.6.1.2.1. 1-Boc-L-Alanino-n'-methyl-ferrocene-carboxylate (2): Flash column 
chromatography using ethylacetate/hexanes (1/1) (Rf = 0.35). Yield (75%), orange 
powder. HRMS (ES): calc for C20H28N2O4Fe: 430.1449; found: 430.1410[M]+. FT-IR 
(KBr, cm-1): 3322 (b, s, N-H), 1711 (s, ester C=O), 1688 (s, amide I), 1519 (s, Amid II). 
UV-vis (CH3CN; λ in nm [ε in Lmol-1cm-1]: 443 [280], 1H-NMR (CDCl3, δ/ppm): 7.65 
(1H, s, br, NH attached to Cp), 5.16 (1H, d,  J = 6 Hz, NH of Ala), 4.77 (2H , s, Cp), 
4.65 (1H, s, Cp), 4.57 (1H, s, br, α-H of Ala), 4.36 (2H, s, Cp), 4.21 (1H, s, br, Cp), 4.02 
(2H, d, J = 6 Hz, Cp), 3.80 (3H, s, CH3 of ester), 1.49 (9H, s CH3 of Boc), 1.45 (3H, d, J 
= 7 Hz, CH3 of Ala). 13C{1H}-NMR (CDCl3, δ/ppm): 172.1 (C=O of ester), 171.4 
(C=ONH), 156.2 (C=ONH of Boc), 95.4 (Fc C attached to carbonyl), 80.8, 72.9, 72.9 , 
72.3, 71.6, 71.4, 66.9, 66.6, 63.5, 63.2 (different Cs of Cps), 52.0 (CH3 of ester), 51.2 (α-
C of Ala), 80.8(tertiary C of Boc), 28.7 (CH3 of Boc), 18.4 (CH3 of Ala).  
 
6.6.1.2.2. 1-Boc-D-Alanino-n'-methyl-ferrocene-carboxylate (3): Flash column 
chromatography using ethylacetate/hexanes (1/1) (Rf = 0.35). Yield (70%), orange 
powder. HRMS (ES): calc for C20H28N2O4Fe: 430.1449; found: 430.1421[M]+. FT-IR 
(KBr, cm-1): 3314 (b, s, N-H), 1717 (s, ester C=O), 1689(s, amide I), 1515 (s, Amid II). 
UV-vis (CH3CN; λ in nm [ε in Lmol-1cm-1]: 443 [282], 1H-NMR (CDCl3, δ/ppm): 7.64 
(1H, s, br, NH attached to Cp) 5.15 (1H, d, J = 6.5 Hz, NH of Ala), 4.75 (2H , s, Cp),  
4.65 (1H, s, Cp), 4.56 (1H, s, br, α-H of Ala), 4.40 (2H, s, Cp), 4.22 (1H, s, br, Cp), 
4.05(2H, d, J = 7 Hz, Cp), 3.80 (3H, s, CH3 of ester), 1.49 (9H, s CH3 of Boc) 1.45 (3H, 
d, J = 7 Hz, CH3 of Ala). 13C{1H}-NMR (CDCl3, δ/ppm): 172.2 (C=O of ester), 171.4 
(C=ONH), 156.2( C=ONH of Boc) 95.3 (Fc C attached to carbonyl), 80.7, 72.5, 72.8 , 
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72.3, 71.7, 71.4, 66.8, 66.5, 63.5, 63.2 (different Cs of Cps), 52.0 (CH3 of ester), 51.2 (α-
C of Ala), 81.0 (tertiary C of Boc), 28.2 (CH3 of Boc), 18.3 (CH3 of Ala). 
 
6.6.1.2.3. 1-Boc-L-Alanino-n'-methyl-ferrocene-carboxylic Acid (4): 5 mmol (2.15g) 
2 was dissolved in 200 mL of dioxane. To it was added the solution of 5mmol of sodium 
hydroxide in 10ml of water. It was stirred at 50°C for one hour. Then the solvent was 
removed by rotovaporation and 100 ml of water was added, and washed with 
dichloromethane to remove unreacted ester. The aqueous layer was cooled in ice bath 
and acidified by 2N HCl and the precipitate was extracted by DCM, dried by sodium 
sulfate and evaporated to get, orange red powder, 1.84 g (89%) of 4.    1H-NMR (CDCl3, 
δ/ppm): 7.67 (1H, s, br, NH attached to Cp), 5.29 (1H, d, J = 6 Hz, NH attached to Boc), 
5.21 (1H, s) 4.94 (2H, s) 4.61 (1H, s), 4.50 (3H, s, br, α-H and of 2H Cp), 4.14 (1H, s, 
br, Cp), 4.06 (1H, s, br, Cp) 1.49 (9H, s, CH3 of Boc), 1.45 (3H, d, J = 7 Hz, CH3, of 
Ala).  
 
6.6.1.2.4. 1-Boc-D-Alanino-n'-methyl-ferrocene-carboxylic Acid (5): Same procedure 
like 4 was used. Yield (84%), 1H-NMR (CDCl3, δ/ppm): 7.68 (1H, s, br, NH attached to 
Cp), 5.29(1H, d, J = 6 Hz, NH attached to Boc), 5.22 (1H, s), 4.94 (2H, s) 4.63 (1H, s), 
4.50 (3H, s, br, α-H and of 2H Cp) 4.16 (1H, s, br, Cp), 4.07 (1H, s, br, Cp), 1.49 (9H, s, 
CH3 of Boc), 1.45(3H, d, J = 7 Hz, CH3, of Ala). 
 
6.6.1.2.5. 1-Boc-L-Alanino-ferrocene-n'-L-Alanino-1-ferrocene-n'-methyl-
carboxylate (6): Flash column chromatography by using ethylacetate/hexanes (2/1, Rf = 
0.35) (70%) reddish yellow colored compound 6. HRMS (ES): calc for C26H38N4O6Fe: 
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728.2210; found: 728.2128[M]+. FT-IR (KBr, cm-1): 3340 (br, N-H), 3273 (br, N-H 
hydrogen bonded) 1715 (s, ester C=O) 1686 (s, Amid I), 1662 (s, Amid I), 1639 (s, 
Amid I), 1524 (s, Amid II). UV-vis (CH3CN; λ in nm [ε in M-1cm-1]): 448 [580] 1H-
NMR (CDCl3, δ/ppm) : 9.94 (1H, s, NH of Cp), 9.17 (1H s, NH of another Cp), 8.06 
(1H, d, J = 3 Hz, NH of Ala), 5.47(1H, s, Cp), 5.28(1H, s, NH of other Ala attached to 
Boc) , 4.95 (1H, s, Cp), 4.80 (2H, d, J = 6 Hz , Cp), 4.76 (2H, s, Cp), 4.75 (H, d, J = 6.5 
Hz, α-H of Ala between two Cp), 4.57 (1H, s, Cp), 4.43 (2H, s, Cp), 4.35 (2H, m, Cp), 
4.31(1H, s, α-H of other Ala) 4.11 (1H, s, Cp), 4.02 (2H, d, J = 7.5 Hz, Cp), 3.98 (1H, s, 
Cp), 3.94 (1H, s, Cp), 3.79 (3H, s, ester), 1.56 (3H, d, J = 7 Hz, CH3 of Ala between Fc), 
1.49 (9H, s, CH3  of Boc), 1.45 (3H, d, J = 7.0 Hz, CH3). 13C{1H}-NMR (CDCl3, 
δ/ppm): 174.6, 172.6, 172.3, 171.6, 156.5, 96.5, 95.9, 80.9, 73.2, 73.1, 72.0, 71.5, 71.3, 
70.9, 70.0, 66.9, 66.8, 65.8, 65.7, 64.3, 63.5, 63.1, 52.0, 51.5, 50.5, 30.0, 28.8, 18.4, 
17.9. 
 
6.6.1.2.6. 1-Boc-D-Alanino-ferrocene-n'-D-Alanino-1-ferrocene-n'-methyl-
carboxylate (7): Flash column chromatography by using ethylacetate/hexanes (2/1, Rf = 
0.35) (70%) reddish yellow colored compound 7. HRMS (ES): calc for C26H38N4O6Fe: 
728.2210; found: 728.2181[M]+. ]+. FT-IR (KBr, cm-1): 3360 (br, N-H), 3273 (br, N-H 
hydrogen bonded) 1715 (s, ester C=O) 1681 (s, Amid I), 1658 (s, Amid I), 1639 (s, 
Amid I), 1525 (s, Amid II). UV-vis (CH3CN; λ in nm [ε in M-1cm-1]): 448 [582] 1H-
NMR (CDCl3, δ/ppm) : 9.93 (1H, s, NH of Cp), 9.14 (1H s, NH of another Cp), 8.07 
(1H, d, J = 3.5 Hz, NH of Ala), 5.46(1H, s, Cp), 5.27(1H, s, NH of other Ala attached to 
Boc) , 4.91 (1H, s, Cp), 4.79 (2H, d, J = 6 Hz , Cp), 4.75 (2H, s, Cp), 4.74 (H, d, J = 6.5 
Hz, α-H of Ala between two Cp), 4.56 (1H, s, Cp), 4.43 (2H, s, Cp), 4.35 (2H, m, Cp), 
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4.31(1H, s, α-H of other Ala) 4.10 (1H, s, Cp), 4.00 (2H, d, J = 7.5 Hz, Cp), 3.99 (1H, s, 
Cp), 3.95 (1H, s, Cp), 3.79 (3H, s, ester), 1.56 (3H, d, J = 7 Hz, CH3 of Ala between Fc), 
1.49 (9H, s, CH3  of Boc), 1.45 (3H, d, J = 7.0 Hz, CH3). 13C{1H}-NMR (CDCl3, 
δ/ppm): 175.1, 172.6, 172.3, 171.5, 156.4, 96.5, 95.7, 81.0, 73.2, 73.1, 72.0, 71.5, 71.3, 
70.9, 70.0, 66.9, 66.8, 65.8, 65.7, 64.4, 63.4, 63.0, 52.0, 51.5, 51.7, 30.0, 28.8, 18.0, 
17.8.  
 
 6.6.1.2.7. 1-Boc-L-Alanino-ferrocene-n'-L-Alanino-1-ferrocene-n'-L-Alanino-1-
ferrocene-n'-methyl-carboxylate (8): Flash column chromatography by using 
ethylacetate/hexanes (2/1, Rf = 0.3), (77%) reddish yellow powder. HRMS (ES): calc for 
C26H38N4O6Fe: 1026.2414; found: 1026.2151[M]+. FT-IR (KBr, cm-1): 3324 (b, N-H), 
3274 (b, N-H hydrogen bonded) 1714 (s, ester C=O) 1691 (s, Amid I), 1661(s, Amid I), 
1629 (s, Amid I), 1528 (s, Amid II). UV-vis (CH3CN; λ in nm [ε in M-1cm-1]): 448 [881] 
1H-NMR (CDCl3, δ/ppm) : 10.48 (1H, s, NH of Cp in the middle), 10.20 (1H, s, NH of 
Cp which is attached to Boc Ala), 8.87 (1H, d, J = 7 Hz, amide NH of Ala in the 
middle), 8.76 (1H, s, NH of Cp with methyl ester), 8.11 (1H, d, J = 7 Hz, amide NH of 
Ala),  5.49(1H, s, Cp), 5.45 (1H, s, Cp), 5.16(1H, s, amide NH of Ala attached to Boc),  
4.97 (1H, s, Cp), 4.90 (1H, s, Cp), 4.78(1H, s, Cp), 4.71 (1H m, α-H of Ala), 4.69 (1H, s, 
Cp), 4.50 (2H, s, Cp), 4.37(1H, s, Cp) 4.30 (1H, d, J = 1.8 Hz, α-H of Ala ), 4.24 (1H, s, 
Cp), 4.20 (1H, d,  J = 8.4 Hz, α-H of Ala), 4.13 (1H, s, Cp), 4.08 (1H, s, Cp), 4.04 (1H, 
s, Cp), 3.96 (2H, d, J = 11 Hz, Cp), 3.86 (2H, s, Cp), 3.75 (3H, s, CH3 of ester), 1.55 
(3H, d, J = 7 Hz, CH3 of Ala in the middle), 1.52 (3H, d, J = 7.5 Hz, CH3 of Ala in one 
end), 1.49 (9H, s, CH3 of Ala of Boc), 1.45 (3H, d, J = 7 Hz, CH3 of Ala attached to 
Boc). 13C{1H}-NMR (CDCl3, δ/ppm): 175.3, 174.9, 172.4, 171.7, 171.5, 156.4, 96.7, 
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96.2, 95.4, 80.9, 73.3, 72.7, 71.6, 71.4, 71.4, 70.8, 70.2, 67.1, 66.9, 65.5, 63.9, 63.8, 
63.2,52.1, 51.8, 51.7, 50.8, 28.8, 18.2, 17.8, 16.9   
 
 
6.6.1.2.8. 1-Boc-D-Alanino-ferrocene-n'-D-Alanino-1-ferrocene-n'-D-Alanino-1-
ferrocene-n'-methyl-carboxylate (9): Flash column chromatography by using 
ethylacetate/hexanes (2/1, Rf = 0.3), (77%) reddish yellow powder. HRMS (ES): calc for 
C26H38N4O6Fe: 1026.2414; found: 1026.2177[M]+. FT-IR (KBr, cm-1): 3326 (b, N-H), 
3270 (b, N-H hydrogen bonded), 1712 (s, ester C=O) 1689 (s, Amid I), 1659 (s, Amid 
I), 1629 (s, Amid I), 1529 (s, Amid II). UV-vis (CH3CN; λ in nm [ε in M-1cm-1]): 448 
[890] 1H-NMR (CDCl3, δ/ppm) : 10.46 (1H, s, NH of Cp in the middle), 10.24 (1H, s, 
NH of Cp which is attached to Boc Ala), 8.80 (1H, d, J = 7 Hz, amide NH of Ala in the 
middle), 8.69 (1H, s, NH of Cp with methyl ester), 8.09 (1H, d, J = 7 Hz, amide NH of 
Ala),  5.49(1H, s, Cp), 5.45 (1H, s, Cp), 5.14(1H, s, amide NH of Ala attached to Boc),  
4.96 (1H, s, Cp), 4.91(1H, s, Cp), 4.78(1H, s, Cp), 4.71 (1H m, α-H of Ala), 4.69 (1H, s, 
Cp), 4.51 (2H, s, Cp), 4.35(1H, s, Cp) 4.30 (1H, d, J = 2 Hz, α-H of Ala ), 4.24 (1H, s, 
Cp), 4.20 (1H, d,  J = 8.4 Hz, α-H of Ala), 4.13 (1H, s, Cp), 4.08 (1H, s, Cp), 4.04 (1H, 
s, Cp), 3.96 (2H, d, J = 11 Hz, Cp), 3.86 (2H, s, Cp), 3.75 (3H, s, CH3 of ester), 1.55 
(3H, d, J = 7 Hz, CH3 of Ala in the middle), 1.52 (3H, d, J = 7.5 Hz, CH3 of Ala in one 
end), 1.49 (9H, s, CH3 of Ala of Boc), 1.45 (3H, d, J = 7 Hz, CH3 of Ala attached to 
Boc). 13C{1H}-NMR (CDCl3, δ/ppm): 175.1, 174, 172.5, 171.5, 171.5, 156.4, 96.6, 96.4, 
95.4, 80.7, 73.3, 72.7, 71.6, 71.4, 71.4, 70.8, 70.2, 67.1, 66.9, 65.5, 63.9, 63.8, 63.2,52.1, 
51.9, 51.9, 50.8, 28.7, 18.1, 17.8, 17. 
 
 135
6.6.1.2.9. 1-Boc-L-Alanino-ferrocene-n'-L-Alanino-1-ferrocene-n'-L-Alanino-1-
ferrocene-n'-L-Alanino-1-ferrocene -n'-methyl-carboxylate (10): Flash column 
chromatography by using ethyl acetate/hexanes (3/1, Rf = 0.28) to get  429mg (79%) 
redish orange powder. HRMS (ES): calc for C26H38N4O6Fe: 1324.2527; found: 
1324.2491[M]+. FT-IR (KBr, cm-1): 3324 (b, N-H), 3272 (b, N-H hydrogen bonded) 
1720 (s, ester C=O), 1681 (s, Amid I), 1660 (s, Amid I), 1628 (s, Amid I), 1528 (s, 
Amid II). UV-vis (CH3CN; λ in nm [ε in M-1cm-1]): 448 [1188] 1H-NMR (CDCl3, 
δ/ppm) : 10.78 (1H, s, NH of Cp in the middle), 10.56 (1H, s, amide NH of Cp in the 
middle), 10.24 (1H, s, amide NH of Cp which is attached to Boc Ala), 9.01 (1H, d, J = 
5.5Hz, amide NH of Ala in the middle), 8.90 (1H, s, br, amide NH of Ala in middle), 
8.77 (1H, s, br, amide NH of Cp) 8.24(1H, br, amide NH of Ala in the middle), 5.60 
(2H, s, br, Cp ), 5.56 (2H, s, Cp), 5.20 (1H, s, Cp),, 5.16 (1H, NH attached to Boc), 5.09 
(1H, s, Cp),  5.00(1H, s, Cp), 4.89 (1H, s, Cp),  4.82(1H, d, J = 2.5 Hz, α-H of Ala), 
4.76(1H, m,  α-H of Ala), 4.74(1H, m, α-H of Ala), 4.69 (2H, s, Cp), 4.67 (1H, s, Cp), 
4.53 (2H, s, Cp), 4.49 (2H, s, Cp), 4.46 (1H, s, Cp), 4.37 (2H, s, Cp), 4.35 (1H, s, Cp), 
4.34 (3H, s, br, Cp), 4.32 (3H, s, Cp),   4.29 (1H, m, α-H of Ala), 4.22 (3H, s, Cp), 4.10 
(2H, m,  J = 1.5Hz, Cp), 3.97 (1H, s, Cp), 3.80 (3H, s, CH3 of ester),  1.59 (3H, s, br 
CH3 of Ala), 1.54 (6H, d,  J = 7 Hz, br CH3 of Ala),  1.49 (9H, s, CH3 of Boc), 1.46 (3H, 
d, J = 6.5Hz CH3 of Ala).  13C{1H}-NMR (CDCl3, δ/ppm):, 175.3, 174.9, 172.4, 171.7, 
171.6, 156.3, 96.5, 96.4, 96.3, 95.5, 80.9, 75.6, 75.3, 73.4, 73.2, 72.9, 72.7, 72.2, 72.1, 
71.6, 71.5, 70.9, 70.8, 70.7, 70.3, 70.2, 69.7, 68.6, 68.4, 67.1, 67.0, 66.4, 66.3, 65.8, 
65.5, 64.7, 64.0, 63.8, 63.7, 63.3, 63.2, 52.1, 51.9, 51.8, 51.7, 51.5, 30.2, 29.7, 28.8, 
20.0, 18.2, 17.8, 17.2.  
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6.6.1.2.10. 1-Boc-D-Alanino-ferrocene-n'-D-Alanino-1-ferrocene-n'-D-Alanino-1-
ferrocene-n'-D-Alanino-1-ferrocene -n'-methyl-carboxylate (11): Flash column 
chromatography by using ethylacetate/hexanes (3/1, Rf = 0.28) to get  429mg (79%) 
redish orange powder. HRMS (ES): calc for C26H38N4O6Fe: 1324.2527; found: 
1324.2485[M]+. FT-IR (KBr, cm-1): 3324 (b, N-H), 3270 (b, N-H hydrogen bonded) 
1721 (s, ester C=O) 1680 (s, Amid I), 1658(s, Amid I), 1628 (s, Amid I), 1528 (s, Amid 
II). UV-vis (CH3CN; λ in nm [ε in M-1cm-1]): 448 [1177] 1H-NMR (CDCl3, δ/ppm) : 
10.79 (1H, s, NH of Cp in the middle), 10.52 (1H, s, amide NH of Cp in the middle), 
10.26 (1H, s, amide NH of Cp which is attached to Boc Ala), 9.05 (1H, d, J = 5.5Hz, 
amide NH of Ala in the middle), 8.90 (1H, s, br, amide NH of Ala in middle), 8.76 (1H, 
s, br, amide NH of Cp) 8.25 (1H, br, amide NH of Ala in the middle), 5.65 (2H, s, br, Cp 
), 5.56 (2H, s, Cp), 5.20 (1H, s, Cp),, 5.14 (1H, NH attached to Boc), 5.00 (1H, s, Cp),  
5.00(1H, s, Cp), 4.89 (1H, s, Cp),  4.82(1H, d, J = 3 Hz, α-H of Ala), 4.76(1H, m,  α-H 
of Ala), 4.74(1H, m, α-H of Ala), 4.69 (2H, s, Cp), 4.67 (1H, s, Cp), 4.53 (2H, s, Cp), 
4.49 (2H, s, Cp), 4.46 (1H, s, Cp), 4.37 (2H, s, Cp), 4.35 (1H, s, Cp), 4.34 (3H, s, br, 
Cp), 4.35 (3H, s, Cp),  4.29 (1H, m, α-H of Ala), 4.21 (3H, s, Cp), 4.10 (2H, m,  J = 
1.5Hz, Cp), 3.98 (1H, s, Cp), 3.79 (3H, s, CH3 of ester),  1.60 (3H, s, br CH3 of Ala), 
1.55 (6H, d,  J = 7 Hz, br CH3 of Ala),  1.49 (9H, s, CH3 of Boc), 1.46 (3H, d, J = 7 Hz 
CH3 of Ala).  13C{1H}-NMR (CDCl3, δ/ppm):, 175.2, 174.5, 172.4, 171.7, 171.5, 156.0, 
96.2, 96.0, 96.3, 95.5, 80.8, 75.5, 75.3, 73.4, 73.2, 72.9, 72.6, 72.2, 72.0, 71.5, 71.1, 
70.8, 70.7, 70.3, 70.2, 69.7, 68.6, 68.4, 67.1, 67.0, 66.4, 66.3, 65.8, 65.5, 64.7, 64.0, 
63.8, 63.7, 63.3, 63.2, 52.1, 51.9, 51.9, 51.8, 51.8, 30.2, 29.6, 28.8, 20.1, 18.2, 17.8, 
17.1. 
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6.6.1.2.11. 1-Boc-poly-L-Alanino-ferrocene -n'-methyl ester(12): 41 mg of ferrocene 
1-Boc-L-Alanino-n'-ferrocene-carboxylic Acid (4) alongwith 5% of 1-Boc-L-Alanino-
n'-methyl-ferrocene-carboxylate (2) were mixed with  2ml of 60% TFA solution in 
dichloromethane and stirred for 30 minutes.Then it was dried in rotovap to remove TFA 
completely putting dichoromethane several times. It was dissolved in 100 ml of 
dichloromethane. Making alkaline with 0.5 ml of DIEPA it was placed in ice bath then 
at 0°C 0.1mmol (5eqv.) of BOP was added. After 5 hours 5% of 4 was added and stirred 
for 4 more hours. Then washed successively with NaHCO3, 10% citric acid solution, 
NaHCO3 solution and then by distilled water. DCM layer was dired by sodium sulfate 
and evaporated in rotovap.Then the solid was washed by cold ethyl acetate to get the 
28mg of yellow polymer 12. FT-IR (KBr, cm-1): 3272 (b, N-H hydrogen bonded) 1721 
(s, ester C=O) 1680 (s, Amid I), 1658 (s, Amid I), 1628 (s, Amid I), 1528 (s, Amid II). 
UV-vis (CH3CN; λ in nm [ε in M-1 (monomer)cm-1]): 448 [290] 1H-NMR (CDCl3, 
δ/ppm) : 10.89-10.84 (1H, m, NH of Cp), 9.09-8.90 (1H, m, amide NH of Ala), 5.79-
3.78 (~9H, m, Cp and α-H of Ala), 1.63 (3H, br CH3 of Ala).  
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6.6.3. NMR  Study  
6.5.3.1. Stack plot of  1H-NMR spectra of compounds 2, 6, 8, 10, 12 (L-series). 
 
 
Figure 6.S1. NMR plot of L series monomer (2), dimmer (6), trimer (8), tetramer (10) 
and polymer (12) showing that as the number of repeating unit increases the amide 
proton shifts towards down field indicating their stronger involvement in hydrogen 
bonding. For the case of polymer only one set of amide proton attached to ferrocene and 
one set attached to alanine are found which implies that almost all protons are hydrogen 
bonded and in the same environment. 
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6.6.3.2. ROESY Study of Compounds 6, 8, and 10  (the L-series of foldamers) 
 
Figure 6.S2. Selected region of ROESY  plot of 6, showing the interactions of Fc-NH 
(i) with β-H Ala(i+1),  Ala-NH (i+1) with  α -H of Ala(i) and β -H of Ala(i+1) with α -H 
of Ala(i). 
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Figure 6.S3. Selected region of ROESY  plot of  8, showing the interactions of Fc-NH 
(i) with β-H Ala (i+1), Ala-NH (i+1) with  α -H of Ala (i) and β -H of Ala (i+1) with α -
H of Ala (i). 
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Figure 6.S4. Selected region of ROESY  plot of 10, showing the interactions of Fc-NH 
(i) with β-H Ala (i+1),  Ala-NH (i+1) with  α -H of Ala (i) and β -H of Ala (i+1) with α -
H of Ala (i). 
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6.6.4. CD Spectroscopy: 
CD spectra were recorded using a PiStar-180 spectropolarimeter (from  Applied 
Biophysics) under an argon atmosphere in the CH3CN solution at the concentrations (1.0 
x 10-5 M) with respect to repeating unit. 
 
Figure S5. Normalized plot of variable temperature circular dichroism spectra. 
 
 
 
6.6.5. FT-IR Study 
FT-IR Spectra in the regions of  1500-1800 cm-1(Amide I and Amide II) showing the 
signature for beta sheet peptide for dimmer to polymer and 3000-3300 cm-1 (Amide a) 
showing the involvement of amide NH in H-bonding. 
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Figure 6.S6. FT-IR spectra of monomers (2 and 3) showing the amide-I, amide-II and 
amide-A regions. 
 
 
 
 
Figure 6.S7. FT-IR spectra of dimers (6 and 7) showing the amide-I, amide-II and 
amide-A regions. 
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Figure 6.S8. FT-IR spectra of trimers (8 and 9) showing the amide-I, amide-II and 
amide-A regions. 
 
 
 
 
Figure 6.S9. FT-IR spectra of tetramers (10 and 11) showing the amide-I, amide-II 
and amide-A regions. 
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Figure 6.S10. FT-IR spectra of polymer (12) showing the amide-I, amide-II and amide-
A regions 
 
 
6.6.6. X-ray Crystallography: 
Suitable crystals of compounds 6 ( yellow; 0.14 × 0.11 × 0.09 mm), 7 (reddish yellow; 
0.12 × 0.14 × 0.09 mm) and 8 (yellow; 0.07 × 0.07 × 0.10 mm were obtained by slowly 
diffusing hexanes in the solution in dichloromethane and of 9 (reddish yellow crystal; 
0.08 × 0.09 × 0.09 mm) was obtained by slow evaporation of chloroform from the 
solution. All measurements were made on a Nonius KappaCCD 4-Circle Kappa FR540C 
diffractometer using monochromated Mo Kα radiation (λ = 0.71073 Å) at -100 °C. An 
initial orientation matrix and cell was determined from 10 frames using φscans.[S1-S4] 
Data were measured using ω-scans.[S1] The data were processed using the standard 
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Nonius software.[S4] The structures were solved using direct methods (2: SIR-97; 3: 
SHELXS-97)[S3,S5] and refined by full-matrix least-squares method on F2 with 
SHELXL97-2.[S2]   
Table S1.  Crystal data and structure refinement for compounds 6 - 9. 
Compound 6 7 8 9 
Empirical  
formula 
C35H42Cl2Fe1
N4O7
C35H42Cl2Fe2 
N4O7
C51H61Fe3 
N6O9
C49H55Cl3Fe3 
N6O9
Formula weight  813.33 
 
 
813.33 1069.61 1145.89 
Crystal Color, 
Habit 
yellow-
orange, plate 
 
yellow-orange,  
plate 
orange, plate yellow-orange, 
 plate 
Crystal 
dimensions (mm) 
0.13 × 0.08 × 
0.08  
 
0.12 × 0.12 
 × 0.12  
0.18 × 0.18  
× 0.15 
0.10 × 0.10  
× 0.10  
Crystal system  monoclinic 
 
orthorhombic tetragonal tetragonal 
Space group  P212121  
[No. 19] 
 
P212121  
[No. 19] 
P41212 
 [No. 92] 
P43212 
 [No. 96] 
a (Å)  13.4220(3) 13.376(2) 13.997(5) 14.0740(2) 
b (Å)  16.7930(4) 16.7560(15) 13.997(5) 14.0740(2) 
c (Å)  16.7920(3) 16.7840(11) 52.108(5) 51.9910(9) 
α (°) 90 90 90 90 
β (°) 90 90 90 90 
γ (°) 90 90 90 90 
V (Å3) 3784.84(14) 3761.8(7) 10209(5) 10298.2(3) 
Zb 4 4 8 8 
F(000) 1688 1688 4472 4736 
Density (ρcalcd) 1.427 Mg/m3 1.436 Mg/m3 1.392 Mg/m3 1.478  
Mg/m3
Absorption 
coefficient (µ) 
0.959 mm-1 
(= 9.59 cm-1) 
0.965 mm-1 
 (= 9.65 cm-1) 
0.902 mm-1  
(= 9.02 cm-1) 
1.050 mm-1  
(= 10.50 cm-1) 
 
The non-hydrogen atoms were refined anisotropically. Hydrogen atoms were included at 
geometrically idealized positions (C-H bond distances 0.95/0.99 Å; N-H bond distances 
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0.88 Å) and were not refined. The isotropic thermal parameters of the hydrogen atoms 
were fixed at 1.2 times that of the preceding carbon or nitrogen atom. 
 
Table 6.S2. Data collection and refinement conditions for compounds 6-9. 
 
 
Compound 
 
     6 
 
  7 
 
    8 
 
     9 
 
Theta range for data 
collection 
 
3.27 to 27.49° 
 
3.90 to 
24.71° 
 
2.14 to 21.95° 
 
1.50 to 24.72° 
Completeness to 
theta = 27.49° 
99.5% 98.1%  99.4% 97.5%  
Reflections collectedd 15746 6024 11895 16805 
Independent 
reflections  
[Fo2 ≥ -3σ(Fo2)]e
8639 [Rint = 
0.0287]f
6024 [Rint = 
0.0000]f
6191 [Rint = 
0.0427]f
8627 [Rint = 
0.1072]f
Observed reflections 
[Fo2 > 2σ(Fo2)]g
7741 5179 4915 5268 
Reflection 
(observed)/parameter 
ratio 
17:1 12:1 8:1 9:1 
Reflection 
(data)/parameter ratio 
19:1 14:1 10:1 14:1 
Goodness-of-fit on F2 1.047 1.140 1.048 1.028 
R1   0.0361 0.0871 0.0505 0.0725 
wR2  0.0845 0.1932 0.1210 0.1558  
Max. Shift/Error in 
Final Cycle 
0.001 0.000 0.000 0.001 
Largest difference 
peak and hole 
0.351 and -
0.590 e-/Å3  
0.925 and -
0.527 e-/Å3  
0.422 and -
0.244 e-/Å3  
0.818 and -0.688 
e-/Å3 
 
 
All data were collected in Nonius KappaCCD difractometer, using Graphite-
monochromated Mo Kα radiation of wave length 0.71073 Å at -100(2) °C. R1= [Σ||Fo|-
|Fc||]/[Σ|Fo|] for [Fo2 > 2σ(Fo2)]i wR2 = {[Σw(Fo2-Fc2)2]/[Σw(Fo2)2]}1/2 [all data] GooF = 
{Σ[w(Fo2-Fc2)2]/(n - p)}1/2 , n: number of reflections, p: number of parameters 
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Table 6.S3.  Intra and intermolecular N(H)···O=C contacts [Å] of 6. 
  
rvdW(N) + rvdW (O) = (1.55 + 1.50) [Å] = 3.05 [Å]  
 
Intramolecular contacts: 
N(21)(H) ····O(12)=C  2.990(3) 
N(11)(H) ····O(22)=C  2.819(3) 
 
Intermolecular contacts: 
N(22)(H)····O(11)*=C  2.881(3) 
N(12)*(H)····O(21)=C  2.930(3) 
N(12)(H)····O(11)**=C 2.930(3) 
N(22)** ····(H)O(11)=C 2.881(3) 
  
Symmetry transformations used to generate equivalent atoms: 
  
*: -x + ½, -y + 2, z - ½ 
**: -x + ½, -y + 2, z + ½ 
 
 
Table 6.S4. Intra and intermolecular N(H)···O=C contacts [Å] of  7. 
  
rvdW(N) + rvdW (O) = (1.55 + 1.50) [Å] = 3.05 [Å]  
  
Intramolecular contacts: 
N(21)(H)····O(12)=C  2.98(1) 
N(11)(H)····O(22)=C  2.824(9) 
 
Intermolecular contacts: 
N(12)(H)····O(21)*=C  2.93(1) 
N(22)*(H)····O(11)=C  2.87(1) 
N(22)(H)····O(11)**=C 2.87(1) 
N(12)**(H)····O(21)=C 2.93(1) 
  
Symmetry transformations used to generate equivalent atoms:  
 
*: -x + ½, -y + 1, z - ½ 
**: -x + ½, -y + 1, z + ½ 
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Table 6.S5. Intra and intermolecular N(H)···O=C contacts [Å] for 8. 
 
rvdW(N) + rvdW (O) = (1.55 + 1.50) [Å] = 3.05 [Å] 
  
Intramolecular contacts: 
N(11)(H)····O(22)=C  2.931(6) 
N(21)(H)····O(12)=C  2.977(6) 
N(41)(H)····O(21)=C  2.971(6) 
N(22)(H)····O(42)=C  2.943(6) 
 
Intermolecular contacts: 
N(42)*(H)····O(11)=C  2.854(7) 
N(12)(H)····O(41)*=C  2.882(7) 
N(12)′(H)····O(41)=C  2.882(7) 
N(42)(H)····O(11)′=C  2.854(7) 
  
Symmetry transformations used to generate equivalent atoms:  
 
*:  y - ½, -x + 1.5, z - ¼ 
′: -y + 1.5, x + ½, z + ¼ 
 
 
Table 6.S6. Intra and intermolecular N(H)···O=C contacts [Å] of 9.  
 
rvdW(N) + rvdW (O) = (1.55 + 1.50) [Å] = 3.05 [Å] 
 
Intramolecular contacts: 
N(11)(H)····O(22)=C  2.929(8) 
N(21)(H)····O(12)=C  2.967(8) 
N(41)(H)····O(21)=C  2.957(8) 
N(22)(H)····O(42)=C  2.995(8) 
 
Intermolecular contacts: 
N(42)*(H)····O(11)=C  2.885(8) 
N(12)(H)····O(41)*=C  2.883(8) 
N(12)′(H)····O(41)=C  2.883(8) 
N(42)(H)····O(11)′=C  2.885(8) 
  
Symmetry transformations used to generate equivalent atoms: 
  
*:  y + ½, -x + ½, z + ¼ 
′: -y + ½,  x - ½, z - ¼ 
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Table 6.S7. Dihedral angles of the selected peptide bonds. 
 
Dihedral angles of 6 for the amide portions 
 
1 C18 N12 C16 C15 -72.38 
2 N12 C16 C15 N11 146.93 
3 C25 N21 C26 C28 -79.98 
4 N21 C26 C28 N22 155.41 
 
Dihedral angles of 7 for the amide portions 
 
1 C18 N12 C16 C15 70.49 
2 N12 C16 C15 N11 -145.49 
3 C25 N21 C26 C28 82.90 
4 N21 C26 C28 N22 -155.43 
 
Dihedral angles of 8 for the amide portions 
 
1 C18 N12 C16 C15 -68.46 
2 N12 C16 C15 N11 138.38 
3 C25 N21 C26 C28 -68.25 
4 N21 C26 C28 N22 145.73 
5 C45 N41 C46 C48 -74.96 
6 N41 C46 C48 N42 143.64 
 
Dihedral angles of 9 for the amide portions 
 
1 C18 N12 C16 C15 67.70 
2 N12 C16 C15 N11 -137.16 
3 C25 N21 C26 C28 68.02 
4 N21 C26 C28 N22 -147.13 
5 C45 N41 C46 C48 74.39 
6 N41 C46 C48 N42 -142.25 
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6.5.6.1. ORTEP diagrams and intermolecular arrangements of 6-9 in crystal: 
(a) (b) 
 
Figure 6.S11. Plot of 6 showing (a) ORTEP diagram and (b) the formation of 
supramolecular helical strand. 
 
 
(a) 
 
(b) 
Figure 6.S12. Plot of 7 showing (a) ORTEP diagram and (b) the formation of 
supramolecular helical strand. 
 
 
 
 
 152
(a) (b) 
Figure 6.S13. Plot of 8 showing (a) ORTEP diagram and (b) the formation of 
supramolecular helical strand. 
 
(a) 
 
(b) 
Figure 6.S14. Plot of 9 showing (a) ORTEP diagram and the formation of 
supramolecular helical strand. 
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Figure 6.S15. Crystal structures of L-series dimer 6 and trimer 8 are mirror images of 
corresponding D-series dimer 7 and trimer 9. 
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Chapter 7 
General Discussion and Conclusion 
 
In my work, I have exploited various 1,n'-disubstituted ferrocene derivatives 
(Fc[COOH]2, Fc[NH2]2 and Fc[NH2][COOH]) for the preparation of peptide conjugates. 
The purpose of this work was to explore the use of the organometallic group as a 
scaffold for stabilizing β-sheets, a ubiquitous secondary structural element found in 
proteins. While there are a number of approaches available, as described in Chapter 1, 
the approach detailed in Chapters 2 – 6, is highly versatile and enabled me to prepare not 
only simple models for β-sheets, but also the first synthetic model for a β-barrel-like 
structure and even parallel β-helices. In my work, I have provided a series of design 
examples, which illustrate the versatility of the ferrocene scaffold for designing some 
challenging secondary and even tertiary structural motifs.  
As was shown in the introduction to my thesis, peptide conjugates of 1,1'-
Ferrocenedicarboxylic acid have been found to arrange in an interesting β-sheet like 
structure, forming a 10-member intramolecular H-bonding. However, in these 
conjugates, the carboxyl ends of the amino acids point away form each other. [1-6] As a 
result, the second amino acid attached to it, does not form any intramolecular inter-
strand H-bonds. Therefore, this simplistic approach appears not to be very promising for 
the design of extended β-sheets. In Chapter 2, I have introduced the concept of 
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cyclization, in order to restrict the flexibility of the podant peptide chains, forcing them 
into a specific conformation that facilitates their interaction by H-bonding. A series of 
pseudocyclopeptides of general formula Fc[AA-CSA]2 were prepared. It is observed that 
they adopted β-sheet like 10-membered intramolecular H-bonded ring and arrange 
themselves in 1,2'-conformation akin to that found in the non-cyclic analogues. 1H-NMR 
in chloroform showed that the NHs originated from the conjugated amino acids were 
involved in intramolecular hydrogen bonding, where as the NHs of cysteamine formed 
intermolecular hydrogen bonds. FTIR spectroscopy also revealed the presence of strong 
H-bonding. From the crystal structure of Fc[CO-Gly-CSA]2 described in Chapter 2, it 
was observed that the intramolecular H-bonding distances (d N-O = ~2.832Å) were 
shorter than the corresponding acyclic analogue, Fc[CO-Gly-NH2]2 (d N-O = ~2.884 Å), 
prepared earlier by Erker.[7] This indicated the presence of a strong interstrand attraction 
and provided structural rigidity, which is maintained in solution. Variable temperature 
1H-NMR experiment showed that the resonances of NHs involved in the intramolecular 
H-bonding, did not change with the increase in temperature. This result proved that the 
cyclization through the carboxyl ends was a promising strategy to control the alignment 
of the ends, without disturbing the β-sheet forming characteristics. 
The concept of cyclization was developed further in Chapter 3 for the purpose of 
designing a new structural motif based on a β-sheet-like structure. Intramolecular β-
sheet-like H-bonding pattern has been successfully extended, which allowed me to 
prepare the first model of a β-barrel structure. From the rigidity of the system and an 
inward twisting in peptide strands, it was hypothized that if the proper sequence of 
amino acids was attached next to the Fc group, in the cyclic systems, it would be 
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possible to extend the β-strand characteristics and develop an interface that enables 
intermolecular H-bonding interactions. In addition, the Fc scaffold in such cyclopeptide 
conjuguates provides sufficient flexibility for the peptide strands to rotate out of the Cp 
plane allowing the conjugates to associate into hollow pore-like structures. This is an 
entirely new concept and further demonstrates the utility of the Fc scaffold. 
This hypothesis has been tested in Chapter 3 by designing two 
pseudocyclopeptides, Fc[Gly-Val-CSA]2 and Fc[Gly-Ile-CSA]2. From X-ray crystal 
structure it was observed that the amino acids in the backbone maintained β-strand 
characteristics. They arranged themselves in parallel and anti-parallel fashions through 
intra- and intermolecular H-bonding, forming a barrel like structure with an internal 
diameter of 8 Å. To the best of our knowledge, this is the only example of “a synthetic 
β-barrel”, although this secondary structural domain has been ubiquitous and known for 
a long time in biological systems. The inside of the barrel is filled with water as 
evidenced from NMR and crystal structure studies.  
 In addition to cyclization, I have discovered that it is also possible to form 
acyclic Fc-conjuguates, which have the podant peptide chains arranged in a β-sheet-like 
fashion. For this approach to work, it is necessary to have glycine as the proximal amino 
acid. Gly provides sufficient flexibility. Furthermore, my studies indicate that it is 
necessary to pay particular attention to the amino acid sequence for this strategy to 
succeed. Taking this into consideration, the two tripeptide conjugates Fc[CO-Gly-Val-
Cys(Bz)-OMe] and Fc[CO-Gly-Ile-Cys(Bz)-OMe] were prepared as described in 
Chapter 4. After the Fc-proximal Gly, the β-strand forming amino acids, Val and Ile 
were chosen. The CD spectral study showed P-helical conformation in the Fc region, as 
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expected for the L-amino acid conjugates. A negative absorbance at 215 nm proved the 
formation β-sheet conformation of the peptide strands. NMR study indicated that the 
NHs of Gly and Cys formed intramolecular hydrogen bond, where as the Val NH 
formed intermolecular hydrogen bonding, which was expected for the proposed 
extended β-sheet conformation. IR spectra showed two absorbance peaks in the amide-I 
region (at around 1630 cm-1 and 1680 cm-1), which was the indication of the presence of 
β-strand conformation. Finally, the X-ray crystal structures of both the compounds were 
found to coincide well with the proposed structures. Thus, in the acyclic systems, we 
were also able to achieve the extended β-sheet like conformation. In light of earlier 
reports by Hirao, my results described in Chapter 4 are very surprising and indicate that 
it is possible to prepare acylic Fc-peptide conjugates in which the podant peptide chains 
adopt a β-sheet-like structure.  
In my work, I also used a the ferrocene diamine derivative Fc[NH-Boc]2, which 
is suitable for making Fc-peptide conjugates by amide bond formation. So far, the amino 
acid of 1,1'-Fc dicarboxylic acid and 1-amino-1'-Fc carboxylic acid have been exploited 
for the formation of peptide conjugates. As shown in the introduction, 1,1'-Fc 
dicarboxylic acid was found to form anti-parallel β-sheet-like 10-membered hydrogen 
bonded rings, whereas 1-amino-1'-Fc carboxylic acid forms parallel β-sheet-like 12-
membered hydrogen bonded rings.  This indicates that amino acid conjugates of 1,1'-
diaminoferrocene may align the peptide strands in an anti-parallel β-sheet. Motivated by 
this hypothesis, I set out to prepare such conjugates. But the chemical instability of the 
necessary intermediate, 1,1'-diaminoferrocene, created a hurdle. This obstacle was 
overcome by synthesizing a very stable derivative Fc[NH-Boc]2, which was compatible 
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with common peptide synthesis protocols. By exploiting this derivative, the conjugates 
with D- and L-alanine were successfully prepared. CD spectroscopic studies 
demonstrated the formation P-helical structure for the L-alanine conjugates and M-
helical alignment for the D, similar to the fact as observed in the conjugates of 1,1'-
ferrocnedicarboxylic acid and 1-amino-1'-ferrocenecarboxylic acid. NMR spectral 
studies showed that the NHs of Fc formed intra-molecular hydrogen bonding as 
expected for the proposed structure. X-ray crystal structure study clearly showed the 
formation of well organized structure through the formation of anti-parallel β-sheet-like 
14-member hydrogen bonded ring. They arranged in a helical fashion assuming 
respectively 1,2'- and 1,5'-conformation. Therefore, we suggest that this is a novel 
method for controlling the peptide structure. 
In my work, I have also demonstrated a unique methodology for preparing a 
model system for β-helical peptides. In Chapter 6, I have described the first de novo  
model for this secondary structural motif, which is present in the tail-spike of several 
bacteriophages and which plays an important role in the transfer of genetic information 
from the phage to the bacteria. Once more, the scaffolding behavior of Fc was exploited 
demonstrating its versatility. It is well known that peptide conjugates of disubstituted 
ferrocenes are capable of providing both β-sheet motif and helical arrangement to the 
attached amino acids.[1,5,6] In our attempt, we exploited both of these characteristics in an 
extended form. Using 1-amino-1'-ferrocenecarboxylic acid as a helical turning motif, a 
series peptide conjugates were prepared, using alternating sequence of Fc amino acid 
and alanine amino acids. In solution, NMR and CD spectral studies indicated the 
formation of proposed β-helical conformation. FTIR spectroscopic study in solid-state 
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showed the signature of β-sheet conformation and the involvement of the amide proton 
with strong hydrogen bonding. The strength of the H-bonding within the molecules was 
found to increase incrementally with increasing length of the Fc-conjugate. X-ray crystal 
structure studies on a series of models demonstrate the presence of 12-membered H-
bonded rings as would be expected in a parallel β-sheet-like structure, which extends 
throughout the length of the conjugates and is even propagated on the supramolecular 
level providing a continuous β-helical structure.  
In conclusion, I have achieved my objectives described in section 1.5 in Chapter 
1 and succeeded in developing the general strategies that allowed me to prepare the 
models of β-sheets and structures that contain this important secondary structural 
element. Specifically, I prepared models for β-barrels and β-helices applying the 
ferrocene group as an integral design element. It is hoped that the methodology 
developed in this thesis will be useful for preparing other challenging structural models 
which will be useful in biological and materials sciences and also will find application in 
de novo protein design.  
In addition, the importance of this work is that it provides access to a range of 
structural motifs that can be investigated separately and in isolation of a protein for their 
individual stability to solvents, pH, temperature, and other effects. In essence it will be 
possible to carry out comparative studies of the relative stabilities of various β-sheet-like 
models and draw conclusions that will be of relevance to β-sheets and to various other 
structural motifs present in proteins. Therefore, these systems may provide a route, in 
the future, to address the protein folding problem using well-defined model systems. 
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